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Investigating the role of hydrogen sulfide in the myometrium 
Hayley Robinson 
Abstract 
Preterm births are increasing worldwide; currently 7 % of UK births are preterm. 
Prematurity is the principal cause of neonatal mortality and a major cause of 
paediatric morbidity. Uterine contractility before term leads to pre-term labour. 
Therefore to reduce pre-term delivery, new pathways and drugs that inhibit uterine 
contractility are of interest. The gasotransmitter H2S has been shown to inhibit 
myometrial contractility without much mechanistic insight and thus is of potential 
interest. Hydrogen sulfide (H2S) is produced in vivo from L-cysteine, by cystathionine β-
synthase (CBS) and cystathionine γ-lyase (CSE). At least two enzymes degrade H2S; 
thiosulfate sulphur transferase (TST) and ethylmalonic encephalopathy 1 (Ethe1).  
Thus H2S will be regulated within cells. NaHS, which releases a rapid bolus of H2S, 
reduces myometrial contractility. However it is not clear if an H2S-generating system is 
present throughout gestation or if more physiological modes of H2S production can 
affect contractility. Previous studies used NaHS as a H2S producer, which is toxic and 
releases H2S as a non-physiological bolus and thus alternative H2S donors suitable for 
drug development are sought. A new H2S generating compound, GYY4137, developed 
to slowly release H2S which better reflects physiological conditions, appears to be such 
a drug.  
The aims of this work were to: (1) characterise the non-pregnant human myometrial 
tissue to determine the inherent spontaneous activity, to monitor whether the 
contractions were stable enough to assess H2S effects when compared to the term 
human myometrium.  In addition, to monitoring changes in contractility in response 
to age, menopausal state and whether the women have endometriosis, (2) examine 
throughout gestation, the effects of GYY4137 on rat myometrial contractility, (3) 
investigate the differences in response to GYY4137 in non- pregnant versus pregnant 
human myometrium (4) compare GYY4137 effects to those of NaHS and L-cysteine in 
rat and human tissues, (5) elucidate the mechanism of H2S effects, and (6) determine 
the myometrial expression of enzymes governing tissue H2S levels.  
Non-pregnant human myometrium gave rise to stable spontaneous contractions. 
The older women become the lower the amplitude and area under the curve of 
contractions. High K+ depolarisations were also diminished with advanced age. As 
women reach post menopause contractions are found to decline when compared to  
pre-menopausal women. Women with endometriosis showed decreased amplitude 
with increased frequency of contractions when compared to their fertile, healthy 
counterparts. This finding suggested a potential involvement of altered myometrial 
activity in women suffering this condition. 
NaHS, L-cysteine and GYY produce uterine relaxation in a dose-dependent manner 
using rat and human tissues. NaHS and GYY4137 effects increased throughout 
gestation using rat myometrial tissue, possibly due to changes in H2S removal rates. 
TST, a H2S breakdown enzyme was not detectable in different gestation rat as well as 
in non- pregnant and term pregnant human myometrial tissue, implying no 
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involvement.. Labouring rat myometrium however was not affected by either H2S 
producer. These data suggest that H2S contributes to uterine quiescence until labour 
onset. Term human myometrial contractions, both spontaneous and oxytocin-
stimulated produced similar inhibitory responses to H2S producers NaHS and 
GYY4137. Non-pregnant spontaneous human contractions were unaffected on 
application of H2S producers. GYY4137 and L-cysteine decreased Ca transients, 
suggesting it affects L-type Ca channels, perhaps via sulfhydration of residues. These 
data were further supported upon use of BayK 8644 a calcium channel opener 
showing reduced effects of L-cysteine. KATP channels were also shown to be involved 
in the mechanism of H2S in the myometrium as use of KATP channel blocker 
glibenclamide caused reduced effects of the H2S producer GYY4137. These data 
suggest that H2S is an attractive target for therapeutic manipulation of human 
myometrial contractility and drugs such as GYY4137 will be effective. Both CBS and CSE 
are present in all the tissues tested in this thesis. It was also demonstrated that these 
enzymes were down regulated at term perhaps showing a role in preparing the 
myometrium for the onset of labour as the enzymes have been shown to further 
decline in labouring tissues. 
In conclusion, the work I have undertaken in this thesis strengthens the evidence of a 
physiologically important role for H2S in the myometrium and suggests it targets ion 
channels to affect calcium signalling and thus contractions.   
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Chapter 1 - Introduction 
1.1The Uterus 
1.1.1 Anatomy of the Uterus 
Human Uterus 
The uterus is a hollow, pear-shaped organ with thick muscular walls. It is situated 
between the rectum and the bladder. The uterus is separated into several regions 
and for descriptive purposes; it is divided into the fundus, body and cervix (Figure 
1.1). The upper area of the uterus is the fundus. The fundus is a broad curved region 
which leads into the uterine tubes, or fallopian tubes terminating at the ovaries. 
Below the fundus is the body of the uterus, triangular in shape. Moving downwards 
to the lower, narrow part of the uterus called the cervix.   
 
The human uterus is a single chambered simplex structure arranged to usually 
support singleton pregnancies (Figure 1.1). The layers of the uterine wall include the 
myometrium, endometrium, and perimetrium. The myometrium is located between 
the endometrium (the inner layer of the uterine wall) and the perimetrium (the 
outer uterine layer).  
The myometrium is the layer under investigation within this thesis and is the middle 
layer of the uterine wall. The myometrium is the spontaneously active smooth 
muscle layer and consists predominately of poorly defined muscle fibre bundles 
arranged in circular (inner layer), longitudinal (outer layer) and diagonal orientation, 
held together by connective tissue. In portions of the human uterus however the 
arrangement of fibres is much more dispersed as the layers of muscle bundles are 
spread transversely, obliquely and longitudinally (Ramsey 1994). This layer accounts 
for the increase in uterine size during pregnancy and is responsible for the powerful 
contractions resulting in the expulsion of the placenta and the foetus during labour. 
The endometrium is an internal mucous membrane lining which is adhered closely to 
underlying tissue throughout the uterine cavity and is non-excitable. During the 
menstrual cycle the endometrium grows to a thick, blood vessel-rich, glandular 
tissue layer to allow for successful implantation of the fertilised ovum. If this occurs 
the endometrium at site of implantation will then adapt to form part of the placenta. 
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If no embryo is implanted the endometrium will shed during menstruation. Changes 
within the endometrium are controlled by ovarian hormones, which lead to these 
distinctive alterations of the endometrium throughout menstruation.  
The outermost layer of the uterus is the perimetrium, also called the serosa. It is part 
of the peritoneal epithelium and is a thin layer which covers the entire uterus. It is 
not known currently to influence the pharmacology of uterine contraction. 
 
Rat Uterus 
Uteri between species have different morphological characteristics which are related 
to function. In rats and other types of rodents the uterus is duplex and consists of 
two horns which meet at the uterine body above the cervix. This duplex uterus 
happily accommodates multiple embryos during pregnancy. However the cross 
sectional morphology of the rat uterus is similar to that of humans. This is separated 
into the same three distinct layers, the endometrium, the myometrium and the 
perimetrium. The rat uterus also consists predominately of poorly defined muscle 
fibre bundles arranged with an outer layer of longitudinal smooth muscle and an 
inner layer of circular muscle (Figure 1.2). 
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Figure 1.1 Anatomy of the human uterus. Adapted from the National Uterine Fibroids 
Foundation Website.  
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Figure 1.2 Anatomy of the rat uterus 
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1.1.2 Uterine Myocytes 
The most dominant cell type within the uterus are smooth muscle cells of the 
myometrium (Young 2007). They are spindle- shaped cells with tapering ends and a 
single, oval-shaped nucleus located centrally. The smooth muscle cells range from 5-
10μm diameter and 30-40 μm long in the non-pregnant uterus. The cells length 
varies between 300μm to 600μm during pregnancy (Broderick and Broderick 1990).   
The generation of contractions is brought about by the interaction of actin and 
myosin within the myocytes. In relaxed muscle, the myosin cross bridges are 
detached from actin filaments. During contraction, they attach and provide the 
contractile force. The contractile machinery (myofilaments, intermediate filaments 
and dense bodies) occupy 80-90% of the total myometrial cell volume. However the 
cells also contain nuclei, mitochondria, Golgi bodies and a calcium store called the 
sarcoplasmic reticulum (Broderick and Broderick 1990).  
Myocytes are excitable cells, producing co-ordinated contractions by acting as a 
syncytium (Wray 1993). This is achieved through cell to cell communication via gap 
junctions (Wray 1993).  Gap junctions are specialised regions of the membrane that 
permit the rapid spread of electrophysiological activity. In humans and other 
mammals, gap junctions are scarce in the myometrium of the non-pregnant uterus 
(Kilarski 1998). Throughout pregnancy the number of gap junctions is low; they have 
poor coupling abilities and decreased electrical conductance results, favouring 
quiescence of the myometrium and maintenance of pregnancy. The number of gap 
junctions increases close to term to enable the rapid spread of electrophysiological 
activity between myocytes to produce co-ordinated contractions to give birth 
(Garfield et al 1978, Tabb 1992). The presence of gap junctions is thought to be 
regulated by the changing of oestrogens and progesterone levels in the uterus 
(Garfield 1998). 
The plasma membrane of the uterine myocyte contains specialised regions called 
caveolae. Caveolae are omega shaped invaginations of the surface membrane. 
Within smooth muscle including the myometrium, a high density of caveolae are 
present, increasing the surface area of the membrane (Noble and Wray 2008). 
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Uterine caveolae have been indicated in a number of signalling pathways and have 
been shown in the uterus to have an effect on calcium signalling and contractility 
(Lee et al, 2001, Kendrick 2004; Smith, Babiychuk et al. 2005). 
 
1.2 Myometrial cell excitability 
1.2.1 Overview 
The myometrium is a phasic smooth muscle that exhibits spontaneous and agonist 
induced contractions. The excitability of a tissue is governed, in part, by the resting 
potential. Several ions determine the resting membrane potential of myocytes 
allowing successful action potential generation; these include Na+, K+, Cl-, and most 
importantly Ca2+, the driving force for contractions in the uterus. Influx of calcium is 
driven by spontaneous changes in membrane potential (Wray 1993).  Although many 
factors are involved in the production of contractions in the myometrium, the 
primary mechanism underlying phasic activity are those that allow spontaneous 
depolarisation of the myometrial cell membrane to occur. 
 
1.2.2 Resting membrane potential and ion channel activation 
Membrane potential is controlled by the distribution of ions across the plasma 
membrane. This ionic distribution facilitates contraction in myocytes. The ionic 
gradient within uterine smooth muscle is maintained such that the internal 
potassium ion content is high, and calcium content is low (Kao 1989). This allows for 
a quick response when small changes in permeability result in significant movement 
of ions. The resting membrane potential in the myometrium is estimated to range 
between -80 and -35mV (Kumar and Barnes 1961, Pressman 1988, Inoue 1990) but is 
dependent upon the species and the gestational status of the uterus (Parkington 
1999). The majority of the work performed on membrane potential in the 
myometrium comes from Parkington and Coleman (Parkington & Coleman 2001). 
Contraction and relaxation of the myometrium occurs through the recurring 
depolarisation and repolarisation of the smooth muscle cell in the form of action 
potentials (Marshell 1962, Kao 1989). Upon depolarisation an influx of Ca2+ occurs as 
well as Na+. Repolarisation is caused by an outward flow of potassium ions. (Figure 
1.3) 
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Depolarisation of the surface membrane is slow and has been associated with 
pacemaker cell activity; however the presence of any pacemaker cells in the 
myometrium remains to be elucidated (Shmygol, Noble et al. 2007). Cells known as 
ICC – interstitial cells of Cajal have been located in other smooth muscles such as 
urinary bladder and gastrointestinal smooth muscle, and play a pacemaker role 
(Sanders 2000; Sergeant 2000; Sui, Wu 2004) ICC-like cells have been found in the 
myometrium (Duquette, Shmygol et al. 2005) but it remains unclear whether they 
play a pace making role.  
Ion channels are discrete membrane-spanning proteins that enable the selective 
transfer of ions across the impermeable, hydrophobic plasma membrane. The 
opening and closing of channels allows differences in ionic concentrations to be 
made and maintained, discriminating between different ions and enabling or 
excluding their passage on the basis of their charge and size.  These ion channels are 
usually selectively permeable to only one ion or one type of ion and are generally 
named after the ion to which they allow passage e.g. Ca2+ channels, K+ channels. Ion 
channels open by specific changes in their local environment and can involve 
alterations in membrane potential/ voltage or binding of a specific agonist (Kim et al 
2002). The main determinant to the change in transmembrane ion distribution is the 
expression of ion channels. However, electrochemical gradients also influence the 
total ion current. A larger electrochemical gradient for a given ion, gives a larger 
driving force and therefore a greater change in concentration per open channel. 
Differences in cell membrane potential and thus changes in the gating of specific ion 
channels has dramatic consequences for the myometrial cell, in particularly this 
includes changes in the open probability and conductance of calcium and potassium 
channels. Upon membrane depolarisation, voltage-gated calcium channels open 
with a threshold for activation at -60 to -30mV and maximum current flow occurring 
at -30 to +10mV (Jmari 1986, Amedee 1987, Triggle 1998, Perez-Reyes 2003). 
Following the opening of these channels, an influx of calcium occurs. Calcium entry 
into the cell is the major component of the action potential upstroke and further 
potentiates plasma membrane depolarisation and increases the open probability of 
these channels (Wray 1993, Shmigol 1998, Wray 2003). Voltage-sensitive K+ 
channels, at a more positive membrane potential, increases its opening probability. 
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Opening allows the efflux of potassium ions, responsible for the downstroke of the 
action potential and cell membrane repolarisation (Wray 1993, Wray 2003). 
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Figure 1.3 Membrane potential, action potential and contraction (adapted from 
(Garfield 1994). A rise in intracellular calcium (from 10-7 M to 10 -5 M) initiates 
movements of ions down their electrochemical gradients. 
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1.2.3 Voltage-gated calcium channels 
Voltage gated calcium channels (VOCC) are divided into three main groups Cav1 (L-
type), Cav2, (P-type, N-type and R-type) and Cav3 (T-type) (Lipscombe, Helton et al. 
2004). Two types of VOCC have been identified in the myometrium; L-type and T-
type channels (Young 1993, Wray 2003, Lee 2009). They have a complex structure 
which is composed of four subunits. There is the pore forming subunit α, and three 
regulatory subunits β, γ, and α2/δ (Collins, Moore et al. 2000). The α subunit has 
been shown to be the subunit that forms the ion conducting pore and to carry the 
characteristic pharmacological and functional properties of the Ca2+ channel for 
voltage sensing, ion permeability and drug binding whilst the others are classed as 
auxiliary subunits. Complete receptor function however requires the presence of all 
subunits and co-expression of the different β subunit isoforms with the same α 
subunit can result in trafficking of the channel to different membrane compartments 
within the cell. The extracellular α2 domain provides the structural support required 
for channel stimulation and is attached to the membrane through the membrane 
spanning δ subunit. The δ subunit influences voltage-dependent activation and 
steady-state inactivation and modulates the inactivation kinetics. 
T-Type calcium channels comprise of three major α subunits - Cav3.1, Cav3.2, and 
Cav3.3 (Blanks, Zhao et al. 2007). T-type calcium currents have been recorded in 
human myometrium (Young, Smith et al. 1993; Young and Zhang 2005). These 
currents are low voltage activated transients and have been implicated in initiation 
of action potentials in uterine smooth muscle (Young and Zhang 2005) as well as the 
generation and modulation of the frequency of spontaneous Ca2+ transients (Lee 
2009). 
The main VOCC in the uterus are L-type calcium channels and are crucial for 
excitation-contraction coupling (Lipscombe, Helton et al. 2004). L-type calcium 
channels produce high voltage activated long lasting currents that flow through the 
primary calcium entry route Cav1.2 calcium channels, and account for the majority of 
the calcium current measured in the myometrium (Shmygol, Blanks et al. 2007). 
Calcium entry through L-type VOCC relies on membrane depolarisation, and is a key 
step for smooth muscle contraction. L-type calcium channels have been found to be 
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under hormonal control and alter during gestation suggesting a role in parturition 
(Young, Smith et al. 1993; Collins, Moore et al. 2000). 
 
1.2.4 Potassium channels 
The main function of potassium channels is to dampen cellular excitability by 
maintaining the cell membrane potential close to the reversal potential of K+ ions 
(around -84mV).  At this negative potential depolarisation is opposed by an outward 
K+ current, which causes hyperpolarization or repolarization thereby terminating or 
rendering action potential generation and ultimately making contraction less 
probable (Khan 2001). 
 
Calcium activated K+ channels 
There are three subclasses of calcium-activated K+ channels, the large conductance 
channel (BKCa), the intermediate (IKCa) and the small (SKCa) conductance calcium-
activated K+ channels. All as suggested by their names are activated when 
intracellular Ca2+ levels are elevated (Blatz & Magleby, 1987; Vergara et al. 1998).  
BKCa channels are present in the non-pregnant rat (Song 1999), non-pregnant human 
(Tritthart 1991) and pregnant human myometrium (Khan 1993).  Activation of a 
small number of BKCa channels has been associated with causing relaxation of the 
uterus (Brainard, Korovkina et al. 2007).Inhibiting BKca with tetraethylammonium, 
barium and 4-aminopyridine thereby reducing the outward potassium current in 
human myocytes, produces an increase in the frequency of contractions. This 
supports the role of BKCa channels in opposing contractility (Khan, Matharoo-Ball et 
al. 2001). Inhibition of BKca channels however has been shown to have little effect of 
myometrial contractility in pregnant and non-pregnant rat myometrium (Aaronson, 
Sarwar et al. 2006). 
The BKCa channels consist of a tetrameric pore forming α subunit, and a regulatory β 
subunit (Garcia-Calvo 1994, Toro 1998). The β subunit is required as it acts as the 
calcium sensor. Its ability to enhance Ca2+ sensitivity in the human myometrium has 
been published (Orio et al 2002). Alternative splicing and post translational 
modifications are thought to result in functionally distinct variants of the receptor 
which also alter their calcium and voltage sensitivity (Korovkina 2001) hormonal 
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sensitivity (Holdiman 2002) and phosphorylation of the receptor and its trafficking 
(Perez and Toro 1994, Bainard 2007). In human myometrium BKca with decreased 
sensitivity are up regulated during labour to allow the uterus to be more excitable 
(Curley, Morrison et al. 2004). In support, Gao et al 2009 also showed down 
regulation of both the α and the β subunits upon labour onset. 
IKCa channels have a similar structure consisting of a central pore, a calcium sensing 
region and 6 transmembrane spanning regions (Tharp and Bowles 2009). Unlike BKCa 
channels they lack a voltage sensing region so are unaffected by membrane voltage. 
IKCa channels play an important role physiologically as they are involved in many 
systems including the hematopoietic system, and salt and fluid transport. They are 
also important for maintaining a negative resting membrane potential to help 
accumulate electrical gradients for ion transport (Jensen, Strobaek et al. 2001; 
Begenisich, Nakamoto et al. 2004). 
SKCa channels are encoded by four genes – SK1, SK2, SK3 and IK1/SK4. The structure 
of SK channels is similar to voltage gated (Kv) potassium channels consisting of six 
transmembrane segments (S1-S6), and a selective pore region for potassium 
conductance (Stocker 2004). SK channels do not contain a calcium binding motif to 
allow direct interaction with calcium, however the proximal c terminal domain 
interacts with calmodulin (Maylie, Bond et al. 2004).  
Activation of SK channels cause a long lasting hyperpolarisation known as a slow 
after hyperpolarisation (sAHP) (Vergara, Latorre et al. 1998). There is a role for SK 
channels in the myometrium as regulators of contractions during gestation and 
labour (Brainard, Korovkina et al. 2007). Over expression of SK3 in transgenic mice 
has been shown to delay parturition and reduce the strength of uterine contractions 
(Bond, Sprengel et al. 2000). Other studies have shown that the expression of SK2 
can affect the coordination of uterine contractions by limiting calcium entry though 
L-type Ca channels (Brown, Cornwell et al. 2007). It has also been shown that SK2 
and SK3 are down regulated in human myometrium during parturition (Mazzone and 
Buxton 2003). In the rat myometrium functional studies show upon inhibition of the 
this channel was larger than that of BKCa channel inhibition suggesting a role for SK 
channels in maintaining uterine quiescence and may in fact contribute more than 
BKCa channels. 
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Voltage- gated K+ channels 
Voltage dependent potassium channels (KV) are extensively expressed in the uterus 
and are activated by depolarisation (Brainard, Korovkina et al. 2007). Voltage gated 
potassium channels have been implicated in maintaining uterine quiescence and the 
initiation of contractions (Knock, Smirnov et al.1999). They also play a role in 
maintaining the resting membrane potential of myocytes (Brainard, Korovkina et al. 
2007) 
There are four major subfamilies of KV channels – KV1 (Shaker) , KV2 (Shab), KV3 
(Shaw), KV4 (Shal) (Xu, Yu et al. 1995) The KV4 subfamily seem to play the most 
important role in the myometrium during pregnancy (Knock, Smirnov et al. 1999). 
The expression of KV4.2 has been shown to increase before parturition where as 
KV4.1 and 4.3 appear to decrease throughout gestation (Suzuki and Takimoto 2005). 
Hormones also affect KV channels. Oestrogen reduces the expression of KV4.3 and 
its function before parturition allowing increases in myometrial contractility (Song, 
Helguera et al. 2001). 17β-estradiol and progesterone have also been shown to 
modulate outward potassium currents in cultured human term myometrial cells 
(Knock, Tribe et al. 2001). 
 
 KATP channels 
The ATP-sensitive potassium (KATP) channel is one of the most abundant potassium 
channels and most likely contributes to the resting membrane potential in smooth 
muscle tissues (Teramoto N, 2006). The channel contains heteromultimers of an 
inwardly rectifying K+ channel (Kir) and a modulatory sulphonylurea receptor subunit 
(SUR) which is responsible for the ATP sensitivity and pharmacological properties 
(Inagaki 1995, 1996, Aguilar-Bryan 1998, Isomoto 1996). The mRNA expression of Kir 
6.1, Kir 6.2, SUR1 and SUR2B in human pregnant myometrium have been detected 
and Kir6.1/SUR2B appear to be the predominant isoform of KATP channel in human 
myometrium (Curley, Cairns 2002). Another study found the expression of all four 
KATP channel subunits in the pregnant myometrium. They found a reduction in the Kir 
6.1 and Kir 6.2 subunits with no change in SUB2B within labouring tissue. This 
reduction could be related to labour onset (Curley, Cairns et al. 2002, Xu 2011) 
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 The functional role of KATP channels have been assessed through use of channel 
agonists and antagonists. KATP channel openers including levcromakalim, diazoxide 
and pinacidil can inhibit spontaneous and oxytocin-stimulated contractions in 
isolated human myometrium (Morrison, Ashford et al. 1993). Other openers, also 
producing an inhibitory affect towards contractions includes diazoxide. Interestingly 
diazoxide was shown to be less potent in term labouring tissue compared to term 
non-labouring tissue, suggesting less of a role for KATP channels in labour and 
overlaps with the reduction in potassium channels expression, allowing for the onset 
of powerful contractions.  
Conversely, KATP channel blocker glibenclamide induces spontaneous uterine 
contractions (Bailie, Vedernikov et al. 2002). The effect of KATP channel manipulation 
with drugs has variable results between pregnant and non-pregnant myometrium 
suggesting difference in expression during gestation. (Bailie, Vedernikov et al. 2002; 
Longo, Jain et al. 2003). Hypoxia has been associated with an increase in K+ efflux 
from the myometrium which is glibenclamide sensitive suggesting involvement of 
KATP channels. An increase in outward potassium current causes hyperpolarisation of 
the surface membrane and decrease excitability of the smooth muscle cells (Heaton, 
Wray et al. 1993).  
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1.3 The regulation of calcium [Ca2+]i in myometrial contraction 
1.3.1 Overview 
Contractions arise due to an elevation in intracellular calcium from 10-7M to 10-6M. 
This occurs through Ca2+ influx via channels or through release from the internal 
store. The key mechanism of calcium entry to produce spontaneous contractions is 
through L-type calcium channels in the uterus. Although calcium can also enter the 
cell through receptor-operated calcium channels (ROCCs) and store-operated 
calcium channels (capacitative calcium entry). However inside the cell, Ca2+ can be 
sequestered into the sarcoplasmic reticulum (SR) and/or extruded through the cell 
membrane by plasma membrane Ca2+-ATPase(PMCA) and or Na2+/Ca2+ exchanger 
(NCX) (Matthew 2004).  
 
1.3.2 Calcium influx mechanisms 
Calcium influx can occur independent of depolarisation through non-specific cation 
channels and receptor operated channels (ROCC). Receptor operated currents have 
been described in a number of smooth muscle tissues with varying degrees of 
calcium selectivity (Wray 2005, Thorneloe and Nelson, 2005). In the myometrium, G-
protein coupled receptors (GPCRs) are activated by a ligand and as a consequence 
the ligand binds to and activates a G protein leading to activation of second 
messengers or ion channels. Some receptors when activated stimulate myometrial 
contraction such as oxytocin, prostaglandin FP and TP receptors where as others 
such as β2-adrenoceptors and prostaglandin EP2 promote relaxation. The above 
stimulators activate Gαq and the relaxors activate Gαs. 
Oxytocin receptors (OTR) are relatively abundant in pregnant uterine tissues ( 
Gimpl&Fahrenholz, 2001). In human myometrium, the OTR protein was found to 
increase at term and after the onset of labour (Kimura 1996). In the rat uterus, the 
OTR mRNA levels were also increased at term and upon labour onset, the levels fell 
by 85% in within 24 hours following parturition (Larcher A 1995). Oxytocin binds to 
OTR’s to increase internal Ca2+. It does this by inhibiting Ca2+ extrusion by 
suppression of Ca2+-ATPase, opening L-type calcium channels and through activation 
of phospholipase C (PLC) liberating Inositol-1,4,5, triphosphate (IP3) which releases 
internally stored Ca2+ ions (Kao1989, Reimer&Roberts, 1986). Inhibition of calcium 
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entry highlights the limited role of the SR in the response to oxytocin where as 
inhibiting the SR reveals no change in the response of oxytocin on myometrial 
contractions (kupittayanant 2002). This elucidates the role of ROCC via its effect on 
L-type calcium channels. 
Store-operated calcium channels (SOCCs) and chloride channels (ClCa) have also been 
implicated in Ca2+ entry. SOCC’s are activated by a reduction in the sarcoplasmic 
reticulum (SR) calcium content, which results in calcium entry known as capacitative 
calcium entry (CCE) or store operated calcium entry (SOCE). This increase in calcium 
availability may contribute to contractility in the myometrium (Tribe, Moriarty et al. 
2000).  In the human myometrium CCE has been demonstrated in oxytocin 
stimulated increases in intracellular free calcium (Monga, Campbell et al. 1999). In 
the rat myometrium it has been shown that SOCE occurs and that it contributes to 
oxytocin-induced contraction (Noble 2009). The mechanism behind store operated 
calcium entry has been linked to transient receptor potential superfamily (Trp). 
TrpC1, TrpC3, TrpC4 and TrpC6 have been shown to be expressed in human 
myometrium (Ku, Babich et al. 2006), and are upregulated in term as well as labour 
suggesting a role in labour (Dalrymple, Slater et al. 2004). 
As for chloride channels ClCa4 are the most abundant form found in smooth muscle. 
Their role in water and salt balance as well as control of excitability has been 
published in rat uterine myocytes (Jones, Shmygol et al. 2004). ClCa2 channels have 
been suggested to cause depolarisation via the opening of L-type calcium channels 
(Arnaudeau, Lepretre et al. 1994, Jones, Shmygol et al. 2004).  
 
1.3.3 Calcium efflux mechanism 
Ca2+ is removed intracellularly in two ways, by the plasma membrane ATPase (PMCA) 
and the Na+/Ca+ exchanger. These mechanisms are ATP dependent and remove the 
bulk of calcium from the cell and if inhibited, the recovery of calcium to resting levels 
is abolished (shmigol 1999). It is the activity of these proteins that is responsible for 
the maintenance of the 10,000-fold concentration gradient across the plasmalemma 
(Matthew 2004). The NCX has a lower affinity for Ca2+, but is a higher capacity 
system (Bradley 2002). It utilises the Na+ gradient provided by Na/K-ATPase to 
operate the efflux of calcium. During each transport cycle, the energy from 3Na+ ions 
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entering the cells is used to export each Ca2+. This reaction can occur in either 
direction dependent upon the concentration of Na+ such that if extracellular Na+ is 
significantly reduced, an increase in intracellular calcium occurs as the exchanger 
operates in reverse. The PMCA extrudes Ca2+ at a lower [Ca2+]i and is calmodulin 
dependent (Blaustein 2002). PMCAs affinity to calmodulin is dependent on its 
isoform. Within uterine cells inhibiting the NCX or PMCA showed 30% of the total 
calcium extruded was via the NCX and 70%, via the PMCA (Shmigol, 1998). This 
highlights the predominant mechanism responsible for calcium extrusion in the 
myometrium is the PMCA. 
 
1.3.4 The sarcoplasmic reticulum (SR) 
Ca2+ transport into the SR 
There are three mechanisms for removal of Ca2+ from the cytosol; the NCX, PMCA, 
and the sarcoplasmic recticulum Ca2+ ATPase (SERCA). The NCX and PMCA are both 
located on the plasma membrane and extrude Ca2+ to the extracellular space and 
have been discussed earlier. The SERCA is located on the SR membrane, and pumps 
Ca2+ to the SR lumen, which offers a finite capacity for storage (Matthew 2004). 
Active transport using the energy from ATP hydrolysis is how Ca2+ is imported into 
the lumen of the SR. SERCA takes up Ca2+ against the electrochemical gradient at the 
cost of the hydrolysis of one molecule of ATP (Marin 1999). Myometrial cells have an 
extensive SR network, which approaches very close to the plasma membrane. There 
are three isoforms of the SERCA pump, SERCA 1, SERCA 2 and SERCA 3 (Wray and 
Burdyga 2010). Within animal and human studies SERCA isoforms 2a, 2b and 3 have 
been identified and change in labour suggesting a potential role of SERCA in 
pregnancy and contraction (tribe 2000, Khan 1993b). The SR has a large capacity for 
storing calcium, however experiments have shown that when other calcium 
extrusion mechanisms are inhibited such as PMCA and NCX, SERCA was unable to act 
alone, suggesting that SERCA acts in conjunction with plasmalemmal calcium 
extrusion mechanisms (Matthew, Shmygol et al. 2004). Blocking of SERCA with 
cyclopiazonic acid CPA and thapsigargin causes an increase in contractility in the 
uterus (Tribe, Moriarty et al. 2000). 
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Ca2+ within the SR is not uniformly distributed it is located in hot spots 
(Young&Mathur 1999). Two proteins involved in the distribution of Ca2+ within the 
cell are Ca2+ binding proteins; calsequestrin and calreticulin. In the uterine smooth 
muscle cells calreticulin acts alone as no presence of calsequestrin was found (Milner 
1991). 
 
Ca2+ release from the SR 
Ca2+ is released from the SR by pores in the SR membrane formed by the 
tetramerisation of IP3R or ryanodine receptors (RyR). Ip3R are activated by agonists 
leading to the activation of IP3 and diacylglycerol (DAG) from the hydrolysis of 
phosphoinositide-bis-phosphate (PIP2). IP3 causes release of calcium by binding to 
the IP3R on the SR (Bultynck 2003). RyR are activated by an increase in the local 
[Ca2+] and inhibited by phosphorylation by PKC (Bonev 1997). In the uterus all three 
isoforms have been identified (IP3R 1- 3) (Morgan, De Smedt et al. 1996). In rat 
myometrium the expression of IP3Rs increased with advancing gestation, except for 
IP3R-2, this increase in expression also coincided with an upregulation of the PLC 
cascade associated with the release of IP3. In the uterus all three isoforms of RyR 
have been identified (RyR 1- 3). RyR receptors have not been shown to have any 
major effect on function (Taggart and Wray 1998, Noble 2009). Further work needs 
to be done to elucidate its role in the myometrium. Both channels are stimulated to 
open by the very ion they release, the opening of a single IP3R or RyR is likely to open 
adjacent SR channels. This process is called Ca2+ induced Ca2+ release (CICR). CICR 
inhibitors have been shown to reduce contractility in the myometrium (Phillippe and 
Basa 1996). Although there is little evidence that shows CICR has a role in the uterus 
(Kupittayanant 2002). 
Calcium has also been shown to leave the SR in the form of a calcium leak. The SR’s 
calcium load comes from the uptake of calcium by the sarcoplasmic reticulum 
ATPase (SERCA). The calcium load of the SR is kept at a steady state by release of 
calcium through vectoral calcium release. Studies of smooth muscle have shown 
evidence of these releases in the form of calcium sparks from RyRs and Ca puffs from 
IP3Rs (Ledoux 2008, Tovey 2001). Ca
2+ sparks occurring from RyR opening have been 
shown to target the Ca2+-activated BKCa channels on the plasma membrane. The 
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sparks increase the local [Ca2+] around BKCa channels and activate them giving rise to 
spontaneous transient outward currents (STOCs), i.e. small membrane 
hyperpolarisations. In turn this leads to a decrease in L-type calcium channel 
opening, a reduction in Ca2+ entry and relaxation (Burdyga and Wray 2005). This 
mechanism has been demonstrated in vascular (Nelson 1995) and utereric (Burdyga 
and Wray 2005) smooth muscle. Although BKCa channels are present in the uterus, 
Calcium sparks and STOCs have yet to be discovered in the uterus (Wray 2007).  
 
1.3.5 Excitation-contraction coupling mechanism 
Excitation-contraction coupling relies on changes in membrane potential of the 
smooth muscle cells and intracellular calcium concentrations. Contractions occur 
upon depolarization of the surface membrane opening L-type Ca2+ channels, 
followed by an influx of Ca2+ entry into the cell (Figure 1.4). Depolarisation occurs 
spontaneously (Duquette 2005) or via opening of channels or due to hormones 
binding to receptors (Miyoshi 2004, Arnaudeau 1994).   Ca2+ then binds to plasma 
membrane calmodulin which dissociates forming a calcium-calmodulin complex 
containing 4 Ca2+ ions. This activates myosin light chain kinase (MLCK) causing 
phosphorylation of serine 19 on myosin light chains (MLC), and triggers the cycling of 
myosin cross bridges with actin leading to contraction (Wray 2007; Aguilar and 
Mitchell 2010, Webb 2003). Consequently, a fall in Ca2+ concentration through 
uptake into the intracellular calcium store, and efflux through plasmalemmal calcium 
extrusion mechanisms, results in the dephosphorylation of myosin by myosin light-
chain phosphatase, deactivation of myosin light chain kinase and dissociation of the 
calcium-calmodulin complex leading to relaxation (Allen 1994, Webb 2003).  
Agonists can cause contraction independent of membrane potential changes 
through release of calcium from the sarcoplasmic reticulum, the entry of calcium 
through receptor operated channels, or through alterations of the contractile 
proteins sensitivity to calcium. This is called pharmacomechanical coupling (Wray 
1993).  
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Figure 1.4 Excitation-contraction coupling pathway in the uterus. 
Action potentials are a result of changes in ionic permeability of the myocyte 
membrane. Upon depolarisation of the myocyte membrane, L-type calcium channels 
open and allow calcium influx. Calcium then binds to calmodulin, activating myosin 
light chain kinase (MLCK), which phosphorylates myosin (Myosin-P) causing cross 
bridge cycling of myosin and actin and therefore promoting contraction. When 
dephosphorylation takes place producing myosin light chain phosphatase (MLCP), 
this leads to relaxation. 
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1.3.6 pH and Contraction 
Each contraction causes a small acidification. Uterine pH was first measured by 
Dawson and Wray in 1985. A value of ~7.1 at 37oC was found in pregnant and non-
pregnant rat uteri using 31P NMR spectroscopy. Changes in external pH are 
transmitted to the cytoplasm where they may affect cellular function (Wray 1993). 
These changes occur due to physiological processes such as increased activity, 
hypoxia, respiratory effort and acid base imbalance. The metabolic demands of 
labour and changes in metabolites, as described previously during contractions, will 
lead to changes in intracellular pH (pHi). Normal labour is associated with the 
development of maternal acidemia (Sjosted 1962, Cerri 2000). 
A significant alkalinisation has been shown to occur when measuring intracellular pH 
over the last few weeks of pregnancy, from pH 7.07 (33 weeks gestation), pH 7.12 at 
36-37 weeks to pH 7.26 at term (40-43 weeks) (Parratt 1995B). Also the mean value 
of resting pH, was found to be significantly lower in the non-pregnant women (7.06 ± 
0.03; n = 39) when compared to pregnant women (7.14 ± 0.01, n=53)(Parratt 1995A). 
Direct measurements of intracellular pH in human myometrial tissue has shown that 
application of a weak acid and base (30mM) produces intracellular pH (pHi) changes 
of around 0.14pH units (Parratt 1995A) and that changes occur rapidly (<1 minute) 
as the weak acids and bases cross the cell membrane and dissociate. Intracellular pH 
is then gradually restored as pH regulatory mechanisms come into play. The 
intracellular pH change occurring is dependent on concentration of the weak acid or 
base.  
Alteration of pHi in human myometrial strips have been shown to have significant 
effects on spontaneous contractions (Parratt 1995A and B) such that acidification 
decreases and alkalinisation increases, spontaneous force and calcium. This is also 
found in the rat myometrium (Taggart 1993). Intracellular acidification can directly 
reduce Ca2+ current in uterine myocytes and has been shown to directly inhibit force 
production at the level of cross bridge cycling (Nagesetty&Paul 1994, Smith 1998, 
Pierce 2003).  
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Most of the effects of extracellular pH (pH0) are thought to arise from the 
consequent change in intracellular pH, as H+ diffuse across the plasma membrane 
and into the cell. The effects however will be slower and probably to less of an 
extent than direct intracellular pH change. pH0 has been shown to influence L-type 
Ca2+ entry as does pHi (Smirnov 2000, Saadoun 1998, Pierce 2003) and Shmigol 1995 
also showed a slow reduction in current when lowering extracellular pH to 6.9. 
Pierce et al shows upon acidification using changes in pH0 show an increase in 
frequency and decrease in amplitude were as an alkalinisation produced an increase 
in force and a decrease in frequency (Pierce 2003). 
pH changes during labour, induced via hypoxic events, will have significant effects on 
the contracting uterus and may affect the progress of the labour. Recently a test 
based on the work done by Liverpool university and Liverpool women’s hospital 
showing that the uterus produced lactic acid as other muscles do when they work 
hard, but that when it reaches a certain level the substance starts to inhibit 
contractions, was established. The test is thought to help doctors monitor lactic acid 
and  determine which women may go on to deliver vaginally and this lactic acid build 
up could be a reason why some slow labouring women do not respond to induction 
of labour through use of oxytocin.  
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1.4 Hydrogen sulfide (H2S)  
H2S is well known for its rotten egg smell and toxicological effect, a result of its 
reaction with metalloenzymes. In the mitochondria, cytochrome oxidase, the final 
enzyme in the respiratory chain, is inhibited by H2S; this disrupts the electron 
transport chain, interferes with ATP production and impairs oxidative metabolism 
(Chou 2003, Reiffenstein 1992). H2S has a recognition threshold of 0.0047 ppm, at 
this concentration only 50% of humans can detect the characteristic odour and at ~ 
500ppm it can be fatal. However in recent years research has focused on H2S as a 
gaseous signalling molecule (Zhao 2001, Mustafa 2009) and its physiological 
contributions. H2S has a growing list of functions e.g. long term potentiation (Abe 
1996), anti-nociception (Distrutti 2006), exocrine secretion (Schicho 2006) and 
control of blood pressure(Yang 2008) which has led to the suggestion that H2S is 
poised to have a large impact on physiology and medicine. Data from studies on 
inflammation, atherosclerosis, hypertension and ischaemic injury indicate that it can 
be cytoprotective especially against oxidative stress and will be useful 
therapeutically (Szabo 2007). However, it has been associated with diseases such as 
diabetes and asthma (Yusuf 2005). It can act as an oxygen sensor and is part of the 
vascular response to hypoxia (Olson 2006) and inhibits production of reactive oxygen 
species (ROS) leading to increased tissue function (Muzaffar 2008). The reduced 
cardiovascular risk associated with garlic eating seems to be due to the production of 
H2S from polysulfides in the plant (Benavides 2007). 
 
1.4.1 H2S chemistry and compounds used to investigate the effects of H2S  
H2S is a extremely reactive, flammable, colourless gas. It is the sulfur analogue of 
water, but is somewhat less polar, giving it the ability to dissolve well in both polar 
and non-polar environments. The gaseous state and lipophilic nature allows H
2
S to 
dissolve into cell membranes and thus no transporters are needed for it to enter or 
leave the cell (Mathai et al., 2009). H
2
S is also a weak acid, and in aqueous solution 
dissociates according to equation 1 (Figure 1.5A) with pKa 7.05, pH 7.4 at 20°C giving 
rise to ~30% H
2
S and 70% HS
- 
(Lide, 1998).  
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Under physiological situations, pH 7.4 and 37°C, give a distribution of about 20% H2S 
and 80% HS-. It should be emphasised that H2S and SH
- may both contribute directly 
to the biological action of hydrogen sulfide, and that SH-, the predominant sulfide 
species under biological conditions, is a nucleophile, which readily binds to metal 
centres in biological molecules (e.g. haemoglobin) or reacts with other compounds. 
Only the first reaction within equation 1 is relevant for biological samples because 
the pKa is in the physiological range. The pKa2 for the second reaction is over 12, 
with some reports suggesting it is as high as 19. S2- is negligible in all physiological 
experiments (Olson 2012). 
H
2
S is a strong reductant, and can spontaneously oxidize to sulfur dioxide or 
elemental sulfur (among other possibilities) as shown in Equations 2 and 3, 
respectively (Figure 1.5B).  These reactions are not particularly fast in the absence of 
catalysts, with halftimes on the order of 30 hr (Millero, 1987). In the presence of 
transition metal ions, such as Fe
2+
, the oxidation rate is greatly increased, and 
addition of the transition metal chelator diethylene triamine pentacetic acid (DTPA) 
to an H
2
S solution effectively blocks this route of oxidation (Tapley, 1999).  
H2S-forming salts are the first compounds used to monitor H2S effects. However, 
they require protons from a solvent and their solvation results in an alkaline 
solution, such as sodium sulfide (Na2S) (Figure 1.5C) which requires 2 protons (Olson 
2012).  Sodium hydrosulfide (NaHS, Figure 1.5C) only requires one proton and  is 
commonly used as an H2S-forming compound, since it dissociates instantaneously to 
Na+ and HS–; the latter then partially binds H+ to form undissociated H2S (Lowicka 
2007). However, as compounds that can release more physiological amounts of H2S 
are sought to better control H2S quantities and monitor its effects, H2S releasing 
compounds have been and are still being produced.  One drug that slowly releases 
H2S following addition to aqueous solution due to its steric hindrance, is GYY4137 
(Figure 1.5C). The likely mechanism of producing H2S is through protonation of the 
sulfide group to form a sulfhydryl moiety followed by hydrolysis to release H2S (Li 
2009). Lee et al confirmed H2S production, illustrating upon incubation of NaHS and 
GYY4137 in culture medium using a methyl blue formation assay resulted in the 
release of measureable amounts of H2S.  Liberation of H2S from NaHS was rapid with 
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plateau from 30-50 mins and declining to undetectable levels by 90 min. H2S release 
from GYY4137 was 10% of that observed with NaHS but was sustained, remaining 
higher than baseline for up to 7 days. Both H2S production enzymes Cystathionine 
beta synthase (CBS) and cystathionine gamma lyase (CSE) use L-cysteine (Figure 
1.5C) as a substrate to produce H2S (described below), hence this has been used to 
investigate H2S effects also. However, L-cysteine is an important amino acid that 
protects stomach lining, the intestines and helps in the absorption of essential 
nutrients from foods also. It is naturally occurring and can be found in most protein 
rich foods ranging from dairy to poultry products.  Naturally occurring garlic derived 
compounds maybe also a good choice of compound to monitor H2S effects as human 
red blood cells convert garlic-derived organic polysulfides into H2S (Benavides 2007). 
Allyl-substituted polysulfides undergo nucleophilic substitution at the α carbon of 
the allyl substituent, thereby forming a hydropolysulfide (RSnH), a key intermediate 
during the formation of H2S. Organic polysulfides (R-Sn-R’) also undergo nucleophilic 
substitution at a sulfur atom, yielding RSnH and H2S. Diallyl disulfide (DADS), and 
Diallyl trisulfide (DATS) are the highest producing H2S, garlic-dervied polysulfides 
producing approximately 35 and 100 µM H2S, respectively on the addition of 100 µM 
of each polysulfide (Benavides 2007). 
NaHS has been reported to relax different vascular tissues with EC50 of 1-300 µM 
(Olson 2010). Another report described an EC50 value of 0.7mM term non labouring 
myometrium and 2mM for term labouring tissue using L-cysteine (You 2011). 
GYY4137, a slow releasing H2S compound has been shown to relax contraction in 
aortic rings with an EC50 of 115 µM (Li 2008). This shows that there is considerable 
inter-tissue differences in EC50 values, although experimental differences may account 
for much of the variation. 
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Figure 1.5 Dissociation of H2S (A), reduction of H2S (B) and H2S-forming compounds 
(C).  
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1.4.2 Endogenous H2S production 
Hydrogen sulfide is produced in mammalian tissues from L-cysteine by two key 
enzymes CBS and CSE. Another enzyme that produces H2S is 3-mercaptopyruvate 
sulfurtransferase (3MST), although this enzyme seems to be the more important 
source of H2S in the brain (See Figure 1.6, Ishigami 2009).  Alterations in CBS and CSE 
activity have been associated with functional effects in a variety of tissues (Hosoki 
1997). The expression of CSE has been shown to be higher than that of CBS in several 
smooth muscles (Zhao 2001, Hosoki 1997). Both the CSE and CBS enzymes are 
expressed in rat and human myometrium (Patel 2009, You 2011). There is also the 
presence of a minor non-enzymatic route via reduction of elemental sulphur to H2S 
using reducing equivalents obtained from the oxidation of glucose. An environment 
where oxidative stress and hyperglycaemia is high promotes H2S generation through 
this route (Searcy 1998). 
CBS depends on pyridoxal 5’ phosphate (PLP, vitamin B6). This enzyme catalyses a β-
replacement reaction with amino acid substrates, including L-cysteine, 3-
chloroalanine and serine. Homocysteine, 2-mercaptoethanol and H2S are nucleophile 
substrates, allowing for other possible reactions to take place (Miles &Kraus 2004). 
CBS can catalyse the β-replacement of the sulfhydryl group on cysteine with water, 
releasing serine and H2S but traditionally on the sulfhydryl group of homocysteine 
with the hydroxyl of serine forming cystathionine (Julian 2002). CBS is a 
homotetramer consisting of 551-amino-acid subunits with a subunit molecular 
weight of ~63KDa which bind two co-factors (haem and PLP) and two substrates 
(homocysteine and serine). Several isoforms have been identified although their 
functional effect of them remains unknown (Singh 2009). The haem component of 
CBS is reported to function as a cellular redox sensor (Maclean 2002) which could 
increase H2S generation in response to oxidative stress (Whiteman 2011). Two 
inhibitors are available in the form of O-(carboxymethyl)hydroxylamine 
hemihydrochloride (AOAA) and hydroxylamine (HA). 
CSE also depends on PLP and is a 405-amino-acid protein consisting of a tetramer 
formed by two homodimers, with active and stable dimer of ~45KDa (Sun 2009, 
Whiteman 2011). CSE catalyses the α,γ-carbon elimination of cystathionine to 
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produce cysteine, α-oxobutyrate and ammonia. Additional cysteine-dependent β- 
and homocysteine-dependent γ-reactions have been suggested (Chiku 2009) to 
generate H2S. Additionally CSE may catalyse the β-elimination of cystine (cysteine 
disulfide) via the formation of thiocysteine, which then decomposes non-
enzymatically to H2S (Chiku 2009). The CSE-catalysed α,β-elimination of cysteine was 
the predominant source of H2S accounting for ~70% of the H2S produced (Chiku 
2009). At least two CSE mRNA splice variants have been demonstrated producing 
long and truncated CSE proteins, although the precise role of these variants in 
regulating CSE activity has yet to be disclosed (Lu 1992, Levonen 2000). A condition 
called hyperhomocysteinemia is when there is excess H2S production (Carson 2010). 
Two CSE enzyme inhibitors are available, reversible inhibitor, β-cyanoalanine (BCA) 
and irreversible inhibitor, D,L propylargylglycine (PAG).  
Little information is available on 3MST and H2S synthesis. 3MST is a ~33 kDa 
monomeric or disulfide-linked dimeric protein containing two rhodanese domains. 
At least two splice variants of human 3MST are present, but as with CSE and CBS, 
their regulation and role in H2S synthesis are not understood and no inhibitors exist 
(Whiteman 2011).  
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Figure 1.6 Production of H2S in mammalian cells. Adapted from Wang 2012. 
CBS, cystathionine β-synthase; CSE, cystathionine γ-lyase; CAT, cysteine 
aminotransferase; 3MST, 30mercaptopyruvate sulfurtransferase. 
51 
 
1.4.3 H2S catabolism 
Oxidation 
Oxidation is the loss of electrons or an increase in oxidation state by a molecule, 
atom, or ion and is the main way to catabolise H2S. It was first reported in 1986 that 
sulfide oxidation occurred in the mitochondria (Powell 1986). H2S is rapidly oxidized 
to thiosulfate (S2O3
2−) by mitochondria and is subsequently converted to sulfite 
(SO3
2−) and sulfate (SO4
2−) (Caliendo 2010). The oxidation of H2S to thiosulfate in the 
rat liver is influenced by heme compounds (Sorbo 1958, Sorbo 1957), metal protein 
compounds and ferritin (Wang 2012). The overall oxidation process take place using 
membrane-bound sulfide-quinone oxidoreductase (SQR) to oxidize H2S to a 
persulfide (S0), the electrons are used to reduce ubiquinone, which then enters the 
electron transport chain. Subsequently, sulphur dioxgenase further oxidizes a 
persulfide to sulfite, consuming O2 and water. The final steps are converting sulfite 
to thiosulfate by the sulfur transferase-catalysed transfer of a second persulfide from 
SQR and excretion of thiosulfate. Thiosulfate is converted to sulfite by thiosulfate 
sulfurtransferase and sulfite is then further metabolized to sulfate by sulfite oxidase 
(stipanuk 2010, Olson 2011, Linden 2012). The production of sulfite and sulfate is 
catalysed by the sulfide-detoxifying enzymes, one of which is Rhodanese (Picton 
2002). Rhodanese consists of two isoforms thiosulfate sulfur transferase (TST), the 
isoform that detoxifies H2S to sulfite and 3MST which cannot (Ramasamy 2006). 
Mice lacking ethylmalonic encephalopathy 1 (Ethe1) exhibit elevated sulphide levels, 
suggesting that Ethe1 is the sulfur dioxygenase involved in H2S metabolism (Linden 
2012). Both Ethe1 and Rhodanese are highly expressed in the liver (Hildebrandt and 
Grieshaber 2008). H2S is a powerful reducing agent and is likely to be consumed by 
endogenous oxidant species in the vasculature also, such as peroxynitrite (Whiteman 
2004), superoxide (Chang 2008), and hydrogen peroxide (Geng 2004). 
 
Methylation 
Primarily methylation takes place in the cytosol. Using thiol S methyltransferase, 
methylation of H2S generates smelly gas methanethiol (CH3SH) and then this can 
slowly be converted to dimethylsulfide (CH3SCH3) through a second methylation. It 
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has been shown that oxidation of H2S happens ~10,000 faster than sulfide 
methylation (Levitt 1999). 
Scavenging 
H2S can be scavenged by methemoglobin to form sulfhaemoglobin and is thought to 
have a short half life (Wang 2012). There is evidence that shows in the presence of 
methemogloblin, H2S production is decreased (Yang 2004). Metallo- and disulfide-
containing molecules such as horseradish peroxidise and oxidized glutathione can 
also scavenge H2S (Smith 1966, Beauchamp 1984). 
1.4.4 Tissue and blood levels of H2S 
Much controversy has been associated with monitoring H2S production and blood 
levels. Tissue production and levels of ‘H2S’ in blood has been the subject of much 
controversy (reviewed in (Whiteman 2009, Olson 2012). H2S levels in blood serum 
and plasma of healthy adults have been measured using the methyl blue method 
and through use of sulfide sensitive electrodes of 20-60µM (Whiteman 2009, 
Lawrence 2000, Yang 2008, Branceleone 2008). More recently fluorimetric-based 
methods have been developed employing monobrombimane to trap ‘free’ H2S and 
the resulting dibimane determined by reverse-phase HPLC to show baseline levels of 
free ‘H2S’ to be in the region of 0.4–0.9 μM (Wintner, 2010). It is therefore likely that 
other methods measure the total sum of H2S-derived species such as HS
− and S2− and 
possibly other physiological H2S ‘carrier’ molecules that exist at physiological pH and 
which release H2S under acidic conditions employed in the analytical processes, 
rather than ‘free’ H2S itself and care should be taken to describe the results as such 
(Whiteman 2009). 
 
 
 
 
 
53 
 
1.4.5 H2S in vascular smooth muscle 
Both the CBS and CSE enzyme have been detected in many smooth muscles tissues 
including airway (Ryu 2009), aorta and mesenteric arteries (Cheng 2004). CSE is the 
predominant enzyme responsible for H2S generation in vasculature smooth muscle 
(Zhao 2001), whereas both CBS and CSE contribute to H2S generation in 
gastrointestinal and penile smooth muscle (Fiorucci 2005, d’Emmanuele di Villa 
Bianca  2009). These data confirm that H2S generation could play a significant role in 
smooth muscle. 
Modulation of smooth muscle activity has been described as one of the main 
functions of H2S in peripheral tissues (Moore 2003). The effects of H2S on smooth 
muscle contractile activity have been examined in several tissues and in general it is 
associated with a reduction in contractile activity. Relaxation has been reported for 
bronchial (Kubo 2007), GI tract (Teague 2002, Gallego 2008, Dhaese 2009), corpus 
cavernosum (Shukla 2009) and bladder (Dombkowsi 2006). In vivo intraperitioneal 
administration of NaHS causes relaxation of the rat colon (Distrutti 2006) and iv 
injection of H2S in rats induced a transient dose-dependent decrease in mean arterial 
pressure (Zhao 2001). In vitro, H2S and NaHS relaxed rat thoracic aorta and portal 
vein pre-constricted with noradrenaline. H2S also relaxed mesenteric arteries (Cheng 
2004); an effect mimicked by L-cysteine. In addition the relaxing effect of L-cysteine 
was abolished by the CSE inhibitor, Propargylglycine (PAG) suggesting that cysteine 
acted through its conversion to H2S. However, some reports in vascular smooth 
muscle have found increased contraction or different effects dependent upon H2S 
concentration (Zhao 2009,Webb 2008). It has been suggested that these differences 
may be due to the lower conversion efficacy of NaHS to H2S at high concentrations 
(Tian 2012). The finding that free H2S values are up to 100-fold higher in smooth 
muscle (aorta) compared to liver, blood, heart and kidney, (Levitt 2011) shows its 
importance in smooth muscle. 
These data suggest H2S is functionally important in smooth muscle as a vasodilator 
(widening of blood vessels leading to a decrease in blood pressure) in diseases were 
high blood pressure is a problem, it highlights a role in new drug synthesis as well as 
help in other diseases such as cystic fibrosis and atherosclerosis (Lowicka 2007).  
54 
 
1.4.6 H2S in the Uterus 
Early studies showed that exposure of pregnant rats to 28-100mg H2S/m3 for 7 
hours a day on gestation day 6- day 21 postpartum might increase the mean 
parturition time and prolong labour (Hayden 1990). This was evidence and created 
interest in the role of H2S in the uterus. It has been shown that H2S is produced in rat 
and human myometrium using a methylene blue technique, both the CSE and CBS 
were expressed and that hypoxia increases H2S production (Patel 2009). Further 
work by You et al looked at the expression of CBS and CSE, as well as quantifying the 
amount of protein and mRNA levels in human non labouring and labouring 
myometrium, showing a decrease in the CBS (~63kDa, 205bp) and CSE (~45kDa, 
149bp) mRNA levels and a decrease in CBS at the protein level in labouring tissue. 
This demonstrates the enzymes are regulated over gestation and their down 
regulation in labour suggests the decrease in H2S production could be involved in 
labour onset.  
CBS-/- knockout mice are infertile and CBS+/- knockout mice have reduced fertility 
wereas CSE-/- knockout mice have normal fertility which highlight a possible role of 
H2S in fertility and that CBS may have an important role in reproduction. It could also 
give insight and warrants further work in understanding hyperhomocysteinemia (CBS 
deficiency), which affects the female reproductive function in many ways. Early 
pregnancy loss, congenital birth defects and maternal obstetric complications such 
as pre-eclampsia are some of the related abnormalities (Wang 2012). This also 
suggests the importance of producing new more specific inhibitors of the enzymes, 
to be used therapeutically. 
Myometrial contractility experiments using L-cysteine and NaHS to monitor the 
effects of H2S have been performed. In the pre-term (19 day) rat myometrium, L-
cysteine and NaHS, H2S producers decreased contractility at 1µM-1mM L-cysteine 
concentrations and 1mM NaHS concentration (Sidhu 2001). Hu et al studied the 
effects of NaHS on spontaneous and oxytocin-stimulated term labouring myometrial 
contractions and showed significant decreases in frequency and AUC at 1µM to 1mM 
concentrations. Another study showed a dose dependent decrease from 0.1µM to 
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10mM L-cysteine with an increase in frequency found at and above 1mM L-cysteine 
in term labouring and non-labouring tissue. They also found that the effects found 
on labouring tissue were less potent as well as there being a decrease in H2S 
production (You 2011). Within this thesis we also found the effects of H2S were less 
in the labouring rat myometrium compared to term pregnant myometrium, further 
suggesting that endogenous H2S could be involved in the transition to labour. 
Inhibitors of CBS and CSE, PAG and AOAA blocked or partially blocked effects of L-
cysteine on contractility (You 2011). The effect of H2S and expression of CBS and CSE 
throughout gestation and in particular late pregnancy in the pregnant rat 
myometrium as well as in the non-pregnant human versus term pregnant human 
myometrium has not been researched. 
As new ways to relax the uterus are required to help prevent the global increase in 
pre-term deliveries and as H2S effects look very promising more work needs to be 
performed to help understand the mechanism. As well as to investigate new more 
controlled and physiological H2S releasing drugs with the potential to be used 
clinically such as GYY4137 and even naturally occurring compounds such as garlic 
derived polysulfides. H2S could also shed some light on the mechanism by which 
uterine quiescence is maintained during pregnancy and the initiation of co-ordinated 
contractions in human parturition. 
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1.4.7 Mechanisms responsible for the effects produced by H2S 
The main mechanism linked to H2S effects is via hyperpolarisation through opening 
of KATP channels. Data indicates that H2S relaxes blood vessels mostly, by opening 
ATP-regulated potassium channels in the vascular smooth muscle cells. First, 
glibenclamide, a KATP channel antagonist, attenuated the hypotensive effect of H2S in 
vivo and vasodilatory effect in vitro (Zhao 2001). Second, the vasodilatory effect of 
H2S was attenuated when vessels were incubated in a high-K
+ medium. Third, patch-
clamp studies have demonstrated that H2S increases KATP-dependent current and 
induces hyperpolarization in isolated vascular smooth muscle cells (Cheng 2004, 
Zhao 2001). In smooth muscle cells isolated from the rat mesenteric artery, H2S 
increased the open-probability of KATP channels without altering their conductance 
(Tang 2005). Interestingly, CSE inhibitors reduced KATP channel current indicating that 
endogenous H2S continuously stimulated the channel under baseline conditions. 
Unlike the direct effect on smooth muscle cells, the endothelium-dependent 
component of H2S-induced vasorelaxation is independent of KATP channels (Cheng 
2004). Other studies however have found no role for KATP channels (Dhaese 2009, 
Boyarsky 1978, Kubo 2007). In the myometrium  although KATP channels are expressed 
(Curley 2002)  they so far appear to have only a limited functional importance 
compared to voltage dependent K channels (Heaton 1993, Aaronson 2006, Longo 2003) 
, thus other targets for H2S  may  be important in the myometrium. The only 
mechanistic data in the myometrium to date is using the KATP blocker glibenclamide 
showing it abolishes the effects of H2S producers NaHS and L-cysteine (Hu 2011, You 
2011). 
Other reports suggest a potential inhibitory mechanism of H2S involving an effect on 
L-Type calcium channels. Recently, a study in cardiomyocytes suggested, H2S inhibits 
L-type [Ca] channels through sulfhydration, as NaHS decreased the functional free 
sulfhydryl groups in the channels (Zhang 2012). In non-contracting (butanedione 
monoxime treated) cerebral artery, Tian et al, used fluo-4 and showed decreases in 
Ca levels as NaHS was increased from 0.1 to 1 mM, and suggested  that NaHS relaxes 
these vessels by reducing L-type Ca current. There have however been no simultaneous 
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measurements of the changes of intracellular Ca with contraction and no research has 
looked at H2S effect on L-type calcium channels in the myometrium. 
BkCa, SKCa and IKCa have a role in myometrial membrane excitability and H2S has been 
associated with stimulating SKCa and IKCa channels in isolated rat mesenteric arteries 
(Mustafa 2011). BKCa channels have been research more and both a decrease in open 
probability in HEK 293 cells transfected stably with human BKCa channel alpha subunits 
(Li 2010) and recently,  the opposite has been documented in rat pituitary tumor cells 
(Sitdikova 2010). This difference could be associated with differences in BKCa channel 
isoforms. Other studies using blockers iberiotoxin and paxillin in rat mesenteric and 
cerebral arteries showed H2S caused hyperpolarisation through the BKCa channel 
opening (Jackson-weaver 2011). 
 Other mechanisms implicated in the effects produced by H2S include myosin light 
chain phosphotase activation investigated in cardiomyocytes (Dhaese 2009) and 
activation of Cl-/HCO-3 in smooth muscle cells, another mechanism concerned with 
mediating excitability (Tang 2010). Lee et al (Lee 2007) explained H2S vasorelaxant 
effects via activation of pH regulating mechanisms. Intracellular signalling pathways 
connected with H2S effects include PKA, cAMP and PKG (Shukla 2009, Srilatha 2009). 
A review of the actions of H2S in neuronal and smooth muscle tissues concluded that 
it was likely to be targeting different pathways in different tissues (Kimura 2005). It is 
more likely that H2S produces effects on ion channels and other targets by 
sulfhydration i.e cysteine’s covalent modification by which -SH groups on  cysteine 
residues of a protein are converted to –S-SH, via addition of  sulphur from H2S 
(Mustafa 2009). This molecular mechanism is similar to the S-nitrosylation effect of 
NO, however, unlike S-nitrosylation, S-sulfhydration activates rather represses, its 
target proteins (Gallyas, 2012). The most widely researched effect of H2S is on KATP 
channels within smooth muscle as discussed, in vascular smooth muscle cells H2S 
stimulated single-channel activity of KATP channels by directly increasing their 
opening probability (Wang 2012).  Recent work has made progress in identifying 
which residues in the channel are affected by H2S, with Cys 6 and 26 on the 
extracellular N terminal of the SUR1 subunit of the channel being identified (Jiang 
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2010). Sulfhydration has also been associated with stabilising cys residues to prevent 
oxidative stress, damage and preserving protein function (Paul 2012). 
Interestingly, recent work identified a channel permeable to HS− anions in the 
bacterium Clostridium difficile, suggesting that the signalling function of HS− anions 
may not be confined to HS− anion-generating cells and that although there is a long 
way to go and much research to be performed to elucidate the mechanism of H2S 
maybe such channels/ receptors are present in mammalian tissues (Czyzewski 2012).  
Concluding that many mechanisms have been related to the effects H2S generates, 
suggesting different mechanisms are targeted in different tissues. In the myometrium 
specifically, only the use of Glibenclamide a KATP blocker has been performed to 
elucidate the mechanism of H2S. Confirming further work is needed to unveil its role 
especially on calcium entry, L-type calcium channels as well as any other potential 
mechanism that could cause the responses found to H2S producers. 
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1.5 Clinical aspects 
Here I will explain the relevant clinical aspects of my thesis. I characterise non-
pregnant myometrial contractility hence I will discuss the menstrual cycle of the non-
pregnant uterus, the menopause and endometriosis. I am looking at the effect of H2S 
on myometrial contractility of the pregnant myometrium and its potential to help in 
pre-term birth therefore I will also describe pregnancy and parturition as well as the 
complications of a pre-term birth. 
1.5.1 Non -pregnant uterus 
The endometrium is the traditionally accepted end target organ for cyclical ovarian 
hormonal activity. Endometrial cycle of proliferation, differentiation and shedding is 
the result (the menstrual cycle). Myometrium also express oestrogen receptors (ER) 
and progesterone receptors (PR) (Geimonen 1998); some myometrial activities are 
regulated by oestrogen and progesterone.  
The main research investigating myometrial function in non-pregnant women over the 
last two decades have been obtained from the use of open-tipped pressure catheter 
recordings, 3D ultrasound, and magnetic resonance imaging (Brosens 1998, van gestel 
2003, Bulletti 2004, Bulletti and de Ziegler 2006). The contractions observed during 
the menstrual cycle have been termed ‘endometrial waves’ (ljland 1996).  These 
contractions appear to involve only the sub-endometrial layer of the myometrium 
(Aguilar 2010). After menstruation, in the early follicular phase, contractile waves 
occur once or twice per minute and last 10–15s with low-amplitude (usually, 30 
mmHg). As ovulation approaches, the frequency increases to 3–4 per minute. During 
the luteal phase, the frequency and amplitude decrease possibly to facilitate 
implantation. When a blastocyst does not implant, the contraction frequency 
remains low but the amplitude increases considerably (50–200 mmHg) producing 
labour-like contractions at the time of menstruation (Aguilar 2010). The difference in 
contractility through the menstrual cycle suggests some cyclical action of oestrogen 
and progesterone. 
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1.5.2 The menopause 
The menopause is defined as the permanent cessation of menstruation brought on 
by ovarian failure (Rees et al 2009). In the UK, the median age for onset of 
menopausal symptoms is 45.5 to 47.5 years (Burbos 2011).  Follicles in the ovaries 
become less responsive to follicle stimulating hormone (FSH) – which stimulates the 
follicles before ovulation – until ovulation ceases. The menopause is a retrospective 
definition made following one year of amenorrhoea (Rees et al 2009). It includes 
different phases, peri menopause, menopause and post menopause (Rees et al 
2009). The peri-menopause (or pre-menopause) is the period from the onset of 
menopausal symptoms, which is when ovarian function begins to decline, to the 
menopause, when oestrogen production ceases as no follicles. Post menopause are 
the years following menopause (when periods have stopped for at least twelve 
months). The age at which the menopause occurs is determined by genetics, 
environmental factors such as smoking, and surgery (oophorectomy), chemotherapy 
or radiotherapy (Rees et al 2009). Premature ovarian failure (early menopause) is 
where the ovaries stop functioning in women under the age of 45 years (Holloway 
2011). 
Common vasomotor symptoms include hot flushes, night sweats, sweating, 
palpitations, insomnia, sleep disturbances, shivering, increased pulse, feeling faint, 
and nausea. Vaginal and urinary symptoms include vaginal infections, post-coital 
bleeding, painful sex, itching or irritation, decreased libido (hormonal causes: 
atrophic changes (loss of elasticity in vaginal tissues), decreased lubrication, change 
in sensory perception), dysuria, atrophic vaginitis – dryness, urinary 
frequency/urgency, stress and urge incontinence. Other symptoms include changes 
in bleeding pattern, irregular periods, heavier periods, long gaps of amenorrhoea, 
skin itching or crawling sensations, and joint pain. Symptoms of the menopause can 
be managed with lifestyle changes (such as regular exercise and weight reduction), 
complementary treatments (homeopathy) prescribed alternatives (such as 
progestogens to control hot flushes) and hormone replacement therapy (HRT). HRT 
is a combination of oestrogen and progesterone which help to relieve the symptoms 
of menopause. 
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There is little research looking at the differences in contractility with onset of the 
menopause. Domali et al showed invitro the effects of endothelin-1 (ET1) on the 
myometrial contractility of pre and post menopausal women showing observations 
from segments of equilibration periods from both groups, concluding pre-
menopausal myometrium contracted quicker, and were more frequent than post 
menopausal myometrium, however no analysis was performed. Although the main 
finding of this research was the long-lasting effectiveness of ET1 in strips collected 
from post menopausal women compared with pre menopausal women, perhaps the 
effect of ET1 is enhanced by the oestrogen deficiency after menopause. They also 
found that there was no change in the response to High K+ in either group and 
suggested that High K+ and ET1 affect uterine contractility through different 
mechanisms and that ovarian steroids may play a regulatory role in human uterine 
responsiveness to ET1 (Domali 2001).  
 
1.5.3 Endometriosis 
Endometriosis is one of the most common gynaecological disorders. It affects 10–
15% of all women in the reproductive years. The incidence is 40–60% in women with 
dysmenorrhoea and 20–30% in those with subfertility (WSHL 2010). Endometriosis is 
a chronic, inflammatory condition characterised by growth of endometrial tissue in 
sites outside the uterus, most commonly in the pelvic cavity, but also in other parts 
of the body (RCOG 2006). The condition is predominantly found in women of 
reproductive age, from all ethnic and social groups (RCOG 2006).  This ectopic tissue 
responds to the hormonal changes of the menstrual cycle, with subsequent bleeding, 
inflammation, and pain. If the ovaries are affected, endometriotic ovarian cysts may 
develop (Bulun 2009). Symptoms associated with endometriosis may include 
infertility defined as the inability to conceive and is one of the problems associated 
with endometriosis. As this inability is often not absolute, the term 'subfertility' is 
preferred. Dysmenorrhoea is severe uterine pain during menstruation. 
Although the condition may be asymptomatic, common symptoms include 
dysmenorrhoea, dyspareunia, non-cyclical pelvic and abdominal pain, and 
subfertility (RCOG 2006). The cause of endometriosis is not known, but several 
factors are thought to be involved in its development. These include retrograde 
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menstruation (backward movement of menstrual fluids); embryonic cells giving rise 
to deposits in distant sites around the body; an abnormal quantity or quality of 
endometrial cells; failure of immunological mechanisms; angiogenesis; and the 
production of antibodies against endometrial cells (Gazvani 2002, Rock 1992, Seli 
2003, Kyama 2003, Oral 1996). 
Pain due to endometriosis can be functional, neuropathic, due to inflammation, or 
result from a combination of these. It may be evoked by a low intensity, normally 
innocuous stimulus (allodynia), it may be an exaggerated and prolonged response to 
a noxious stimulus (hyperalgesia), or it may be spontaneous in the absence of any 
apparent peripheral stimulus (Lundeberg 2008). In addition, oestrogens and 
prostaglandins probably play key modulatory roles in endometriosis and the pain it 
causes (Lundeberg 2008). Consequently, current medical treatments for the 
condition include drugs such as non steroidal anti-inflammatories (NSAIDs), 
combined oral contraceptives, progestogens (Provera, Mirena coil), 
antiprogestogens (Danazol and Gestrinone) and gonadotrophin releasing hormone 
analogues, as well as surgical excision of endometriotic lesions. However, 
management of pain in women with endometriosis is often inadequate. 
Retrograde contractions are contractions propagating from the cervical end of the 
uterus towards the fundus aiding in sperm transport or possibly in retention of iron 
for example, following blood losses at menstruation (Kunz and Leyendecker 2002). In 
the pregnant uterus, these retrograde contractions may also have roles in the 
maintenance of early pregnancies within the uterine cavity (de Vries et al. 1990), but 
possibly also in causing endometriosis, as menstrual debris enters the peritoneal 
cavity. Despite the common occurrence and the huge economic burden of 
endometriosis, the many biological studies using a range of models have not yet 
identified the causative mechanisms. Changes in myometrial contractions could be 
involved in increasing the back flow of menstrual debris in to the pelvic cavity, giving 
rise to endometriotic deposits. Only in vivo techniques have been investigated to 
look for changes in myometrial contractility in response to endometriosis. In 1995, 
Salamanca and Beltran in a study of inner myometrial contractility using transvaginal 
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sonography in women with endometriosis found a predominantly retrograde pattern 
of subendometrial contractions during menstruation (Salamanca 1995). In 2002, 
intrauterine pressures were recorded showing increased frequency, amplitude and 
basal pressure tone within infertile endometriosis patients when compared to 
infertile patients without endometriosis (control). Retrograde bleeding was found in 
73% of these patients with endometriosis compared to 9% of the control group. This 
study also shows 45% endometrial debris within the cul-de-sac of endometriosis 
patients compared to 0% in controls which could implant (Bulletti 2002). Both 
studies indicate abnormal alterations of uterine contractility at the time of menses 
are involved in the development of endometriosis. No in vitro studies to look at 
myometrial contractions of women with endometriosis have been performed.  
 
1.5.4 Pregnancy 
The uterus has a number of important functions that are fundamental for successful 
pregnancy to occur. It provides an appropriate environment for implantation of the 
fertilised ovum, after which time it undergoes alterations in size and structure to 
accommodate to the needs of the growing embryo. During pregnancy, the uterus 
provides nourishment for the fetus and also serves as a mechanical barrier 
throughout the entire developmental stage. As gestation progresses and term 
approaches however, the uterus undergoes a number of preparatory changes in 
readiness for the onset of labour and for the activity required for successful delivery 
of the fetus and placenta. 
 
1.5.5 Labour 
Human labour is the process whereby the products of conception (fetus, placenta 
and membranes) at a gestation where the fetus is viable (term) are expelled from 
the genital tract. In humans the process begins naturally at term (37- 42 weeks of 
gestation).  Labours that occur between 24-37 weeks of gestation are referred to as 
pre-term labours. 
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The safe passage of the fetus through the birth canal is dependent upon five 
unknown factors of labour (Beazley 1995): 
i) The efficiency of uterine contractions 
ii) the ‘give’ of the pelvis 
iii) the moulding potential of the fetal head 
iv) the fortitude of the mother  
v) the adaptability of the child’s physiology. 
The process of parturition is continuous but traditionally it is divided into three 
stages: 
The first stage 
This is from the onset of uterine contractions to full dilation of the cervix. It is the 
subdivided into the latent phase and the active phase. 
The time onset of spontaneous labour is difficult to determine and indeed the trigger 
for the commencement of this physiological process is still unknown. Clinically, the 
extrusion of the mucus ‘plug’ from the cervix, which appears as a jelly-like substance 
streaked with blood, commonly indicates that the labour process is about to 
commence. This occurs during the latent phase as the cervix undergoes extensive 
changes from a sphincter, designed to retain the products of conception to a dilator. 
The ground substance of the cervix hydrates, collagen is denatured and there is an 
increase in hyaluronidase. As a result, the ground substance changes from a gel to a 
fluid medium permitting deformation of the cervix (Gee &Olah 1993). 
During the active stage of labour the cervix dilates rapidly. The rate of dilation was 
described by Freidman in 1955 as 1cm per hour. This is adhered to today as the rate 
of ‘normal’ progress in labour; however this changes amongst different populations. 
Throughout the first stage of labour, contractions increase in their frequency and 
duration becoming more powerful and painful to the mother. 
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The second stage 
This is from full dilatation of the cervix to delivery of the infant. It can be subdivided 
into two phases; the descent phase, when the presenting part of the infant descends 
through the maternal pelvis, triggering a ‘need to push’ response from the mother 
and a second expulsive phase which results in active maternal pushing and delivery 
of the infant. 
The third stage 
From delivery of the infant to separation and expulsion of the placenta and 
membranes. 
1.5.6 Premature Labour 
Preterm birth is defined as any delivery, regardless of birth weight, that occurs 
before 37 completed weeks of gestation but after the gestation of viability (WHO 
1969). Prematurity is the principal cause of neonatal mortality (Mathews 2004)  and 
a major cause of paediatric morbidity and long-term disability (Hack 2002, 
Mccormick 2002); it is associated with at least 50% of all paediatric 
neurodevelopmental disorders (Goldenberg 1998). The incidence is gradually 
increasing and currently complicates 7% of all pregnancies. These rates however, 
vary considerably between races and populations being about 8.8% in Caucasian and 
18.9% in black communities (Lyon 1994). 
The aetiology of spontaneous premature labour is often unknown. Risk factors 
include: low socioeconomic status, low maternal weight at time of conception, 
maternal smoking, uterine abnormalities, cervical incompetence, antepartum 
haemorrhage, pre-eclampsia, multiple gestations, previous preterm labour and 
infection. 
In some cases prevention of contractility can be a useful way to prevent pre-term 
labour and improve neonatal outcome but in cases of antepartum haemorrhage, 
pre-eclampsia and infection this may not be the case. As of yet there is no clinical 
evidence for the use of tocolytic drugs in prolonging gestation. 
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The choice of tocolytic drug remains controversial. Magnesium sulphate, calcium 
channel blockers, prostaglandin synthase inhibitors, nitric oxide donors, β-adrenergic 
receptor agonists, oxytocin antagonists as well as progesterone (P4) have all been 
suggested to be effective (Arrowsmith 2010). All help to relax the uterus to promote 
quiescence. There is no consensus on the best tocolytic of choice although the rate 
of pre-term delivery has not declined. This suggests the invention used is not 
effective and new ones are needed and that a better understanding of the 
mechanisms of force production by the uterus may therefore lead to the 
development of improved tocolytic agents. 
Overall, there is a need to find better ways to treat uterine dysfunctions. Recent 
evidence suggests a physiological role for H2S for example in the control of blood 
pressure and in changing contractility. Enzymes that produce H2S have been found in 
the myometrium and H2S causes a decrease in contractility suggesting H2S could give 
insight into the mechanism of quiescence and potentially help in pre-term birth. 
However, there are many unknowns in the understanding of H2S, its mechanism and 
its physiological relevance in the myometrium. 
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1.6 Thesis Aims 
The aims of my thesis was to investigate my hypothesis which is –  
H2S relaxes the myometrium and could potentially help therapeutically to reduce the 
incidence of preterm birth. Reduced contractility in the presence of H2S has been 
indicated in other smooth muscles as described in my introduction as well as few 
studies in the uterus. I examined H2S through the use of three H2S producing 
compounds NaHS, GYY4137 and L-cysteine. NaHS is the most widely used H2S 
producing compound although its toxicity and release of H2S in a non-physiological 
large bolus reveals the need for alternative H2S donors suitable for drug development.  
A new H2S generating compound, GYY4137, developed to slowly release H2S and thus 
better reflects physiological conditions and therefore is a more promising drug for 
clinical use. L-cysteine is a substrate for H2S production through the presence of 
enzymes CBS and CSE within tissues, an alternative and more physiological way to 
produce H2S compared to NaHS. Dose response curves were performed for novel 
compound GYY4137 upon myometrial contractility.  
I investigated whether the response to H2S producers changes throughout gestation 
and its potential involvement in quiescence through use of different gestational 
state rat myometrium as well as non-pregnant and term pregnant human 
myometrium. Firstly I characterised the non-pregnant human tissue samples 
received to see how contractility changed with age and pre or post menopausal 
hormonal status. I also looked at whether H2S has an affect on oxytocin stimulated 
term pregnant myometrial contractions. I explored the mechanism of H2S action in 
the myometrium. As suggested by other studies on smooth muscle, KATP channels are 
the most widely researched for its involvement in the relaxant affect produced by 
H2S. In the myometrium, L-type calcium channels are a key target to initiate changes 
in contractility. Therefore I examined the affect of H2S on both L-type calcium 
channels and KATP channels through use of calcium sensitive indicator indo-1, high K, 
BayK as well as KATP channel inhibitor glibenclamide.  
As myometrial contractility is reduced throughout gestation I carried out 
immunohistological analysis on sections of myometrium from non-pregnant and 
term pregnant women to look for the distribution of H2S production enzymes CBS 
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and CSE and performed Westerns to indicate any differences in expression of both 
enzymes present within these tissues. Rhodhanese is involved in detoxifying H2S. 
Rhodanese consists of two sulfurtransferase components, thiosulfate 
sulfurtransferase (TST) and mercaptopyruvate sulfur-transferase (MST), with close 
structural and size similarities. There is evidence that rhodanese, particularly TST, 
might be involved in detoxification of H2S 
Therefore I examined the presence and expression of TST within the myometrium to 
see if there is any difference between tissues. Overall, looking at both production 
and breakdown of H2S to assess whether or not the alterations in the responses 
found in contractility in response to H2S were due to their upregulation or down 
regulation. 
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Chapter 2 - General Materials and Methods 
2.1 Tissue  
Both human and animal tissues were used for the work performed in this thesis. 
2.1.1 Animal Tissue 
In this study female non-pregnant and time mated Wistar rats (Charles River, KENT, 
UK) were used. For the time mated Wistar rats the male was placed in the cage on 
Day 0 and left overnight to mate. The pregnant rat was allowed to reach 14, 18 and 
term, (day 22) and killed prior to labour. Labouring animals were also used and were 
taken on delivery of the first pup. All animals were humanely killed by cervical 
dislocation under CO2 anaesthesia in accordance with UK Home Office legislation. 
Pups were delivered by caesarean section and killed by decapitation in accordance 
with UK Home Office legislation. Once all pups had been removed the uterus was 
dissected and immediately placed into physiological saline solution (PSS): (154mM 
NaCl; 5.6mM KCl; 1.2mM Mg204.7H2O; 10.9mM 2-[4-(2-hydroxyethyl)piperazin-1-
yl]ethanesulfonic acid (HEPES); 8mM glucose; 2mM CaCl2, pH 7.4). The uterine tissue 
was then rinsed and cleaned, removing any foetal membranes, placenta, fat and any 
excess blood prior to myometrial dissection. 
 
2.1.2 Human Tissue 
The human tissues used for these studies were non-pregnant and pregnant 
myometrial biopsies. Non-pregnant tissues were collected from women undergoing 
hysterectomy and pregnant tissues from elective caesarean section. Ethical approval 
was sought separately for the use of pregnant and non-pregnant hysterectomy 
myometrium within this project and granted (Appendix 2). For myometrial tissue 
from the Liverpool Women’s NHS Foundation Trust Hospital Myometrial Research 
Tissue Bank (MRTB) a further application was submitted to the hospital (Appendix 3). 
Access was granted from the MRTB.  
Patients were consented by research midwives and clinicians at the preoperative 
clinic. Written informed consent was obtained and proformas detailing any relevant 
clinical history and medical conditions was also filled in (Appendix 4). 
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 Biopsies from non-pregnant women undergoing hysterectomy were taken 
immediately after the removal of the uterus from the lower half of anterior uterine 
wall, so as to approximate the area where the biopsy was removed from the 
pregnant uterus. For pregnant tissues, full thickness biopsies measuring 1cm x 1cm 
were taken after delivery from the middle of the upper edge, lower segment uterine 
incision at time of caesarean section.  All biopsies were then placed immediately into 
chilled Hanks Balanced Salt Solution(HBSS): (137mM NaCl; 5.1mM KCl; 0.44mM 
KH2PO4; 0.26 Na2HPO4 ; 5mM glucose, 10mM HEPES, pH 7.2) and then transferred to 
the physiology department. All biopsies were collected and handled using a protocol 
to prevent tissue degradation and to ensure all condition for experiments were the 
same. Biopsies were used either on the day of collection (within 3 hours of removal 
from organ) or the next day after storage at 4 oC. Biopsies were never used more 
than 18 hours after delivery. Observations from Crankshaw et al (Hillcock and 
Crankshaw (1999) Senchyna and Crankshaw (1999) and Popat and Crankshaw 
(2001)) have indicated that human myometrium stored in PSS for up to 18 hours and 
at room temperature do not behave differently upon exposure to a number of 
different agents compared to fresh samples. Unpublished results obtained within 
our group and my own findings would also confirm this. 
 
2.2 Tissue Preparation and Dissection 
 
Each tissue type was placed in a dissection dish containing PSS solution at room 
temperature. 
 
2.2.1   Animal Tissue Dissection 
A small section approximately 1cm in length of the uterine horn was cut from the 
ovarian end. An incision to the uterine tube longitudinally was cut and opened out, 
then pinned out with the myometrium facing upwards. The surface of the tissue was 
cleaned using a cotton cue tip to remove any serosal cells. Strips of longitudinal 
myometrium were dissected avoiding any underlying circular smooth muscle and 
endometrium and were placed into physiological saline solution. 
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2.2.2    Human Biopsy Dissection 
Samples were transferred from HBSS into PSS where they were cleaned and trimmed 
of any blood, endometrium, and peritoneum. Using blunt dissection an opening was 
made between muscle bundles to expose the inner tissue not subjected to any 
external trauma. Small longitudinal strips of muscle were dissected from the biopsy, 
each approximately 1x5mm and placed into physiological saline solution. 
In specimens from pregnant women, hypertrophy of the smooth muscle bundles 
enabled dissection of strips where the majority of the muscle fibres were running in 
the same direction. Dissection of tissue from non-pregnant women was more 
difficult and it was composed of more interwoven fibres. 
 
2.3. Chemical and Solutions used for Contractility Experiments 
All chemicals used were purchased from Sigma (Dorset, UK) unless otherwise stated. 
In stock solutions of certain substances that did not dissolve within PSS, solvents 
such as ethanol and DMSO were used. These substances do not alter the myometrial 
strip contractile activity as reported previously. (Taggart &Wray, 1997, Taggart & 
Wray 1998, Noble & Wray 2002). 
 
High Potassium Solution 
119.6mM NaCl; 40mM KCL; 1.2mM Mg2047H2O; 10.9mM HEPES; 8mM glucose; 
2mM CaCl2, 
pH 7.4 
 
GYY4137  
A 1mM GYY4137 (Santa Cruz biotechnology, USA) stock solution was prepared in 
PSS. The solution pH was adjusted (pH7.4) before use and made fresh before each 
experiment. Then serial dilutions were prepared from the stock to produce 1nM, 
1µM, 0.1mM. GYY4137 is a H2S donor. 
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Sodium hydrogen sulphide (NaHS) 
A 1mM NaHS solution (Alfa Aesar, uk) was prepared in PSS. The solution pH was 
adjusted (pH7.4) before use and made fresh before each experiment. NaHS is a H2S 
producer. 
 
Dithiothreitol (DTT) 
A 1mM DTT solution (Sigma Aldrich, uk) was prepared in PSS. The solution pH was 
adjusted (pH7.4) before use and made fresh before each experiment. DTT is a 
reducing sulphydryl modifier. DTT transforms disulphide bonds to thiol groups. 
 
Diamide (DM)  
A 1mM DM solution (Sigma Aldrich, uk) was prepared in PSS. The solution pH was 
adjusted (pH7.4) before use and made fresh before each experiment. DM is a 
oxidant sulphydryl modifier. Diamide converts thiol groups to disulphide bonds. 
 
L-Cystiene 
A 1mM L-cysteine stock solution was prepared in PSS. The solution pH was adjusted 
(pH7.4) before use and made fresh before each experiment. Then serial dilutions 
were prepared from the stock to produce 1nM, 1µM, 0.1mM. L-cysteine is the 
substrate H2S production enzymes use in tissue to form H2S. 
 
D-cysteine, 
A 1mM D-cysteine stock solution was prepared in PSS. The solution pH was adjusted 
before use and made fresh before each experiment. D-cysteine is the opposite 
stereoisomer of L-cysteine. Isomers are molecules that have the same molecular 
formula but differ in the way the atoms are arranged around the central atom. 
 
Oxytocin 
A 1mM Oxytocin was prepared by dissolving the lyophilized powder in double 
distilled water. From the 1mM stock a further diluted stock of 10μM solution was 
prepared, aliquoted and stored at -20°C. For use in contractility experiments a 
concentration was used that would not cause a tonic response but would augment 
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contraction frequency and force. A concentration of 0.5nM was used for human 
myometrial strips.  
 
BayK 8644 (BayK) 
BayK was dissolved in ethanol (63mg/ml) to produce a 10 mM stock solution. A 0.1 
µM solution was used in rat tissue and was diluted using PSS. Above 0.5 µM 
concentrations were not used as tonic rather than phasic contractions were found. 
BayK is a calcium channel agonist and increases the open probability to L-type 
calcium channels (Lauven et al 1999). 
 
L-serine 
 A 1mM L-serine stock solution was prepared in PSS. The solution pH was adjusted 
before use to 7.4 and made fresh before each experiment. L-serine is an analogue of 
L-cysteine in which the sulphur atom is replaced with an oxygen atom. 
 
Sodium pyruvate 
 A 1mM sodium pyruvate stock solution was prepared in PSS. The solution pH was 
adjusted before use to7.4 and made fresh before each experiment. 
 
Propylargylglycine (PAG)  
A 1mM PAG stock solution (Santa Cruz biotechnology, USA) was prepared in PSS. The 
solution pH was adjusted to 7.4 before use and made fresh before each experiment. 
H2S is produced by two enzymes Cystathionine gamma lyase (CSE) and Cystathionine 
beta synthase (CBS). PAG is a CSE enzyme inhibitor. 
 
Aminooxyacetic acid (AOAA) 
A 1mM AOAA stock solution was prepared in PSS. The solution pH was adjusted 
before use to 7.4 and made fresh before each experiment. AOAA is a CBS inhibitor. 
 
Hydroxylamine (HA) 
A 1mM HA stock solution was prepared in PSS. The solution pH was adjusted before 
use to 7.4 and made fresh before each experiment. HA is a CBS inhibitor. 
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Garlic  
Solutions from 0.0025- 1 mg/ml Garlic powder(100% pure garlic powder, RAJAH) 
were prepared in PSS. The solution pH was adjusted before use to 7.4 and made 
fresh before each experiment. 
 
Glibenclamide 
A 10mM stock solution was prepared every week in DMSO, then aliquoted and 
stored at -20°C. For use in contractility experiments a 1mM solution using this stock 
was prepared. Glibenclamide is a KATP channel inhibitor.  
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2.4 Measurement of Intracellular calcium 
The concentration of intracellular ions such as Ca2+, Na+ and H+, are important in the 
regulation of cell function. Calcium is the main ion responsible for smooth muscle 
contraction, although pH differences can also be responsible for some of the 
changes we see in contractility especially in response to agonists. The work in this 
thesis involves establishing not only changes in smooth muscle contractility under 
differing conditions but also the associated changes in intracellular calcium ([Ca2+]i), 
and intracellular pH (pHi). 
Fluorescent probes are the most popular method for establishing intracellular 
concentrations of ions. This is because (Tsien 1989): 
 In most cell types the probes can be incorporated into the intact functioning 
cell without any breaching of the plasma membrane. 
 Indicators allow ion activities or free concentrations to be measured. 
 Fluorescent probes can be used at all levels of organisation from whole 
organs to isolated tissue fragments to populations of disaggregated cells to 
single cells to subcellular domains of single cells. 
 Simple application of fluorescent indicators only need a fluorometer but also 
sophisticated instruction is available leading  to dual-wavelength ratio 
fluorometry, digital ratio imaging microscopy and scanning confocal 
microscopy. 
For a fluorescent compound to be a useful indicator, the fluorescence intensity must 
change as a function of the concentration of the measured ion. In addition a valuable 
property is that either the excitation or emission spectrum should change in shape, 
thus allowing dual wavelength measurements (Valdeolmillos & Eisner, 1991). 
 
2.4.1 Fluorescence process 
Fluorescence is a process that begins with excitation. A photon of energy is applied 
via an external source such as a lamp or laser and the energy is absorbed by the 
fluorophore. This forms an elevated ‘excited’ energy state of the fluorophore. This 
excited state however, is not infinite and some of the energy becomes dissipated 
revealing a more relaxed state but does not completely reach its original (ground 
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energy state). Fluorescence then concludes with the emission of a photon of energy 
from the fluorophore returning back to the ground state. Some energy is dissipated 
during the excited state therefore the energy of the photon emitted is lower and is 
therefore of a longer wavelength than the initial excitation photon. This difference is 
called the Stokes shift and is fundamental to fluorescence techniques as it allows for 
emission photons to be detected against a background of excitation photons. 
This process of fluorescence can reoccur as long as the fluorophore is not irreversibly 
destroyed (i.e photobleaching) therefore the same fluorophore can be repeatedly 
excited and detected. Each fluorophore is also capable of generating thousands of 
photons. For fluorescence to be detected an excitation source, a fluorophore, 
wavelength filters to isolate emission photons from excitation photons and a 
detector that registers emission photons and produces an output that can be 
recorded are required. For detection of cellular ions such as calcium, as used in this 
thesis, often the fluorescent indicator used has different excitation or emission 
spectra for its free and ion-bound form. Fluorescence systems such as these are 
called ratiometric systems since the ratio of the optical signals (ie. excitation or 
emission spectra) can be used to measure the change in the free and ion bound 
indicator forms which in turn can be used to quantify ion concentrations.  
 
2.4.2 Fluorescent indicators and measurement of intracellular calcium and 
intracellular pH (cytosolic free) 
 
The fluorescent indicators Indo-1 and Carboxy SNARF-1 have been used in this 
dissertation. 
Indo-1 AM (Figure 2.1) have binding sites which are modelled on the Ca2+ selective 
chelator ethylene glycol bis(β-aminoethyl ether) N, N’-tetracetic acid (EGTA). EGTA 
at pH 7 is normally occupied by two protons, but the incorporation of the aromatic 
rings in the fluorescent indicators lowers the PKa of the amine nitrogens to 6.5 or 
below thus eliminating all the proton interference for pH>6.8. Ca2+ binding diverts 
the nitrogen lone pair electrons away from the aromatic system, causing large 
spectral changes. The more electron donating or withdrawing the aromatic nucleus, 
the higher or lower the Ca2+ affinity (Tsien 1980). Indo-1 is a dual emission calcium 
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sensitive indicator. Two emission wavelengths are collected, calcium free (approx 
500nm) and calcium bound (400nm), once excited at about 340-350nm (Figure 2.3).  
5- (and 6)-Carboxy SNARF-1 AM (Figure 2.2) is used by exciting the dye at between 
488 nm -530 nm, while monitoring the fluorescence emission at two wavelengths, 
the proton-bound and unbound forms of SNARF emit at 590 and 640 nm (Figure 
2.3), respectively. These are pH-dependent emission shifts going from yellow-orange 
to deep-red fluorescence as conditions become more basic. The absorption 
spectrum of the carboxy SNARF-1 pH indicator undergoes a shift to longer 
wavelengths upon deprotonation of its phenolic substituent (Invitrogen). The use of 
dual emission spectroscopy increases the precision of the measurement, reduces the 
effects of instrumentation shift, movement artefacts or loading dye content, and 
permits the quantification of the signal without knowing the concentration of 
intracellular indicator. The fluorescent signal is also independent of the cell thickness 
(valdeomillos & Eisner, 1991, Grynkiewicz, Poenie et al. 1985). 
These indicators were incorporated into cells as ester AM (acetoxymethyl ester) 
derivatives. This form of the indicator is readily cell permeable as it is uncharged and 
hydrophobic and thus can cross lipid membranes, gaining entry to the interior of 
cells (Kao, 1994). The carboxyl groups in the indicator are essential to the ability of 
the indicator molecule to sense Ca2+; therefore the AM groups must be removed 
once the AM ester has entered the cell. The AM esters are cleaved by cytosolic 
esterases once inside the cell which restricts the indicator to the cytosolic 
compartments. This is because the polycarboxylate form of both indicators is 
multiply charged and thus becomes trapped within the cell. 
 
Tissue loading with indicators can be improved by adding the detergent Pluronic F-
127 as it is a mild non ionic surfactant and dispersing agent for AM esters. Pluronic is 
presumed to sequester the AM ester in micellar from, thus preventing precipitation 
and the micelles are presumed to serve as a steady source to replenish AM esters 
taken up by cells (calcium in living cells, Whitaker, 2010). Both Pluronic acid and AM 
ester stock solutions in Dimethylsulfoxide (DMSO) are mixed intimately before 
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dispersal into an aqueous medium, facilitating the solubilisation of the water-
insoluble dyes in physiological media and improving the loading of indicators into 
cells, this methodology was incorporated into the loading technique. 
 
 
 
 
Figure 2.1 Diagram of the structural modifications involved in loading cells using 
Indo-1 AM. The membrane-permeable  acetoxymethyl (AM) ester derivative of Indo-
1 (Indo-1 AM) is insensitive to Ca2+ions and therefore does not bind to Ca2+. 
However, once inside the cells it is readily hydrolysed to Indo-1 by ubiquitous 
endogenous esterases, releasing the ion sensitive indicator. Cleavage if the ester 
produces a polar form of the indicator which is cell impermeable and is therefore 
retained within the cells interior. (Figure adapted from Johnson I, current protocols). 
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Figure 2.2 Diagram of the structural modifications involved in loading cells using 6-
(and 5) carboxy SNARF-1 AM. The membrane-permeable acetoxymethyl (AM) ester 
derivative of SNARF-1 (SNARF-1 AM) is not affected by pH. However, once inside the 
cells it is readily hydrolysed SNARF-1 by ubiquitous endogenous esterases, releasing 
the pH sensitive indicator. Cleavage if the ester produces a polar form of the 
indicator which is cell impermeable and is therefore retained within the cells 
interior. (Johnson I, current protocols). 
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Figure 2.3 Fluorescence emission spectra of Indo-1 and 5-(and 6)- Carboxy SNARF-
1. 
Ca2+- dependent emission spectra of Indo-1 excited at 338nm, shifts from~475nm in Ca2+- 
free medium to ~400nm when the dye is saturated with Ca2+. pH-dependent emission 
spectra of carboxy SNARF-1 when excited at 488nm shifts from ~640 nm when proton  
bound  form ~590nm when  in its proton unbound form. Figures taken from Invitrogen 
Handbook. 
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2.4.3 Advantages and disadvantages of indicators 
 
Photobleaching 
Photobleaching is the irreversible destruction of the excited fluorophore. Another 
factor contributing to loss of signal is leakage of fluorophore out of the cell. For 
mammalian cells the loss rate is maximal at 37oC and drops sharply as temperature is 
lowered (Kao, 1994). To help reduce photobleaching, detection sensitivity can be 
increased to maximum so allowing a reduction in the intensity of excitation. This was 
undertaken in all experiments. Also neutral density filters were inserted in front of 
the excitation light to reduce light intensity in the tissues (Tsien 1989, Haugland 
1995).  
 
Autofluorescence 
Tissue autofluorescence results from naturally occurring cellular fluorophores, such 
as NADH, and riboflavin. If the contribution from autofluorescence is significant this 
will affect the total fluorescence readings and thus an estimate of autofluorescence 
is required in order to calculate intracellular calcium. It has been shown that 
myometrial strips have autofluorescence at 340nm (luckas et al 2000), which will 
increase the 500nm signal in response to an increase [Ca]i. However the same 
author showed that this autofluorescence was very small (<5%) and the signals 
changed in opposite directions, thus the autofluorescence of myometrial strips is not 
significant. 
 
Subcellular compartmentalisation of fluorophores 
Indicators can be compartmentalised into other organelles such as sarcoplasmic 
reticulum and mitochondria. In order to correct for the contribution of the above 
fluorescence signal, an estimate of their contribution to the signal can be made via 
quenching with manganese (Mn) (Hesketh et al, 1983). The measured emission 
following quenching is subtracted from the total signal, the difference equalling the 
signal derived from cytosolic free indicator. 
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Despite these disadvantages, preventative steps have been put in place to avoid cell 
toxicity and compartmentalisation of the dye. These steps include minimising the 
indicator loading time (<4 hours), loading in a dark place to avoid photobleaching, 
and therefore loss of fluorescence as well as loading at lower temperatures (room 
temperature).  
 
2.5 Force, Calcium and pHi Measurements 
Indo 1AM and Carboxy SNARF-1 AM were prepared by dissolving in DMSO. There is 
no significant effect of DMSO on myometrial contractility at the concentration used 
for Indo-1 AM and Carboxy SNARF-1 AM loading (Taggart, Menice et al. 1997).   
 
2.5.1 Calibration of force 
Force was calibrated to Newtons (N). The electrical signal from the transducer was 
amplified and converted to a digital signal and record on a computer using Axoscope 
software (Figure 2.4). Force was calibrated by comparing force traces to traces 
obtained from a known amount of force. This was done by suspending weights from 
the transducer and converting to force using the equation: N=kg.ms-2 where 1kg is 
9.8N. 
 
2.5.2 Loading Tissue with Membrane Permeable Calcium Indicator Indo -1 
To monitor changes in intracellular calcium concentrations [Ca2+]i  the ratiometric 
calcium indicator Indo-1 acetoxymethyl ester (Indo-1AM, Molecular Probes, Oregon, 
USA) was used. To load myometrial strips 50μg of Indo-1/AM was dissolved in 50μl 
of a solution of 200µl dimethyl sulphoxide (DMSO) containing 0.05g pluronic acid. 
This solution was added to 4ml of PSS and vortexed creating a 12.5μM solution. This 
solution was separated into two 5ml vials to which the dissected myometrial strips 
(no more than 6 strips per 2mls) were added. These were then incubated for 3 hours 
at room temperature on a rotating platform, once loaded tissue was transferred to 
PSS. 
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2.5.3 Loading Tissue with pHi Indicator SNARF 
To monitor changes in pHi  the ratiometric pH indicator caroboxy SNARF-1 (carboxy 
SNARF-1 AM, Molecular Probes, Oregon, USA) was used. To load myometrial strips 
50μg of carboxy SNARF-1/AM was dissolved in 50μl of a solution of 200µl dimethyl 
sulphoxide (DMSO) containing 0.05g pluronic. This solution was added to 8ml of PSS 
and vortexed creating a 11μM solution. 4mls of this solution was separated into two 
5ml vials to which the dissected myometrial strips (no more than 6 strips per 2mls) 
were added. These were then incubated for 2 hours at room temperature on a 
rotating platform, once loaded tissue was transferred to PSS.  
 
2.5.4 Simultaneous Measurements of Calcium and Force or pHi and Force 
All strips were stretched to a resting tension of 2mN to ensure the degree of stretch 
exerted to all samples was standardised across experiments. Loaded myometrial 
strips were transferred to a dissection dish to attach aluminium foil clips either end 
of the strip. These strips were then placed into a 1ml perfusion bath above an 
inverted microscope. The strips were held in place by attaching one clip to a fixed 
hook inside the perfusion chamber and the other to a hook attached to a force 
transducer connected to a digi data acquisition system. This system includes the 
software Axoscope which records the contractility data and output from the photo 
multiplier tubes (PMT’s) for ratio metric measurements of indo-1AM and carboxy 
SNARF-1AM. Once the tissue was attached a stretch of 2mN was given as a standard 
resting tension for all experiments. In the bath the strips were super-perfused with 
physiological saline solution pH7.4 at 37°C and spontaneous contractions were left 
to equilibrate for 60-90miniutes. The inverted microscope objective was focused 
onto the tissue and the fluorescent dye now loaded in the tissue was excited by 
ultraviolet illumination from a xenon lamp at a wavelength of 340nm (indo-1AM), 
530nm (Carboxy SNARF-1AM). Light emitted at both wavelengths for each dual 
emission indicator was detected by the photomultiplier tubes and recorded using 
Axoscope software (Figure 2.4). The rise and fall of intracellular calcium which is 
responsible for myometrial contractions is measured by the changes in the Indo-
1AM ratio calculated from the shifts in the emission signals from the 400nm and 
500nm photomultiplier tubes, as described above. The rise in intracellular pH is 
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measured by the changes in the SNARF-1 ratio calculated from the shifts in the 
emission signals from the 590nm and 640 photomultiplier tubes. 
When incubation experiments were performed (Figure 2.5) for monitoring the 
effects of GYY4137, NaHS, and PSS (control) strips were placed on the rig for a 
control period and then incubated in test solution for 45 minutes, within a hot plate 
in a fume hood at 37oC and then strips were re-attached between the fixed hook and 
force transducer and contractions monitored after 5 minutes of re-attachment.  
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Figure 2.4 – Diagram of Equipment designed to record Simultaneous 
Measurements of Force and Calcium or Force and intracellular pH (pHi).  
To excite the calcium fluorescent dye Ultraviolet illumination is provided by a xenon 
lamp (1). A heat filter (2) and neutral density filter (3) are placed in the path of light 
to reduce the light intensity and heat on the excitation filter (4). A mechanical 
shutter (5) in the excitation pathway keeps the tissue light exposure time to a 
minimum to prevent photobleaching. The excited light hits the dichroic mirror 1 
(DM1) which is angled to reflect onto the indicator loaded tissue strip through a 
focused microscope objective (6). The light emitted by the fluorescence indicator is 
then passed back through the microscope objective, through dichroic mirror1, 
reflected by a sliding mirror and directed through and adjustable diaphragm (7). The 
light then hits a DM2 mounted at 45°. The longer wavelength emitted light is 
diverted to the video camera and the shorter wavelength light is passed through a 
DM3 directed to the photomultipliers (8, PMTs). The DM3 splits the emitted light 
and passes it through emission filters (9) of specific wavelengths for both indo-1 and 
6-(and 5) Carboxy SNARF-1 emissions. To avoid interference from the microscope 
light with the fluorescence measurements, a long pass filter (10) is positioned in 
front of the microscope lamp (11).  
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Figure 2.5- Diagram of the incubation technique to monitor the contractility 
changes using GYY4137 and NaHS. This was performed as H2S is a very potent gas 
and is poisonous at ppm levels. Firstly 1x5mm myometrial strips from rat of varying 
gestation and human tissue were dissected (A). Then once the strips were clipped up 
attached to a fixed hook and force transducer (same set up as Figure 2.4) and 
monitored for a control period (B). After establishing a control period strips were 
incubated in a fumehood at 37oC for 45 minutes (C) and then placed back on the rig 
to monitor changes in contractility (B).All ultimately to produce a force trace, 
underlying calcium transients were also monitored using the same technique via the 
use of Indo-1 (D).  
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2.5.5 Measurements of Force alone 
The same experimental setup as described in section 2.5.4 was used for force alone 
measurements except the tissue was not loaded with a fluorescent dye. For control 
periods, once spontaneous contractions were established the strips were left for 
approximately 30minutes – 60minutes to allow for a sufficient control period of 
contractions of similar force, duration and frequency to develop. Any treatments to 
be used were then either super-perfused through the tissue or incubated at 37oC, pH 
7.4 (Figure 2.5) and the effect on contractility was measured. 
A time control showing a stable period of contractions is depicted in Figure 2.6. 
These are 5 hour traces showing that my dissected myometrial strips can contract 
for over 5 hours before any decline in force is seen due to tissue fatigue within both 
animal and human tissue. An incubation control for both animal and human tissue is 
also shown showing no change in contractility in control PSS solution before and 
after incubation re-attachment (Figure 2.7). 
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Figure 2.6 Control traces - showing a 5 hour period of myometrial contractions 
generated by a small longitudinal strip of myometrium dissected from A) a term rat 
myometrium and B) a term human biopsy.  
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Figure 2.7 Control incubation technique traces. Control contractility before and 
after incubation in physiological saline solution (PSS) of a term rat (A)and human (B) 
myometrial strip . (Strips were placed under a resting tension of 2mN and 
superfused continually with physiological saline solution (pH 7.4) at 37°C before and 
after the 45 minute incubation periods in PSS or NaHS (pH 7.4) at 37°C.  
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2.5.6 Analysis of Contractility Data 
There are four main parameters that were analysed for contractility data. All analysis 
was carried out in Origin Pro (Version 8.5).  
 
Force amplitude 
Force of contractions (mN) was measured by subtracting the value of the baseline 
from the peak of the contraction to be measured. An average of 10-30 minutes 
worth of contractions was taken for the control period which was then compared to 
the average obtained from any treatment periods. 10 minutes worth of contractions 
was assessed in the rat myometrium were as 30 minutes was monitored in the 
human myometrium to accommodate the slower rate of contractions. 
 
Duration 
Duration was measured by calculating the time (minutes) at the half maximal 
amplitude (t50)  point of the contraction. The duration of the same contractions used 
for the average force control period were measured and the same for the treatment 
period. 
 
Frequency 
A period of control contractions was selected and the time period between the 
beginning of one contraction to the beginning of the next was measured. This was 
done for 3-6 contractions and the average time was calculated. From this average 
the number of contractions in a ten minute period for rat contractility or 30 minute 
period for human contractility was calculated for both control and treatment 
periods. 
 
Area under the Curve (AUC)/Mean Integral of Force 
A period of 10-30 minutes control and treatment contractions were selected and the 
area under each contraction in the time period was measured. This gives an 
indication of the overall effects of frequency, duration and force. 
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Figure 2.8 Parameters measured for contractility. 
A) Force amplitude of contraction represented in force (mN) and corresponds to the height 
of the contraction (represented by the red arrow), B) Duration of contraction is represented 
as how long a single contraction lasts (minutes) and was measured at half the maximal peak 
of contraction (dotted blue lines show contraction height and half the contraction height, 
red arrow indicates duration), C) Frequency of contraction, D) AUC of contraction, a measure 
of the overall contractile activity. This data was obtained over 10 minutes for rat contractility 
and 30 minutes for human contractility. 
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2.6 Immunohistochemistry 
2.6.1 Fixation of tissue for immunohistochemistry 
Small pieces of myometrium approx 0.5mm x 0.5mm x 0.5mm were dissected and 
placed into neutral buffered formalin containing 10 % formalin. The fixed samples 
were left for 24 hours in the physiology fridge before transferring back to Liverpool 
Women’s Hospital. The fixed samples were processed and embedded in paraffin wax 
by Kelly Harper at Liverpool Women’s Hospital for human sections, and animal 
sections in the pathology department in the University of Liverpool Veterinary 
School and 4μm sections were cut, then mounted onto glass slides. Sections were 
cut from 6 pregnant and non-pregnant women as well as different stage gestation 
rats. For control tissues and antibody optimisation animal tissue was also used. 
Aorta and Kidney were dissected from 22 day pregnant Wistar rats, also non-
pregnant, 10, 14, 18, 22 day as well as labouring rat uterus were dissected. They 
were then placed in Formalin solution, neutral buffered, 10%. Embedding and 
sectioning was carried out in the pathology department in the University of Liverpool 
Veterinary School. 
 
2.6.2 Staining for CBS and CSE  
CBS enzyme – CBS monoclonal antibody, Abnova, clone 3E1 : 1:50 
CSE enzyme- CTH monoclonal antibody, Abnova, clone 4E1-1B7 : 1:150 
Both CBS and CSE antibodies have been used multiple times in recent literature 
(Rashid 2012, Kasparek 2011, Fu 2012). 
Beta Actin - beta Actin antibody, Abcam : 1:500 
Sections from human myometrium were labelled appropriately before combining in 
a metal rack. The rack was placed into a glass bath containing 100% Xylene for 
30minutes to remove the paraffin wax from the section. The sections were then 
dipped in a series of ethanol baths from 100%. 95%, 85%, 70% and 50% in order to 
rehydrate the sample before being placed into a bath of distilled water for 5 
minutes. The slides were then placed into a bath of boiling 14mM Sodium Citrate 
buffer pH6.0 in a microwave for 20mins to allow optimum antigen retrieval. The 
slides were allowed to cool for 20minutes on ice before washing with distilled water. 
Each slide was removed of excess water before circling the tissue section with 
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ImmEdge Hydrophobic barrier pen (Vector Laboratories) which allows reagents to 
remain localized. To block endogenous peroxidise activity 3% hydrogen peroxide 
(30% Hydrogen peroxide in tris buffered saline (TBS) solution) was dropped onto 
each tissue section and incubated for 30 minutes in a humid chamber. Slides were 
then rinsed with TBS-T (0.05% Tween20) and incubated for 1hour with non specific 
block 5% Bovine Albumin Serum (BSA) dissolved in 0.05% TBS-T. Slides were then 
rinsed again in TBS-T before overnight incubation with the appropriate antibody in 
blocking solution at 4°C. As a negative control one section from both non-pregnant 
hysterectomy and term pregnant patients, as well as a multiple stage rat 
myometrium slide, were incubated overnight in blocking solution alone. As a positive 
control an animal section that is known to express the protein of interest was used 
and for an antibody control beta actin was used. 
The following day the primary antibody was removed by 3 X 15 minute washes with 
TBS-T 
0.05% before incubating with secondary antibody at room temperature for 1hour 
(impress 
Universal Antibody anti-mouse Ig /anti-rabbit Ig, peroxidise polymer detection kit, 
Vector Labs). The secondary antibody was then removed by 3 X 15minute washes 
with TBS-T 
0.05%. As a HRP labelled secondary was used 3,3'-Diaminobenzidine (DAB) was used 
for developing (3,3′-Diaminobenzidine (DAB) Enhanced Liquid Substrate System 
tetrahydrochloride, Sigma). DAB was dropped onto the positive control slide first and 
placed under a microscope until a brown colour developed. The reaction was 
stopped by placing slide into distilled water. All slides from pregnant and non-
pregnant human were developed for the same time to reduce any bias in the 
experiments; the same was done for the different stage gestation animal tissue. 
Once all slides were developed the slides were counterstained with Haematoxylin by 
incubating with the stain for 1 minute followed by washing with tap water for 5 
minutes. The slides were then dehydrated by dipping in a series of ethanol baths 
from 50%, 70%, 85%, 95% and 100% before being placed into xylene. This removed 
any excess paraffin pen that was encircling the section. Cover slips were then 
mounted using DPX mountant and left to dry overnight before image capture. 
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2.6.3 Image Capture of Myometrial Biopsy Sections – DAB Stained. 
The setup used was provided by Liverpool Women’s Hospital university department 
and was composed of the following - 
1. Nikon Eclipse 50i Microscope, Nikon Corporation, Tokyo 100-8331, Japan 
2. Nikon DS-Fi1 digital camera Head 5M pixel, Nikon Corporation, Tokyo 100-8331, 
Japan 
3. Nikon Digital control unit DS-U2 USB, Nikon Corporation, Tokyo 100-8331, Japan 
4. Nikon C-Mount TV adaptor, 0.63x, Nikon Corporation, Tokyo 100-8331, Japan 
5. NIS-Elements-F software, developed for Nikon Instruments 
6. Personal computer (minimum specification 1GB RAM, 2.8GHz processor) 
After launching the NIS- Elements-F software a slide was placed on the microscope 
stage and moved to an area that contained a section of myometrial biopsy. The 
settings were adjusted to normal mode, 640x480 resolution, 1280x960 quality 
capture, and high colour contrast and sharpness. The microscope was calibrated 
using a scale slide for each objective 
– 4x, 10x and 40x. The whole tissue section was scanned on 4x objective and 10 x 
objective to examine which areas would be most representative of the entire tissue 
for photographing. The negative control was examined first to make sure there was 
no staining 
– if any staining was present then the experiment would have to be repeated. All 
slides were blinded to the observer to reduce any bias. After locating the areas with 
a high amount of staining the 40x objective was used to photograph 10 different 
areas of the section. This was repeated for all sections in each 
immunohistochemistry. 
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2.7 Western Blotting 
2.7.1 Protein Extraction  
A small section of myometrium was dissected, blotted onto filter paper and weighed 
to obtain a maximum of 1 gram of tissue. This was done for compiled non-pregnant, 
14, 18, and 22 day rat myometrial strips as well as pregnant and non-pregnant 
hysterectomy human. Once weighed the samples were snap frozen with liquid 
nitrogen and stored at -20°C. Once a sufficient number of samples were reached the 
tissue was removed from the freezer, diced with a scalpel and ground to a fine 
powder keeping it cold with liquid nitrogen before placing into protein extraction 
buffer – RIPA (Radio-Immunoprecipitation Assay) Buffer (1xPBS, 1.0% IGEPAL,0.5% 
Sodium Deoxycholate, 0.1%Sodium dodecyl sulphate). Just before use 30μl 
of100mM Sodium orthovanadate, 90μl Aprotinin, and 30μl of 10mg/ml of PMSF 
(phenylmethanesulfonylfluoride) was added to each 3ml of RIPA. For each 1g of 
tissue 3ml of prepared RIPA buffer was added, the tissue was then homogenised in 
5ml Bijou tubes using IKA Ultra Turrax T258N on level 5. The homogeniser was 
cleaned between each protein extraction and the samples all placed on ice. The 
homogenate was transferred to Eppendorfs and centrifuged at 12,000 RPM at 4°C 
for 10minutes. The supernatant was transferred to new Eppendorfs tubes and 
recentrifuged at 12,000 RPM at 4 C for 10minutes. Any samples that were in 
separate Eppendorfs were pooled and mixed, aliquoted and stored at -20°C. 
 
 
2.7.2 Protein Assay of Extract from Human Myometrial Biopsies 
A detergent compatible (Dc) technique was used to quantify the level of protein 
within samples. Bio-Rad DC Protein Assay is a colorimetric assay for protein 
concentration following detergent solubilization. The reaction is similar to the well-
documented Lowry assay, but with the following improvements: The reaction 
reaches 90% of its maximum colour development within 15 minutes thereby saving 
valuable time, and the colour changes not more than 5% in 1 hour or 10% in 2 hours 
after the addition of reagents.  
The assay is based on the reaction of protein with an alkaline copper tartrate 
solution and Folin reagent. As with the Lowry assay, there are two steps which lead 
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to colour development: The reaction between protein and copper in an alkaline 
medium, and the subsequent reduction of Folin reagent by the copper-treated 
protein. Colour development is primarily due to the amino acids tyrosine and 
tryptophan, and to a lesser extent, cystine, cysteine, and histidine. Proteins effect a 
reduction of the Folin reagent by loss of 1, 2, or 3 oxygen atoms, thereby producing 
one or more of several possible reduced species which have a characteristic blue 
colour with maximum absorbance at 750 nm. 
The protocol I used was firstly to make a 2ml/mg protein standard stock (0.01g BSA 
in 5ml RIPA) using nominal protease free bovine serum albumin (BSA). Then from 
this, solutions of 1, 0.5, 0.3, 0.25, 0.1 and zero mg/ml standards were produced 
within testubes.  Extracted protein samples were defrosted and diluted in RIPA 
(usually 1:50) within test tubes. All solutions were then vortexed. The Dc reagent 
was then prepared, 20 μl of reagent S to each ml of reagent A (an alkaline copper 
tartrate solution). 500 μl of this reagent was then added to each of the standards 
and proteins of interest (a solution of 100 μl ). Then addition of 4mls of reagent B(a 
dilute Folin Reagent) was added to each test tube and vortexed immediately. After 
15 minutes absorbances could be read using a wavelength of 750nm. A standard 
curve was produced each time the assay was performed and used to acquire protein 
concentrations of test solutions. 
 
2.7.3 Preparation of Protein Samples for Western Blotting 
Once the protein content for the samples had been calculated the samples were 
then prepared to run western blots. 25μg of protein was prepared in 3x loading 
buffer/Laemmili buffer (1M Tris-HCl pH 6.8 2.4ml , 20% Sodium dodecyl sulphate 
3ml, Glycerol 3ml, Bromophenol blue 6mg, beta mercaptoethanol 1.6ml). The 
samples were then boiled at 100°C for 5minutes, placed into ice ready for loading 
onto a gel. 
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2.7.4 Western Blotting 
Antibodies 
CBS enzyme – CBS monoclonal antibody produced in mouse, Abnova, clone 3E1, – 
Dilution 1:250 
CSE enzyme- CTH monoclonal antibody produced in mouse, Abnova, clone 4E1-1B7, 
– Dilution 1:200 
TST enzyme – Anti-TST antibody produced in rabbit, Abcam, ab96543– Dilution 
1:1000 
Beta Actin - beta Actin antibody produced in mouse, Abcam,  Ab8227, – Dilution 1: 
5000 
Secondary Antibody - Goat Anti-Rabbit IgG (H+L), Peroxidase Conjugated, A0545 
 1:100,000 
Secondary Antibody – Goat Anti-Mouse IgG (H+L), Peroxidase Conjugated, A2554, – 
Dilution 1:10000 
1mm spacer plates and glass plates were cleaned using 70% Ethanol and distilled 
water before being assembled into a casting kit (Omni PAGE kit). 12% acrylamide 
tris-HCL resolving gels (30% Acrylamide:Bis-Acrylamide ,distilled water, 1.5M Tris-
HCL pH8.8, 10% SDS, 10%APS, TEMED) were cast, overlaid with distilled water and 
left to polymerise for 1hour at room temperature. The distilled water was poured off 
and a 2.5% acrylamide stacking gel was cast (30% Acrylamide:Bis-Acrylamide, 
distilled water, 0.5M Tris HCl pH 6.8,10% SDS, 10% APS, TEMED) and 1mm 10 well 
combs inserted. This was then left to polymerise for 30minutes. Once the gels were 
fully polymerised they were inserted into the gel tank containing fresh running 
buffer (25mM Tris-base, 192mM glycine, 0.1% SDS, distilled water, pH8.3) and the 
combs were removed. 8μl of protein standard was added to wells on both ends of 
the gel (SeeBlue® Plus2 Pre-Stained Standard) and 20μl of the prepared proteins 
were added to the remaining wells. The gel was then run at 150 volts for 90 mins or 
until the loading buffer ran off the end of the gel. The gels were then removed from 
the tank and moved to blotting cassettes for protein transfer to nitrocellulose 
membrane (Whatman Protran nitrocellulose membrane). 
The assembled cassettes were placed into the gel tank on top of a magnetic stirrer 
surrounded by ice. Transfer buffer was poured into the tank (Tris-Base, glycine, 
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distilled water, 10% methanol) and the tank was run at 40V for 1hour at room 
temperature. Once transferred the nitrocellulose membranes were placed into 
blocking solution (5% BSA dissolved in TBS-T 0.1%) for 2 hours. The antibodies to be 
used were diluted to the appropriate concentrations in prepared antibody solution 
(TBS, 0.1%BSA, 0.1% Sodium Azide) and the membranes were incubated in 
containers overnight at 4°C on a rocker. The following day the primary antibody was 
removed and the membranes were washed 3x10minutes with TBS-T 0.1% then 
incubated with the appropriate secondary antibody diluted in 5% BSA for 1hour at 
room temperature. The membranes were then washed for 1x 15mins and 4 x 
5minutes before incubation for 5minutes with chemiluminescent (ECL) substrate for 
horseradish peroxidase (HRP) enzyme (SuperSignal West Pico Chemiluminescent 
Substrate, Thermo Fisher Scientific). The membranes were then transferred to a film 
cassette where they were exposed to film for the required amount of time (CL-
XPosure Film, ThermoFisher scientific). The films were then developed using Kodak 
processing chemicals developer and fixer. 
 
2.7.5 Analysis of Western Blots 
Analysis of Western blots was carried out in Image J 
(http://rsb.info.nih.gov/ij/index.html). 
The original blot was scanned and saved as a TIFF file. The image was then opened in 
ImageJ. Using the rectangular selection tool a rectangle was drawn around the first 
band in the image. This same rectangle is then used to select every band on the 
image. Once all have been selected a profile plot is generated showing peaks which 
represent the density of each band. Using the wand tool each peak was highlighted 
which gave the area and percentage of each peak. This process was repeated for the 
loading control used (actin) so that there were two set of percentage values – one 
for Actin and one for the samples. The percentage value for the sample was then 
divided by the loading control to get an adjusted density for each sample. 
2.8 Statistics 
For statistical analysis and construction of graphs and tables Microsoft excel, origin 8 
and Graphpad Prism 5 were used. 
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All data was normally distributed. The standard deviation, standard error of the 
mean were calculated. As the data followed the Gaussian distribution Student’s t-
test, 
ANOVA, and Spearman’s correlation were used, as detailed in each results chapter. 
 
For all tests significance was taken as a p value less than 0.05 (p<0.05*).  
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Chapter 3 -  
Characterisation of non- pregnant human myometrium: Examining the 
differences in myometrial contractility from pre-and post menopausal 
women and from women with endometriosis 
3.1 Abstract  
This chapter characterises the contractile activity of non-pregnant human myometrium 
particularly looking at age of women, menopausal state and the effect of 
endometriosis.  Characteristics of spontaneous and high K+ depolarisation-induced 
contractile activities of each tissue type are discussed. 
Myometrial tissue was obtained from 40 women aged between 27-74 years and 
contractility was assessed. The contractile functions of the uterus and the changes it 
undergoes from pre-menopausal to post-menopausal state will be discussed and any 
changes in myometrial contractility and responses as women age. Here its indicated 
that in the non-pregnant state there is a significant decrease in contractility for both 
spontaneous and depolarised-induced contractions, with age. Hence, concluding 
that there is a decrease in the contractile activity of the myometrium in the post-
menopausal state. Muscle atrophy and down regulation of Ca channels may account 
for this. 
Endometriosis is defined as the presence of endometrial tissue outside the uterine 
cavity. Altered contractions of the uterine muscles (myometrium) may be involved in 
the pathogenesis, as they may increase the back flow of menstrual debris in to the 
pelvic cavity, where it can be implanted and give rise to endometriotic deposits.  I 
found that the forces of myometrial contractions from women with endometriosis 
are decreased when compared to fertile, healthy, pre-menopausal women, having a 
hysterectomy for menorrhagia, irregular bleeding, or pelvic pain, but the frequency of 
these contractions increased. These data suggest a potential involvement of altered 
myometrial activity in women suffering with this condition. 
In summary this data provides the most extensive in vitro characterisation of non-
pregnant human myometrium to date and shows significant effects of aging and 
endometriosis on its activity. 
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3.2 Introduction 
 The smooth muscle of the uterus, the myometrium, is active throughout a woman’s 
life, not just during labour and delivery. The mechanism generating the contractile 
activity and its physiological regulation are reasonably well understood and have 
been described within Chapter 1.  
The purpose of this chapter is to characterise and consider how aging, menopausal 
state and endometriosis may affect uterine function in non-pregnant women. 
Characterising this tissue is necessary background information needed to further my 
work on the effects of H2S on the non-pregnant compared to the term pregnant human 
myometrium. There has however been little previous in vitro work investigating non-
pregnant myometrium, discussed below.  
The first recording of contractile activity in the non-pregnant uterus was performed by 
Heinricius using a balloon technique in 1889 (Heinricius 1889). The main research 
investigating myometrial function in non-pregnant women over the last two decades 
have been obtained from the use of open-tipped pressure catheter recordings, 3D 
ultrasound, and magnetic resonance imaging (Brosens 1998, van gestel 2003, Bulletti 
2004, Bulletti and de Ziegler 2006). The contractions observed during the menstrual 
cycle have been termed ‘endometrial waves’ (ljland 1996).  These contractions 
appear to involve only the sub-endometrial layer of the myometrium (Aguilar 2010). 
After menstruation, in the early follicular phase, contractile waves occur once or 
twice per minute and last 10–15s with low-amplitude (usually, 30 mmHg). As 
ovulation approaches, the frequency increases to 3–4 per minute. During the luteal 
phase, the frequency and amplitude decrease possibly to facilitate implantation. 
When a blastocyst does not implant, the contraction frequency remains low but the 
amplitude increases considerably (50–200 mmHg) producing labour-like contractions 
at the time of menstruation (Aguilar 2010). However there are few in vitro studies 
performed on non-pregnant human myometrial strips. Domali et al showed the 
effects of endothelin-1 (ET1) on the myometrial contractility of pre and 
postmenopausal women showing observations from segments of equilibration 
periods from both groups, concluding pre-menopausal myometrium contracted 
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quicker, and were more frequent than post menopausal myometrium, however no 
analysis was performed. Although the main finding of this research was the long-
lasting effectiveness of ET1 in strips collected from postmenopausal women 
compared with premenopausal women, perhaps the effect of ET1 is enhanced by the 
oestrogen deficiency after menopause. They also found that there was no change in 
the response to KCl in either group and suggested that KCl and ET1 affect uterine 
contractility through different mechanisms and that ovarian steroids may play a 
regulatory role in human uterine responsiveness to ET1 (Domali 2000). The only 
other study using strips mounted in organ baths demonstrated smaller contractions 
produced by the non-pregnant myometrium when compared to non labouring term 
pregnant myometrium, whilst time between contractions was lower in the non-
pregnant myometrium. This study also suggested that SK/IK channels are present 
and functional in myometrium from pregnant and non-pregnant women 
(Rosenbaum 2012). This chapter will explore more extensively, the statistical 
differences in contractility of the non-pregnant myometrium, specifically in pre and 
post menopausal women. 
In non-primate species, the myometrium consists of two distinct layers—an outer 
longitudinal layer and an inner circular layer. However, in the human, the 
myometrial substructure is not so well defined (Huszar and Naftolin, 1984). Looking 
at the oestrus cycle in the non-pregnant rat, four distinct periods are found: pro-
oestrus, oestrus, metoestrus and dioestrus. Pro-oestrus typically lasts 12–14 h, 
oestrus 25–27 h, metoestrus is shortest lasting 6–8 h and dioestrus lasts 55–57 h (38, 
39). Mating occurs during the oestrus period (‘heat’) and as rats are nocturnal 
breeders, under normal lighting conditions, oestrus occurs overnight, typically 
commencing between 16.00–22.00 h. Ovulation is timed to coincide with copulation, 
and usually occurs 8–11 h after the onset of oestrus (Hafez 1970). During pro-oestrus 
electrical and mechanical activity of the rat myometrium has shown a relative 
quiescence with little propagation of any electrical events. Noble et al showed using 
longitudinal myometrial tissue strips that Ca2+ signalling and mechanical activity are 
greatest in metoestrus and dioestrus compared to pro-oestrus and oestrus (Wray 
2008). Ca2+ signalling still needs to be addressed in the non- pregnant human 
myometrium. 
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The first contractions felt by a woman are those occurring once menstruation has 
started, possibly those giving rise to uterine cramping (dysmenorrhoea) often 
associated with menstruation. Non-pregnant myometrium has been shown to 
undergo different patterns of contractility during the menstrual cycle; one being 
‘focal and sporadic bulging of the myometrium’, (Togashi 2007; Togashi et al. 1993) 
giving rise to sustained contractions and the other, rhythmic, ‘wave-like’ 
contractions, sometimes called uterine peristalsis, which are thought to aid in the 
sloughing of the endometrium (Bulletti et al. 2000; de Vries et al. 1990; 
Lyons et al. 1991). The female steroid hormones change during the menstrual cycle 
and influence the pattern of myometrial activity in women and other animals (Wray 
and Noble 2008). These hormones will also control levels of ATP and other 
metabolites needed for contraction (Crichton et al. 1993; Wray and Tofts 1986) and 
can affect excitability (Parkington et al. 1999). Recordings of uterine pressures in the 
non-pregnant uterus as well as MR imaging have shown that the pattern of 
myometrial activity, such as the direction of contraction propagation throughout the 
uterus varies with the different phases of the menstrual cycle, already discussed 
(Bulletti et al. 2000; Kunz and Leyendecker 2002; Nakai et al. 2003; Togashi 2007), 
although diurnal variations, have not been observed (Kido et al. 2006). The pattern 
of contractile activity in the non-pregnant uterus is closely related to uterine 
function. Thus antegrade contractions, that is contractions propagating from the 
fundus towards the cervical end of the uterus, favours forward emptying or 
discharge of uterine content i.e. menstrual blood, (Lyons et al. 1991) whilst cervico-
fundal contractions aid in sperm transport or possibly in retention of iron for 
example, following blood losses at menstruation (Kunz and Leyendecker 2002). In 
the pregnant uterus, these retrograde contractions may also have roles in the 
maintenance of early pregnancies within the uterine cavity (de Vries et al. 1990), but 
possibly also in causing endometriosis, as menstrual debris enters the peritoneal 
cavity, discussed below. 
The menopause is another major feature in a woman’s life. With the gradual decline 
in hormonal secretion from the ovaries, up to the point when the ovaries cease to 
function, the menopause is characterised by a loss of regular menstruation and 
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eventually permanent cessation of menses (Burger et al. 2002). One might assume 
that following the menopause, uterine activity ceases. However, rhythmical 
myometrial contractions have been seen  by ultrasound examination in 
postmenopausal women (de Vries et al. 1990) and one previous study has reported 
spontaneous activity in strips from human post-menopausal myometrium in vitro 
(Domali et al 2001). However to date no study has looked at the function of 
myometrium from women much over 40, and certainly not for women in their 50s or 
even older, nor at the activity of the non-pregnant uterus with age, menopausal 
state described within this chapter. 
There is growing awareness of the potential importance of abnormal myometrial 
function in common disorders of reproduction. Endometriosis is one of the 
commonest benign gynaecological conditions; it causes severe pelvic pain, painful 
periods, painful sexual intercourse and infertility. Endometriosis has a prevalence of 
38.5% and 5.2% in infertile and fertile women, respectively (Wheeler 1989, Verkauf 
1987). Despite the common occurrence and the huge economic burden of 
endometriosis, the many biological studies using a range of models have not yet 
identified the causative mechanisms. Changes in myometrial contractions could be 
involved in increasing the back flow of menstrual debris in to the pelvic cavity, giving 
rise to endometriotic deposits. Only in vivo techniques have been investigated to 
look for changes in myometrial contractility in response to endometriosis. In 1995, 
Salamanca and Beltran in a study of inner myometrial contractility using transvaginal 
sonography in women with endometriosis found a predominantly retrograde pattern 
of subendometrial contractions during menstruation (Salamanca 1995). In 2002, 
intrauterine pressures were recorded showing increased frequency, amplitude and 
basal pressure tone within infertile endometriosis patients when compared to 
infertile patients without endometriosis (control). Retrograde bleeding was found in 
73% of these patients with endometriosis compared to 9% of the control group. This 
study also shows 45% endometrial debris within the cul-de-sac of endometriosis 
patients compared to 0% in controls which could implant (Bulletti 2002). Both 
studies indicate abnormal alterations of uterine contractility at the time of menses 
are involved in the development of endometriosis. An interesting histological study 
on human non-pregnant myometrial sections, staining for nerve fibres illustrated 
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increased nerve fibre density in both the endometrium and myometrium of 
endometriosis women implying a role in the mechanism of pain generation in this 
disease (Tokushige 2007). This chapter is the first in vitro study to look at myometrial 
contractions of women with endometriosis.  
 
The aims of this chapter were: 
1) to characterise the in vitro contractile activity of the non-pregnant human 
myometrium 
2) to compare activity between pre- and post-menopausal women, 
 3) to examine the influence of age on contractility 
4) to examine the effects of  women suffering from endometriosis on contractility 
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3.3 Methods 
3.3.1 Tissue 
Non-pregnant human myometrial tissue was obtained from women undergoing a 
hysterectomy. I was blinded to the details of the sample until experiments had been 
performed and analysed. Once performed details including age, menopausal state, 
medication, reason for hysterectomy and whether they had endometriosis was 
obtained. Further details of how the tissue was obtained are described in the general 
methods section, Chapter 2. 
Non-pregnant samples were obtained from hysterectomy specimens. The indications 
for surgery were as follows: menorrhagia (25), prolapse (8), irregular bleeding (1), pelvic 
pain (2) and not stated (4). Therefore the total number of non-pregnant samples in this 
study group was 40, with 22 women in the pre-menopausal group, 8 in the post 
menopausal group and 10 in the endometriosis group (all pre-menopausal). The 
endometriosis group was then separated into no medication including women with 
mirena coil (n=6) and those on medication (n=4). Medication included gonadotropin-
releasing hormone therapy (GnRHa,2), hormone therapy (1) and Provera (1). All surgery 
was performed under general anaesthesia and the biopsy was removed immediately 
following removal of the uterus at surgery. The median age of all 40 women studied 
was 52.2 years. 
Endometrium was scrapped off all biopsies. Looking down the microscope all strips 
dissected were clearly muscular. The tissue size used for all experiments was 
standardized at 5x2x1mm. Within hysterectomy samples, the tightly bound muscle 
fibres, made dissection of individual muscle fibres more challenging compared to the 
pregnant tissue in which identification of the longitudinal muscle fibres was easier. 
Strips could be attained just as easily in the non-pregnant human myometrium from 
pre, post-menopausal and endometriosis samples.  
3.3.2 Measurement of tension 
Tissue preparation and measurements of tension are the same as those described in 
Chapter 2. 
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3.3.3 Solutions  
PSS and High K+ solutions were produced as described in Chapter 2. 
3.3.4 Statistics 
Contractility measurements were made and analysed blinded to the woman’s age, 
menopausal state, and condition. Significance was tested by Student’s t-test with 
P<0.05 taken as the significance value. When more than two groups were tested 
ANOVA with Bonferroni post hoc test were performed. All data was normally 
distributed. All values represent the mean ± s.e.m where ‘n’ is the number of 
samples with each representing a different woman. In some cases results are 
expressed as percentage of control contractions were control is 100%. 
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3.4 Results 
Data were obtained from 40 non-pregnant hysterectomy samples. These samples 
varied in age, (From 27 to 74 years) and menopausal status, 32 pre-menopausal, 
including 10 who had endometriosis and 8 post menopausal women. These details 
and other relevant information is given in Tables 3.1 and averages in Table 3.2.  
For analysis of contractile parameters, including time to establishment of activity, 
data are first analysed and presented from the entire 40 patients and then divided 
into the following sub-groups (1) menopausal status, (2) the effects of endometriosis 
and (3) the effects of medication. There was no significant difference between BMI, 
and time to spontaneously contract in any of the sub groups. However age was 
significantly increased in the post–menopausal group as expected. These differences 
are explored later in this chapter. 
 
Table 3.1 – Demographics for non-pregnant women - showing Age, reason for 
hysterectomy, BMI, medication and if they had endometriosis or not for each patient 
(n=40) 
 
Age 
(years) 
Reason for 
Hysterectomy 
BMI Medication Endometriosis? Pre or Post 
menopausal? 
45 Menorragia 25.3 NONE NO Pre 
50 Not stated 25.2 NONE NO Pre 
48 Menorragia 22 Mirena coil NO Pre 
34 Irregular bleeding 26.1 Implanon NO Pre 
44 Menorragia 28 NONE NO Pre 
37 Menorragia 23.7 Mirena coil NO Pre 
43 Pelvic pain 28.2 NONE NO Pre 
27 Menorragia 22.7 Tranexamic and 
mefenamic acid 
NO Pre 
46 Menorragia 21 NONE NO Pre 
32 Not stated 27.2 Mirena coil NO Pre 
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44 Not stated 23.7 Norethisterone until 
previous day 
NO Pre 
27 Not stated 23 NONE NO Pre 
44 Menorragia 30.4 Mirena coil NO Pre  
45 Menorragia 29.4 Mirena coil NO Pre 
48 Menorragia 29.9 NONE NO Pre 
37 Pelvic pain 29 NONE NO Pre 
46 Menorragia 35.4 NONE NO Pre 
46 Menorragia 23.2 NONE NO Pre 
46 Menorragia 27.4 NONE NO Pre 
31 Menorragia 24.9 NONE NO Pre 
27 Menorragia 23.8 NONE NO Pre 
46 Menorragia 29 NONE NO Pre 
44 Menorragia 34.9 NONE Endometriosis 
(stage1) 
Pre 
48 Menorragia 22.9 NONE Endometriosis 
(stage1) 
Pre 
39 Menorragia 29.4 Mirena coil Endometriosis 
(stage1) 
Pre 
47 Menorragia 25.5 NONE Endometriosis 
(stage 3) 
Pre 
44 Menorragia 33.3 Mirena coil Endometriosis 
(stage 3) 
Pre 
31 Menorragia 21.0 Mirena coil Endometriosis 
(stage 4) 
Pre 
  39 Menorragia 27.2 GnRHa Endometriosis 
(stage 4) 
Pre 
47 Menorragia/Fibroids 31.2 GnRHa Endometriosis 
(stage 2) 
Pre 
39 Menorragia 25.9 Hormone therapy Endometriosis 
(stage 2) 
Pre 
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45 Menorragia 29.2 Provera Endometriosis Pre 
71 Prolapse 24.1 HRT 17 years NO Post 
62 Prolapse 24.4 HRT 6 years NO Post 
47 Prolapse 28.0 NONE NO Post 
63 Prolapse 28.1 NONE NO Post 
58 Prolapse 20.0 NONE NO Post 
69 Prolapse 24.7 NONE NO Post 
62 Reduce risk of ovarian 
cancer 
32.2 NONE NO Post 
74 Prolapse 32.0 NONE NO Post 
 Rows highlighted in pink are pre-menopausal women, in purple are pre-menopausal 
women with endometriosis and in blue are post-menopausal women. 
 
Table 3.2 – Summary of demographics of all 40 non-pregnant women as well as 
separated into subgroups of menopausal status (pre and post menopausal women) 
and endometriosis- showing average age, BMI and times to contract for each group.  
 
Averages 
Age 
(years) 
BMI Subgroups Time to spontaneous 
activity (mins) 
45.6 26.8 All women (n=40) 43.7 
41.1 26.8 Pre-menopausal (n=32) 48.5 
63.2*# 26.7 Post menopausal (n=8) 24.7 
42.3 28.1 Endometriosis (n=10) 54.7 
 
* Represents a significant difference between pre-menopausal and post menopausal, and # between 
pre-menopausal and endometriosis patients using ANOVA with Bonferroni pos hoc test 
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3.4.1 Establishment of spontaneous contractions in vitro. 
All tissues were superfused with physiological salt solution (PSS) at 37 oC, pH 7.4 until 
spontaneous contractile activity was established. In general from my observations 
the commencement of contractions occurred within 1 hour of continuous perfusion, 
average time to contract for entire 40 patients was 43.7±4.5 minutes. Once 
contractions reached equilibrium, contractions were monitored for 1-2 hours and 
then high K + solution applied to enable maximal force to be obtained.  
All samples contracted apart from those dissected from a 71 year old woman, the 
second oldest in this cohort.  
Table 3.3 Contractile parameter averages for the entire 40 non-pregnant patients 
studied within this chapter.  
 Mean (± S.E.M) 
n- number 40 
Amplitude (mN) 2.4mN±1.6 
Frequency (no. Per 
30 minutes) 
6.4± 0.6 
 
Duration 
( minutes) 
0.9 ± 0.3 
 
AUC  
(30 minutes) 
9.1± 1.0 
 
High K+ response 
(mN) 
2.4± 0.4 
 
 
Amplitude of contraction is peak force (mN); Frequency of contraction is the number 
of contractions occurring in 30 minutes; Duration of contraction is duration of 
contraction (min) measured at the half maximal peak of contraction; AUC is a 
measure of the overall contractile activity occurring in 30 minutes and High K+ 
response is the maximal force of contraction measured in mN. 
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3.4.2 Comparing the contractility of pre-menopausal women with post menopausal 
women. 
Firstly, the contractility of all 40 women in Table 3.1 was assessed in response to 
menopausal status. The average age of this group was 45.6 and average BMI was 
26.8 as found in Table 3.2.  
(a) Contraction amplitude 
The mean force amplitude of spontaneous contractions recorded for post-
menopausal women (n=8) was significantly reduced, 0.3±0.1 mN, compared to pre-
menopausal women (n=32), 2.9 ±0.4 mN. Representative recordings of 
spontaneously contracting myometrium from pre-menopausal and post menopausal 
women are shown in Figure 3.1. 
(b) Frequency 
Frequency of contractions was greater (Figure 3.1) for post-menopausal women, 8 ± 
1.8 contractions per 30 minutes; pre-menopausal women: 6 ± 1.3 contractions per 
30 minutes. No significant difference was found. 
(c) Duration 
The mean duration of contraction was shorter (Figure 3.1) in post-menopausal 
women; 0.5 ± 0.2 minutes, pre-menopausal women; 1.0 ± 0.1 minutes. The 
difference however did not reach significance. 
(d) Area under the curve (AUC, 30 minutes) 
AUC of contractions, which is an index of the total work done by the tissue over a 
given time period, was calculated by measuring the area under the contraction curve 
in 30 minutes. For post-menopausal women mean AUC calculated was 1.4± 0.6 a.u 
compared to 11.1± 1.6 a.u recorded for pre-menopausal women. Contractile activity 
of post-menopausal women was significantly reduced compared to pre-menopausal 
women. 
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(e) High K+ depolarisation-induced contractions 
Depolarisation was produced by external elevation of [K+] in the PSS to 40mM for 2 
minutes. Under application of a K+ depolarisation stimulus, the pattern of contractile 
activity is noticeably increased compared to spontaneous phasic contractions, high 
K+ producing a maintained ‘tonic like’ force of contraction. As the response to high K+ 
is thought to measure the maximal contractile activity that the tissue can yield via 
membrane depolarisation and consequently opening of L-type calcium channels, I 
examined and compared this response in both the pre and post-menopausal groups. 
The high K+ response achieved by post-menopausal myometrium was significantly 
lower, 0.5±0.2mN compared to the pre-menopausal myometrium 2.7± 0.4mN. 
(f) Time to commencement of spontaneous activity 
Spontaneous contractions occurred in vitro, in pre-menopausal myometrium (n=32) 
after 48.5 ± 5.0 minutes compared with post menopausal (n=8) myometrium after 
24.7± 7.4 minutes. This was proven to be a significantly lower time to spontaneously 
start contract in the post menopausal women using a Student’s t-test. 
 
Table 3.4 summarises the mean values of contraction amplitude, frequency, 
duration, AUC and High K+ responses of spontaneous contractions as well as the 
mean time to spontaneously contract in pre and post-menopausal myometrium 
(n=40). 
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Figure 3.1 Contractility of pre and post-menopausal women. 
Representative recordings of spontaneous contractions of human non-pregnant 
myometrium from women that have undergone hysterectomy’s; and are in (A) pre-
menopausal and (B) post-menopausal. In this and subsequent figures, the tissues 
were superfused with PSS (pH 7.4) at a flow rate of 1.5ml/min and maintained at 36-
37 oC.  
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Table 3.4 Summary of spontaneous contractile activity of pre and post- 
menopausal non-pregnant myometrium. 
 Pre-menopausal Post menopausal P-value 
n- number 32 8     --- 
Amplitude (mN) 2.9mN±0.4 0.3mN±0.1 0.001* 
Frequency (no. Per 
30 minutes) 
6.0± 1.3 
 
8 ± 1.8 
 
0.266 
Duration 
(minutes) 
1.0 ± 0.1 
 
0.5 ± 0.2 
 
0.076 
AUC  
(30 minutes) 
11.1± 1.6 
 
1.4± 0.6 
 
0.007* 
High K+ response 
(mN) 
2.7± 0.4  
 
0.5± 0.2 
 
0.044* 
Time to spontaneous 
activity (minutes) 
48.5 ± 5.0 24.7± 7.4 0.032* 
Average age 41.1 63.2 2.5x10-9* 
Average BMI 26.8 26.7 0.921 
*denotes significance recorded at p<0.05 level 
Table 3.4: Student T-test identified that mean force amplitude of contraction, AUC of 
contraction, mean High K+ response and time to spontaneously contract was 
significantly reduced in the myometrium from post-menopausal women. Frequency 
of contraction of post-menopausal myometrium was shown to be increased 
however, not significance compared to pre-menopausal women. Amplitude of 
contraction is peak force (mN); Frequency of contraction is the number of 
contractions occurring in 30 minutes; Duration of contraction is duration of 
contraction (min) measured at the half maximal peak of contraction; AUC is a 
measure of the overall contractile activity occurring in 30 minutes, High K+ response 
is the maximal force of contraction measured in mN and time to spontaneously 
contract measured in minutes. Average age and BMI in both groups are also found 
showing significant differences in the age of both groups. 
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3.4.3 Comparing the contractility of pre-menopausal women with post menopausal 
women excluding endometriosis patients. 
Endometriosis did not make the tissue less likely to contract. However, next the 
contractility of the 10 women with endometriosis were removed to see if the 
contractility pattern changes and to see if the statistical differences remain. All the 
endometriosis patients are removed from the pre-menopausal group. The average 
age of the 30 women being assessed is 46.6 and the average BMI is 26.4, not much 
different to when the entire 40 women were examined. 
(a) Contraction amplitude 
The mean force amplitude of spontaneous contractions recorded for post-
menopausal women (n=8) remained significantly reduced, 0.3±0.1 mN, compared to 
pre-menopausal women (n=22), 3.3±0.5 mN. 
(b) Frequency 
Frequency of contractions was greater for post-menopausal women, 8 ± 1.8 
contractions per 30 minutes; pre-menopausal women: 5± 0.8 contractions per 30 
minutes. Without endometriosis patients, frequency became closer to significance. 
(c) Duration 
The mean duration of contraction was shorter in post-menopausal women; 0.5 ± 0.2 
minutes, pre-menopausal women; 1.2 ± 0.2 minutes. A student t-test showed this to 
be significantly shorter at p<0.05 level of significance without using endometriosis 
patients. 
(d) Area under the curve (AUC, 30 minutes) 
For post-menopausal women mean AUC calculated was 1.4± 0.6 a.u compared to 
12.6± 2.2 a.u recorded for pre-menopausal women. Contractile activity of post-
menopausal women remained significantly reduced compared to pre-menopausal 
women. 
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(e) High K+ depolarisation-induced contractions 
The high K+ response achieved by post-menopausal myometrium was still 
significantly lower, 0.5± 0.2mN compared to the pre-menopausal myometrium 3.1± 
0.5mN. 
(f) Time to commencement of spontaneous activity 
Spontaneous contractions occurred in vitro, in pre-menopausal myometrium (n=22) 
after 45.7± 6.6 minutes compared with post menopausal (n=8) after 24.7± 7.4 
minutes. This reduction in the time to spontaneously contract in the post 
menopausal women did not reach significance. 
 
Table 3.5 summarises the mean values of contraction amplitude, frequency, 
duration, AUC and High K+ responses of spontaneous contractions as well as the 
mean time to spontaneously contract in pre and post-menopausal myometrium 
without endometriosis patients incorporated. 
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Table 3.5  Summary of spontaneous contractile activity of pre and post 
menopausal non-pregnant myometrium without patients with endometriosis 
incorporated. 
 Pre-menopausal Post menopausal P-value 
n- number 22 8     --- 
Amplitude (mN) 3.3mN±0.5 0.3mN±0.1 0.001* 
Frequency (no. Per 
30 minutes) 
5± 0.8 
 
8 ± 1.8 
 
0.072 
Duration 
(minutes) 
1.2 ± 0.2 
 
0.5 ± 0.2 
 
0.036* 
AUC  
(30 minutes) 
12.6± 2.2 
 
1.4± 0.6 
 
0.005* 
High K+ response 
(mN) 
3.1± 0.5 
 
0.5± 0.2 
 
0.045* 
Time to 
spontaneous 
activity (minutes) 
45.7± 6.6 
 
24.7± 7.4 0.087 
Average age 40.6 63.2 1.3x10-7* 
Average BMI 26.3 26.7 0.794 
*denotes significance recorded at p<0.05 level 
Table 3.5: Student T-test identified that mean force amplitude of contraction, mean 
duration of contraction, AUC of contraction and mean High K+ response was 
significantly reduced in the myometrium from post-menopausal women. Frequency 
of contraction of post-menopausal myometrium was shown to be increased 
however, this did not reach statistical significance compared to pre-menopausal 
women. Time to spontaneously contract did not reach significance either. Amplitude 
of contraction is peak force (mN); Frequency of contraction is the number of 
contractions occurring in 30 minutes; Duration of contraction is duration of 
contraction (min) measured at the half maximal peak of contraction; AUC is a 
measure of the overall contractile activity occurring in 30 minutes, High K+ response 
is the maximal force of contraction measured in mN and time to spontaneously 
contract measured in minutes. Average age and BMI in both groups are also found 
showing significant differences in the age of both groups. 
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3.4.4 In vitro non-pregnant pre-menopausal women compared to post-menopausal 
women contractility, age and BMI-matched. 
To investigate whether the changes found are age related or menopausal status 
related or both, a subset of samples from both the pre and post-menopausal groups 
were age and BMI matched as close as possible. With 9 women in the pre-
menopausal group with a mean age of 46.4 years old and BMI 26.4 and 5 women in 
the post-menopausal with mean age of 58.4 years old and BMI 26.5 groups were 
compared. Representative age matched traces are seen in Figure 3.2.  These data 
suggest that the changes we see are somewhat age related although there are not 
enough n numbers or younger post menopausal women to accurately assess.  
However, it was found that still there is a significant decrease in force amplitude in 
the post menopausal group, all other parameters were not significant as seen in 
Table 3.6. 
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Figure 3.2 Pre and Post-menopausal myometrial contractility age-matched. 
 
 Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from a (A) 50-year old pre-menopausal women, and (B) 47-year old post 
menopausal woman. Strips were placed under a resting tension of 2 mN and 
superfused continually with physiological saline solution (pH 7.4) at 37 oC. 
 
121 
 
Table 3.6 Summary of spontaneous contractile activity of pre and post- 
menopausal non-pregnant myometrium age and BMI matched. 
 Pre-menopausal Post menopausal P-value 
n- number 9 5     --- 
Amplitude (mN) 3.6±0.8 0.4±0.1 0.017* 
Frequency (no. Per 
30 minutes) 
5.3± 1.7 
 
7.2 ± 1.6 
 
0.493 
Duration 
(minutes) 
1.4 ± 0.3 
 
0.7 ± 0.3 
 
0.213 
AUC  
(30 minutes) 
13.5 ± 4.4 
 
1.6± 0.9 
 
0.030 
High K+ response 
(mN) 
3.7± 0.9 
 
0.5± 0.2 
 
0.018 
Time to 
spontaneous 
activity (minutes) 
43.8±9.7 23.2±9.0 0.187 
 
*denotes significance recorded at p<0.05 level 
Student T-test identified that mean force amplitude of contraction was significantly 
reduced in the myometrium from post-menopausal women compared to pre-
menopausal. All other parameters were not significantly changed. AUC and High K+ 
were close to significance. 
Amplitude of contraction is represented by force (mN); Frequency of contraction is 
represented by the number of contractions occurring in 30 minutes; Duration of 
contraction is represented by how long a single contraction lasts (min) and is 
measured at the half maximal peak of contraction; AUC is a measure of the overall 
contractile activity occurring in 30 minutes and High K+ response is the maximal force 
of contraction measured in mN. Time to spontaneously contract measured in 
minutes. 
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3.4.5 How does non-pregnant contractility of the myometrium change with age? 
Spontaneous contractions of non-pregnant human myometrium irrespective of 
menopausal state or presence of endometriosis was examined in relation to age. 
Figure 3.3 shows four original contractility recordings of a non-pregnant women 
aged 32 (A), 48 (B), 62 (C) and 74 (oldest women in study) (D). A very clear loss of 
force is apparent with increasing age. The mean data shown in Table 3.7 also 
supports this observation. There was no significant change in the time to commence 
contractions although time to commence contractions tended to be shorter in the 
patients >50, showing that the older uterus is not deterred in producing 
contractions.  When contractions from all women are plotted on a scatter graph 
(Figure 3.4) this clear drop in force with age is seen (r=-0.6969, significant negative 
correlation, p<0.0001 , n=40). To investigate the effects of age on the non-pregnant 
uterus in more detail, the effects of stimulating the uterus with high K+ (40 mM) 
which maximally activates functional voltage-gated L-type Ca channels inducing Ca 
entry and a large tonic contraction was examined (Wray 2001). For each tissue, 
spontaneous contractions were normalised to this maximal high K+-induced 
contraction to determine the degree of activation of the contractile mechanisms. 
The results have been analysed for age cohorts of 25-29, 30-39, 40-49, >50 as shown 
in Figure 3.5.  
The reduction in spontaneous force with age produced by the non-pregnant uterus 
was prominent (Figure 3.5 A) and is also seen when L-type Ca channels are 
maximally activated with high K+ (Figure 3.5 B). These data suggest that there might 
be loss of functional muscular tissue (e.g. less muscle cells) or decreased expression 
of L-type Ca channels, with age (Floyd and Wray 2007; Taggart et al. 1997), although 
larger sample numbers are required before these suggestions can be tested. In 
Figure 3.5 C the spontaneous contractions are normalised to the high K+ contraction 
to control for any effects of age on decreased muscle or L-type Ca expression. 
Relative to high K+ the amplitude of spontaneous activity decreases with age, 
suggesting that the mechanisms generating spontaneous contractions are also 
affected. Thus in non-pregnant myometrium the suggestion is that force may decline 
as a consequence of muscle loss and/or decreased Ca entry and thus decreased 
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activation of the contractile proteins. Reduced levels of oestrogen with aging would 
be expected to cause atrophy of the myometrium, and thus explain some of the 
decreased strength of contractions. There is evidence that the L-type calcium 
channel subunits and function are hormonally regulated, with oestrogen associated 
with increasing, (Batra 1987) and progesterone decreasing (Tezuka et al. 1995) 
calcium channel expression. Thus as oestrogen decreases with aging, levels of L-type 
Ca channels will be expected to fall. 
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Figure 3.3 Non-pregnant  myometrial contractility in relation to age.  
 
 Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from a (A) 32-year old, (B) 48-year old and (C) 62-year old woman  (D) 74-
year old woman undergoing hysterectomy (expanded version of contractions can 
also be seen within D). Strips were placed under a resting tension of 2 mN and 
superfused continually with physiological saline solution (pH 7.4) at 37 oC. 
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Table 3.7 Summary of spontaneous contractile activity of non-pregnant 
myometrium in relation to age.  
 
 Age 
25-29 
Age 
30-39 
Age 
40-49 
Age 
>50 
n- number 3 9 19 9 
Amplitude (mN) 6.4 ± 0.6 2.8± 0.4* 2.2± 0.4* 0.8± 0.5* 
Frequency (no. Per 
30 minutes) 
2.7± 0.7 8.3±4.0 5.7±0.9 6.7± 1.6 
Duration 
(minutes) 
1.1± 0.3 1.1± 0.3 1.1± 0.2 0.5± 0.2 
AUC  
(30 minutes) 
20.3± 0.9 
 
12.4± 2.5 8.5±2.3* 1.63±0.6* 
Time to 
spontaneous 
activity (minutes) 
66.8± 27.9 43.5± 8.3 49.1± 5.8 23.1± 6.7 
 
 
*denotes significance recorded at p<0.05 level when compared to age 25-29 group. 
ANOVA with Bonferroni post hoc test identified that mean force amplitude of 
contraction, and AUC of contraction was significantly reduced in the myometrium 
from the age of over 40. Frequency of contraction, mean duration of contraction and 
time to spontaneously contract were not significantly different. 
Amplitude of contraction is represented by force (mN); Frequency of contraction is 
represented by the number of contractions occurring in 30 minutes; Duration of 
contraction is represented by how long a single contraction lasts (min) and is 
measured at the half maximal peak of contraction; and AUC is a measure of the 
overall contractile activity occurring in 30 minutes. Time to spontaneously contract 
was measured in minutes. All data are expressed as mean ± S.E.M. 
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Figure 3.4 Scatter graph to show the relationship between AUC and age 
Plot of spontaneous contractile activity (quantified as area under the contraction 
curve, (AUC, in arbitary units, au) of strips of non-pregnant myometrium obtained 
from women undergoing a hysterectomy, against age. Post menopausal women are 
denoted by blue triangles and pre-menopausal women are denoted by red diamonds 
(unless patient is pre-menopausal and suffers from endometriosis, these patients are 
denoted as purple diamonds). Spearman’s rank test found a significant negative 
correlation between integral of force and age combining pre and post menopausal 
women (rs=-0.6969, significant negative correlation, p<0.0001, n=40).  
 
R=-0.6969, P<0.0001 
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Figure 3.5 Uterine activity with age of non-pregnant myometrium. 
A)Spontaneous force of contraction, B) force of contraction under high K+ (40 mM) 
depolarisation and C) force of contraction normalised to high K+ (where high K+ 
equalled 100 %), according to age group. Mean force of contraction declined with 
increasing age group 
(A) with little activity observed from myometrial strips from women over 50 years of 
age, in comparison to their younger counterparts. Similarly, maximal force achieved 
under high K+ (B) was reduced in samples from older women, and normalised force 
shown in (C) also declined with advancing age. Values represent means ± SEM 
denoted by error bars, values in white indicate n-numbers. Anova with Bonferroni 
post hoc test was used, * represents p<0.05, **represents p<0.01, *** represents 
p<0.001. 
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3.4.6 How does non-pregnant contractility change with age excluding 
endometriosis patients? 
Next the 10 endometriosis patients were taken out to see if the significant changes 
in contractility parameters and correlation in relation to age still remained. The 
endometriosis patients were only removed from ages 30-39 and 40-49. The mean 
data of 30 women without endometriosis separated by age can be found below in 
Table 3.8. The same age groups (30-39, 40-49, >50 when compared to 25-29 year 
olds) remain significant with and without the inclusion of patients with 
endometriosis. Frequency, duration and time to spontaneously contract remain not 
significantly changed. When contractions from these 30 women without 
endometriosis are plotted on a scatter graph (Figure 3.6), the significant negative 
correlation is still found in force with age. The correlation seen is slightly more 
negative at rs=-0.7214 (significant negative correlation, p<0.0001 , n=40). 
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Table 3.8 Summary of spontaneous contractile activity of non-pregnant 
myometrium in relation to age excluding patients with endometriosis.  
 
 Age 
25-29 
Age 
30-39 
Age 
40-49 
Age 
>50 
n- number 3 5 13 9 
Amplitude (mN) 6.4 ± 0.6 2.5± 0.3* 2.5± 0.5* 0.8± 0.5* 
Frequency (no. Per 
30 minutes) 
2.7± 0.7 4.9±1.2 5.4±1.3 6.7± 1.6 
Duration 
(minutes) 
1.1± 0.3 1.4± 0.4 1.2± 0.3 0.5± 0.2 
AUC  
(30 minutes) 
20.3± 0.9 13.5± 3.4 8.5±2.3* 1.63±0.6* 
Time to spontaneous 
activity (minutes) 
66.8± 27.9 30.8± 8.8 48.1± 6.0 23.1± 6.7 
 
 
*denotes significance recorded at p<0.05 level when compared to age 25-29 group 
Anova with bonferroni post hoc test identified that mean force amplitude of 
contraction, and AUC of contraction was significantly reduced in the myometrium 
from the age of over 40. Frequency of contraction, mean duration of contraction and 
time to spontaneously contract were not significantly different. 
Amplitude of contraction is represented by force (mN); Frequency of contraction is 
represented by the number of contractions occurring in 30 minutes; Duration of 
contraction is represented by how long a single contraction lasts (min) and is 
measured at the half maximal peak of contraction; and AUC is a measure of the 
overall contractile activity occurring in 30 minutes. Time to spontaneously contract 
was measured in minutes. 
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Figure 3.6 Scatter graph to show the relationship between AUC and age without 
endometriosis patients included 
Plot of spontaneous contractile activity (quantified as area under the contraction 
curve, (AUC, in arbitary units, au) of strips of non-pregnant myometrium obtained 
from women undergoing a hysterectomy, against age. Post menopausal women are 
denoted by blue triangles and pre-menopausal women are denoted by red 
diamonds. Spearman’s rank test found a significant negative correlation between 
integral of force and age combining pre and post menopausal women (rs=-0.7214, 
significant negative correlation, p<0.0001, n=30).  
 
 
R=-0.7214, P<0.0001 
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3.4.7 Myometrial contractility of women with endometriosis. 
All endometriosis patients used within this thesis were pre-menopausal. Hence the 
control group used to compare the contractility of endometriosis patients were pre-
menopausal women without endometriosis. Both groups were age and BMI matched 
as close as possible with the pre-menopausal group at an average age of 41.2 years 
old and average BMI 26.4 and with the endometriosis group at an average age of 
42.0 years old and average BMI 28.0. Both BMI’s are in the overweight category. 
(a) Contraction amplitude 
The mean force amplitude of spontaneous contractions recorded for women with 
endometriosis (n=10) was reduced, 2.1±0.4 mN, compared to pre-menopausal 
women (n=21), 3.2±0.5 mN. Representative recordings of spontaneously contracting 
myometrium from pre-menopausal women and a women suffering from 
endometriosis are shown in Figure 3.7. 
(b) Frequency 
Frequency of contractions was greater (Figure 3.7) for endometriosis women, 9.0 
±3.5 contractions per 30 minutes; pre-menopausal women: 5± 0.8 contractions per 
30 minutes. 
(c) Duration 
The mean duration of contraction was shorter (Figure 3.7) in endometriosis women; 
0.8± 0.1 minutes, pre-menopausal women; 1.2 ± 0.2 minutes.  
(d) Area under the curve (AUC, 30 minutes) 
For women with endometriosis mean AUC calculated was 7.9± 1.7 a.u compared to 
12.3± 2.3 a.u recorded for pre-menopausal women. Contractile activity of 
endometriosis women was reduced compared to pre-menopausal women. 
(e) High K+ depolarisation-induced contractions 
The high K+ response achieved by the myometrium from women with endometriosis 
was lower, 1.8± 0.4mN compared to the pre-menopausal myometrium 3.0± 0.6mN. 
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(f) Time to commencement of spontaneous activity 
Spontaneous contractions occurred in vitro, in pre-menopausal myometrium after 
45.7 ± 6.6 minutes compared with patients with endometriosis after 54.7± 6.7 
minutes. This increase in the time to spontaneously contract in the women with 
endometriosis was not statistically different. 
 
Table 3.9 summarises the mean values of contraction amplitude, frequency, 
duration, AUC and High K+ responses of spontaneous contractions as well as mean 
time to commence spontaneous contractions in pre-menopausal myometrium and 
myometrium from women with endometriosis. 
All results did not reach significance. However as some of the endometriosis patients 
were on hormone therapy potentially affecting myometrial contractions, the 
contractility of women with endometriosis and on no medication other than mirena 
coil (a contraceptive) were compared.  
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Figure 3.7 Endometriosis and Pre-menopausal myometrial contractility. 
 
 Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from a (A) 44-year old pre-menopausal women, and (B) 46-year old woman 
with endometriosis. Strips were placed under a resting tension of 2 mN and 
superfused continually with physiological saline solution (pH 7.4) at 37 oC. 
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Table 3.9 Summary of spontaneous contractile activity of women with 
endometriosis and pre- menopausal non-pregnant myometrium. 
 Pre-menopausal Endometriosis P-value 
n- number 21 10     --- 
Amplitude (mN) 3.2±0.5 2.1±0.4 0.168 
Frequency (no. Per 
30 minutes) 
4.9± 0.8 
 
9.0 ± 3.5 
 
0.139 
Duration 
(minutes) 
1.2 ± 0.2 
 
0.8 ± 0.1 
 
0.162 
AUC  
(30 minutes) 
12.3± 2.3 
 
7.9± 1.7 
 
0.221 
High K+ response 
(mN) 
3.1± 0.5 
 
1.8± 0.4 
 
0.238 
Time to 
spontaneous 
activity (minutes) 
45.7 ± 6.6 54.7± 6.7 0.411 
 
*denotes significance recorded at p<0.05 level 
All parameters were not significantly changed. 
Amplitude of contraction is represented by force (mN); Frequency of contraction is 
represented by the number of contractions occurring in 30 minutes; Duration of 
contraction is represented by how long a single contraction lasts (min) and is 
measured at the half maximal peak of contraction; AUC is a measure of the overall 
contractile activity occurring in 30 minutes and High K+ response is the maximal force 
of contraction measured in mN. Time to spontaneously contract measured in 
minutes. 
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3.4.8 Myometrial contractility of women with endometriosis and not on 
medication. 
The pre-menopausal group included 13 patients not on any medication and 2 
patients with mirena coil. The endometriosis group included 3 patients not on any 
medication and 3 patients with mirena coil. Average age and BMI for each group can 
be found in table 3.10. 
(a) Contraction amplitude 
The mean force amplitude of spontaneous contractions recorded for women with 
endometriosis (n=6) was reduced, 1.7±0.5 mN, compared to pre-menopausal women 
(n=13), 3.1±0.6 mN.  
(b) Frequency 
Frequency of contractions was significantly greater for women with endometriosis, 
12 ± 5.6 contractions per 30 minutes; pre-menopausal women: 4± 0.4 contractions 
per 30 minutes. A student t-test at p<0.05 level of significance was used. 
(c) Duration 
The mean duration of contraction was shorter in endometriosis women; 0.7 ± 0.2 
minutes, pre-menopausal women; 1.3 ± 0.2 minutes.  
(d) Area under the curve (AUC, 30 minutes) 
AUC of contractions, which is an index of the total work done by the tissue over a 
given time period, was calculated by measuring the area under the contraction curve 
in 30 minutes. For women with endometriosis mean AUC calculated was 7.8± 2.8 a.u 
compared to 13.7± 2.8 a.u recorded for pre-menopausal women. Contractile activity 
of endometriosis women was reduced compared to pre-menopausal women. 
(e) High K+ depolarisation-induced contractions 
The high K+ response achieved by myometrium from endometriosis women was 
lower, 1.8± 0.5mN compared to the pre-menopausal myometrium 3.0± 0.6mN. 
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(f) Time to commencement of spontaneous activity 
Spontaneous contractions occurred in vitro, in pre-menopausal myometrium (n=13) 
after 52.4± 6.8 minutes compared with patients with endometriosis on no 
medication (n=6) after 45.5 ± 7.9 minutes. No significant difference found. 
 
Table 3.10 summarises the mean values of contraction amplitude, frequency, 
duration, AUC and High K+ responses of spontaneous contractions as well as mean 
time to commence spontaneous contractions in pre-menopausal myometrium and 
myometrium from women with endometriosis on no medication. 
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Table 3.10 Summary of spontaneous contractile activity of women with 
endometriosis and not on medication and pre- menopausal non-pregnant 
myometrium. 
 Pre-menopausal Endometriosis P-value 
n- number 13 6     --- 
Amplitude (mN) 3.1mN±0.6 1.7mN±0.5 0.182 
Frequency (no. Per 
30 minutes) 
4.1± 0.4 
 
12.5 ± 5.6 
 
0.040* 
Duration 
(minutes) 
1.3 ± 0.2 
 
0.7 ± 0.2 
 
0.169 
AUC  
(30 minutes) 
13.7± 2.8 
 
7.8± 2.8 
 
0.277 
High K+ response 
(mN) 
3.0± 0.6 
 
1.8± 0.5 
 
0.316 
Time to 
spontaneous 
activity (minutes) 
52.4 ± 6.8 45.5± 7.9 0.550 
Average age 43.1 42.2 0.755 
Average BMI 27.8 27.8 0.998 
*denotes significance recorded at p<0.05 level 
Student’s T-test identified that mean Frequency of contraction was significantly 
increased in the myometrium from women with endometriosis not on medication 
compared to the pre-menopausal women control group. All other parameters were 
not significantly changed. 
Amplitude of contraction is represented by force (mN); Frequency of contraction is 
represented by the number of contractions occurring in 30 minutes; Duration of 
contraction is represented by how long a single contraction lasts (min) and is 
measured at the half maximal peak of contraction; AUC is a measure of the overall 
contractile activity occurring in 30 minutes and High K+ response is the maximal force 
of contraction measured in mN. Average age and BMI in both groups are also found. 
Time to spontaneously contract measured in minutes. 
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3.4.9 Myometrial contractility of women with endometriosis and on medication. 
The pre-menopausal group included 10 patients not on any medication, 2 patients 
with mirena coil, 1 patient on Tranexamic and mefenamic acid and 1 patient on 
Norethisterone until previous day. The endometriosis group included 2 patients on 
GnRHa, 1 patient on provera and the other on hormone therapy. Average age and 
BMI for each group can be found in table 3.11. 
(a) Contraction amplitude 
The mean force amplitude of spontaneous contractions recorded for women with 
endometriosis (n=4) was reduced, 2.8mN±0.8, compared to pre-menopausal women 
(n=14), 3.2mN±0.6. No significance was found.  
(b) Frequency 
No significant difference in frequency of contractions was found unlike in the women 
with endometriosis on no medication. Women with endometriosis, 3.8± 1.0 
contractions per 30 minutes; pre-menopausal women: 4.2± 0.4 contractions per 30 
minutes.  
(c) Duration 
The mean duration of contraction was shorter in endometriosis women; 0.8 ± 0.2 
minutes, pre-menopausal women; 1.3 ± 0.2 minutes.  
(d) Area under the curve (AUC, 30 minutes) 
AUC of contractions, which is an index of the total work done by the tissue over a 
given time period, was calculated by measuring the area under the contraction curve 
in 30 minutes. For women with endometriosis mean AUC calculated was 7.9± 1.8 a.u 
compared to 13.8± 2.8 a.u recorded for pre-menopausal women. Contractile activity 
of endometriosis women was reduced compared to pre-menopausal women. 
(e) High K+ depolarisation-induced contractions 
The high K+ response achieved by myometrium from endometriosis women was not 
calculated as only one KCl response was recorded for the group.  
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(f) Time to commencement of spontaneous activity 
Spontaneous contractions occurred in vitro, in pre-menopausal myometrium (n=14) 
after 49.4.4± 6.3 minutes compared with patients with endometriosis on medication 
(n=4) after 68.5± 8.7minutes. No significant difference found. 
Overall there was no significant difference in the contractility parameters of the pre-
menopausal control group compared to the patients with endometriosis and on 
medication. 
Table 3.11 summarises the mean values of contraction amplitude, frequency, 
duration, AUC and High K+ responses of spontaneous contractions in addition to 
mean time to commence spontaneous contractions in pre-menopausal myometrium 
and myometrium from women with endometriosis on medication. 
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Table 3.11 Summary of spontaneous contractile activity of women with 
endometriosis and on medication and pre- menopausal non-pregnant 
myometrium. 
 Pre-menopausal Endometriosis P-value 
n- number 14 4     --- 
Amplitude (mN) 3.2mN±0.6 2.8mN±0.8 0.743 
Frequency (no. Per 
30 minutes) 
4.2± 0.4 
 
3.8 ± 1.0 
 
0.692 
Duration 
(minutes) 
1.3 ± 0.2 
 
0.8 ± 0.2 
 
0.268 
AUC  
(30 minutes) 
13.8± 2.8 
 
7.9± 1.8 
 
0.345 
Time to 
spontaneous 
activity (minutes) 
52.4 ± 6.8 45.5± 7.9 0.154 
Average age 49.4 48.5 0.903 
Average BMI 27.5 28.4 0.528 
*denotes significance recorded at p<0.05 level 
All parameters were not significantly changed. 
Amplitude of contraction is represented by force (mN); Frequency of contraction is 
represented by the number of contractions occurring in 30 minutes; Duration of 
contraction is represented by how long a single contraction lasts (min) and is 
measured at the half maximal peak of contraction; and AUC is a measure of the 
overall contractile activity occurring in 30 minutes. Average age and BMI in both 
groups are also found. Time to spontaneously contract measured in minutes. 
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3.5 Discussion 
In 98% of non-pregnant biopsies worked on in this chapter, spontaneous 
contractions were established. The muscle bundles within the non-pregnant 
myometrium compared to the pregnant myometrium are more tightly bound, 
although dissection using a microscope and the tissue undergoing an endometrial 
scrape aided in the dissection of clear muscular tissue strips. It took an average of 44 
minutes until spontaneous contractions occurred. Usually from my observations 
within the term pregnant human myometrium initiation of contractions takes 
around 70-90 minutes. In both tissue types, stable contractions were monitored for a 
period of 1- 2 hours. 
Biopsies from non-pregnant women undergoing hysterectomy were taken 
immediately after the removal of the uterus from the lower half of anterior uterine 
wall, so as to approximate the area where the biopsy was removed from the 
pregnant uterus. For pregnant tissues, biopsies were taken after delivery from the 
middle of the upper edge, lower segment uterine incision at time of Caesarean 
section. Both lower and upper segments of the myometrium have been shown to 
have similar contractile profiles (Luckas and Wray 2000) All biopsies were collected 
and handled in the same way using a protocol to prevent tissue degradation and to 
ensure all conditions for experiments were the same, allowing for comparison of 
both tissues in proceeding chapters.   
To the best of my knowledge, this chapter is the most extensive in vitro study of non-
pregnant human myometrium and shows that good strong regular contractions do 
occur. It also demonstrates significant effects of aging, menopausal state and 
endometriosis on myometrial activity. The only findings from in vitro observations of 
non-pregnant human contractility without statistical evidence is that contractions of 
pre-menopausal myometrium contracted at a greater frequency, and were more 
frequent than post menopausal myometrium (Domali 2001). The only other study 
demonstrated smaller contractions were produced by the non-pregnant 
myometrium when compared to non labouring term pregnant myometrium while 
time between contractions was reduced in the non-pregnant myometrium 
(Rosenbaum 2012), discussed further below.  
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3.5.1 The effect of menopausal status on myometrial contractility 
Once spontaneous activity was established, post menopausal myometrium had 
contractions that were lower in amplitude, shorter in duration but at a higher 
frequency than pre-menopausal myometrium. Overall, mean AUC of contraction 
confirmed the activity of the post-menopausal myometrium is significantly reduced 
compared to pre-menopausal myometrium. Although, when age and BMI are taken 
into account, only the significant decrease in force amplitude of contraction remains. 
This suggests age partially affects the results obtained. Thus, reduced uterine activity 
appears to be an inherent property of post menopausal women. 
Interestingly contractility although low, is maintained well into post-menopause. This 
is consistent with an earlier in vitro study which found spontaneous activity in post-
menopausal women (Domali 2001). These latter authors also demonstrated 
responsiveness to endothelin 1, which could be modified by ovarian steroids. This 
again emphasizes that post-menopausal human myometrium remains active and 
responsive to hormonal environment. Reduced contractile activity is the main 
finding in the post- menopausal myometrium, but what is the reason for this?  
Uterine contractility is a directly related to underlying electrical activity in 
myometrial cells. Spontaneous contractions of the myometrium are produced by 
spontaneous changes in cell membrane potential towards a more positive potential 
(membrane depolarisation) which triggers the firing of a single action potential or 
bursts of action potentials (Kawarabayashi et al 1988), opening of L-type calcium 
channels and calcium influx (Wray 1993, Shmigol 1998). Contraction of the 
myometrium then transpires from the resulting myofilament cross-bridge cycling. 
The frequency of myometrial contractions is therefore directly related to changes in 
membrane potential and the frequency of bursts. The increase in contraction 
frequency recorded in post menopausal women in this study suggests that the cell 
membrane potential in these women is more excitable i.e. less negative than pre-
menopausal women such that it would reach the threshold potential for action 
potential generation more readily than in pre-menopausal myometrium. This helps 
to explain why as women reach post menopause they spontaneously contract 
quicker than in the pre menopausal women. Instead, the increased frequency of 
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contraction may also be due a faster repolarisation or recovery of the membrane to 
resting potential. 
However given the data in my study illustrating reduced contraction amplitude and 
duration for post menopausal myometrium, it would indicate that despite the higher 
frequency of reaching threshold for activation in these tissues, the mechanical 
activity produced by the change in membrane potential is still reduced. This could be 
due to poor propagation of calcium signalling events in the muscle cells of post 
menopausal myometrium and less recruiting of muscle cells or muscle bundles to 
contract, or alternatively reduced smooth muscle with advancing menopausal state 
and therefore less L-type calcium channels and reduced calcium entry resulting in 
the reduced force produced. Reduced levels of oestrogen with reaching post 
menopause could directly affect L-type expression as already discussed below. 
 
3.5.2 The effect of aging on non-pregnant myometrial contractility 
The results of this study are the first to show aging decreases non-pregnant uterine 
contractility. It also suggests that in the non-pregnant uterus, the majority of the 
decline may occur by the age of 35 years. Suggested mechanisms for this underlying 
decrease in contractility with age could be through morphological changes or 
hormonal changes of the myometrium. However data on how the myometrium 
changes with age are scarce. Whereas the morphology of endometrial tissue has 
been shown to change as a result of reductions in steroid hormones, how aging 
affects the morphology of the myometrium has not yet been examined, although 
studies on the microanatomy of the aging reproductive tract have been published 
(Heyn 2005). Changes in the biophysical properties of the myometrium with age also 
appear to have been neglected. It would be interesting to examine how myocytes 
size, muscle mass and connective tissue content are affected by aging. 
Within this chapter the negative relationship showing a decrease in contractility with 
age, correlates with the poorer obstetric outcomes noted with advancing age which 
in turn may attribute to the greater incidence of high risk medical conditions that are 
associated with older women. Interestingly, we find that upon increasing age (25-43 
years old) within the pregnant myometrium this significant correlation is lost 
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(Arrowsmith 2012). This more or less maintained force in pregnant women up to 
around age 40, suggests that if a woman becomes pregnant at this age, the uterus 
will respond to the hormonal environment of pregnancy, and increase its muscle 
mass, and hence contractile potential, removing any age-related differences (Wu et 
al. 2008). This suggestion is consistent with the uterine responses of women in their 
50s and 60s to hormonal treatment for IVF and the uterus safely bearing these 
pregnancies to term. Oxytocin however, may have reduced efficacy in the 
myometrium of older women which may have implications clinically such as in cases 
of poor labour progression. Further studies should investigate the details of the 
underlying mechanisms. 
Aging produces changes in metabolism including an increase in cholesterol and LDLs. 
Body mass index (BMI) also increases as women age. Both cholesterol and BMI have 
been shown to depress myometrial contractility (Zhang 2007a, b), and could 
therefore contribute to a reduction in function. Conversely, removal of cholesterol 
using cholesterol sequestering agents enhances contractile activity, thus in the 
uterus, cholesterol inhibits function. Partially, due to effects on K channel activity 
(Shmygol 2007; Noble 2006). Furthermore, myometrial strips with high cholesterol 
content (measured using thin layer chromatography) contracted more poorly in the 
laboratory than those with a lower cholesterol content (Noble 2009). 
Overall this reduction in spontaneous force with age produced by the non-pregnant 
uterus was prominent and is also seen in the responses to high K+. Hence these data 
support the theory that there might be loss of functional muscular tissue (e.g. less 
muscle cells) or decreased expression of L-type Ca channels, with age (Floyd and 
Wray 2007; Taggart et al. 1997), although larger sample numbers are required and 
morphological studies before these suggestions can be tested. Spontaneous 
contractions were normalised to the high K+ contraction to control for any effects of 
age on decreased muscle or L-type Ca expression. Relative to high K+ the amplitude 
of spontaneous activity decreases with age, suggesting that the mechanisms 
generating spontaneous contractions are also failing. Thus in non-pregnant 
myometrium the suggestion is that force may decline as a consequence of muscle 
loss and/or decreased Ca entry and thus decreased activation of the contractile 
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proteins. Reduced levels of oestrogen with aging would be expected to cause 
atrophy of the myometrium, and thus explain some of the decreased strength of 
contractions. There is evidence that the L-type calcium channel subunits and 
function are hormonally regulated, with oestrogen associated with increasing, (Batra 
1987) and progesterone decreasing (Tezuka et al. 1995) calcium channel expression. 
Thus as oestrogen decreases with aging, levels of L-type Ca channels will be expected 
to fall. 
 
3.5.3 Does endometriosis affect myometrial contractility? 
Assessing the spontaneous contractility of non-pregnant myometrium from women 
with endometriosis shows differences in the contractility profile when compared to 
their pre-menopausal healthy counter parts. These data show an increase in 
frequency of contractions. This parameter reaches significance when patients with 
endometriosis and on medication are removed, a trend decrease in all other 
parameters of contraction is found. The women on medication removed were on 
hormone therapy. This study suggests that perhaps hormone therapy is dampening 
the increase in frequency found.  The high K+ data demonstrates a decrease in high 
K+ response within the endometriosis women possibly due to a decrease in the L-
type calcium channels. The overall data obtained from this study supports the 
previous findings, of increased frequency as observed in early in vivo intrauterine 
pressure recordings and videosonography of uterine peristalsis (Leyendecker 2004, 
Bulletti 2002). The increase in frequency of contraction in vivo was two times greater 
than there healthy counterparts were as in vitro the frequency was three time 
greater than when compared. Bulletti et al compared the contractility of infertile 
women with and without endometriosis., Thus the differences in frequency found 
may be accounted for by fertility status. The differences in contractile amplitudes 
between this study and Bulleti et al may also be attributed to the fact that they were 
monitoring whole uterine activity in vivo whereas we are looking at the contractility 
of myometrial tissue strips in vitro. The theory of retrograde menstruation 
(Sampson, 1922) proposes that retrograde bleeding occurs at the time of menses in 
women with endometriosis. This results in transtubal migration of viable 
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endometrial cells that attach and implant in the pelvic cavity, to ultimately develop 
into endometriotic implants (Bulletti 2002). It is also found that there is a much 
higher incidence of these retrograde contractions in women with endometriosis. 
Overall these findings support a causal role of alterations in myometrial contractility 
in the genesis or continuation of endometriosis. This also suggests that this change in 
contractility could have an important effect on the uterine retrograde transport 
capacity and consequently fertility. This was highlighted in 
hysterosalpingoscintigraphy showing that transport of labelled inert particles is 
drastically increased during the early and  mid-follicular phases of the cycle, but the 
directed transport of the particles into the tube ipsilateral to the dominant follicle is 
absent in the periovulatory phase, concluding in women with endometriosis directed 
sperm transport is impaired (leyendecker 2004). 
 
3.5.4 Conclusion 
The results of this study are novel. In this chapter I have compared myometrial 
contractility from pre-, and post-menopausal women as well as from women with 
endometriosis.  This is also the first study to look at the effect of advancing age on 
the non-pregnant myometrium. The data demonstrates clear effects of age and 
menopausal state upon myometrial contractility. It shows that aging significantly 
decreases uterine contractility as does progressing menopausal state, which is not 
surprising as there is a strong relationship between the two.  Endometriosis also 
shows an increase in frequency of contractions and a non-significant but consistent 
decrease in the other parameters of contractility. Consistent with an earlier in vitro 
study which had found spontaneous activity in post-menopausal women, and earlier 
in vivo studies showing more frequent  contractions within the myometrium with 
endometriosis (Domali 2001, Bulletti 2002), these changes in the myometrial 
contractions of women with endometriosis could be implicated as having a causal 
role in the genesis and continuation of the disease. 
The reasons behind this impaired contractility may be related to alterations in 
calcium signalling in the post - menopausal and women with endometriosis. Reduced 
calcium transients are indicative of less calcium entry through L-type voltage calcium 
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channels or perhaps alterations in the expression of L-type calcium channels, which 
is supported by the High K+ data I presented in this chapter, where High K+ 
contractions were reduced in the post menopausal women as well as a trend 
decrease in women with endometriosis. Reduced muscle content could also be 
contributing to the reduced contractility found in this chapter, especially with 
advancing age. Further work needs to be performed to investigate this. 
 
In summary, contractions of the non-pregnant myometrium can be measured in vitro 
and are stable allowing for investigation of the effects of H2S compared with the 
term pregnant myometrium as discussed next in Chapter 4.  
 
3.5.5 Limitations of Study 
One of the main issues to be addressed for future work is the low n numbers as this 
will allow for further insight to be given with respect to contractility differences in 
response to the different medications the women are on such as HRT, GnRH, 
progestagens as well as to define further any differences in contractility in response 
to endometriosis. 
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Chapter 4 
Investigating the role of H2S within the myometrium through H2S 
producers NaHS and novel slow releasing H2S-generating compound, 
GYY4137. 
4.1 Abstract  
Better tocolytics are required to help prevent preterm labour. The gasotransmitter 
Hydrogen sulfide (H2S) has been shown to reduce myometrial contractility and thus is 
of potential interest. However previous studies used NaHS, which is toxic and releases 
H2S as a non-physiological bolus and thus alternative H2S donors suitable for drug 
development are sought.  A new H2S generating compound, GYY4137, developed to 
slowly release H2S and thus better reflects physiological conditions, appears to be such 
a drug.  
The effects of GYY4137 were examined on contractility and compared to NaHS, in 
human and rat myometrium. As it is unknown how the effects of H2S vary with 
gestation, its involvement in the mechanism for transition to labour, and its effects in 
the presence of oxytocic drive, this was also investigated, to increase understanding of 
its physiological importance. The effects on contractility in response to GYY4137 
(1nM-1mM) and NaHS (1mM) were examined on myometrial strips from, biopsies of 
women undergoing elective caesarean section or hysterectomy, and from non-
pregnant, 14, 18, 22 day (term) gestation or labouring rats.  
In pregnant rat and human myometrium dose-dependent and significant decreases 
in spontaneous contractions were seen with increasing concentrations of GYY4137, 
which also reduced underlying Ca transient, measured using Indo-1 fluorescence. 
NaHS (1mM) also significantly decreased contraction.  Both H2S producers 
significantly reduced force in oxytocin-stimulated preparations and their inhibitory 
effects increased as gestation advanced, but were abruptly reversed in labour. The 
effects of GYY4137 and NaHS also occurred in depolarized preparations. 
Glibenclamide, an inhibitor of ATP-sensitive potassium (KATP) channels, abolished the 
inhibitory effect of GYY4137.  
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These data suggest (i) H2S contributes to uterine quiescence from mid-gestation until 
labour, (ii) that H2S affects L-type calcium channels and KATP channels reducing Ca 
entry and thereby myometrial contractions, (iii) add to the evidence that H2S plays a 
physiological role in relaxing myometrium, and thus (iv) H2S is an attractive target for 
therapeutic manipulation of human myometrial contractility and that drugs such as 
GYY4137 may be effective. 
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4.2 Introduction 
H2S is a gaseous signalling molecule that has been implicated in several physiological 
and pathophysiological processes from long term potentiation (kimura 2002) and 
inflammation (Li 2005), to smooth muscle contractility (Teague 2002, Zhao 2009, 
Dhaese 2009, Sidhu 2001).  Two cytosolic enzymes, cystathionine β-synthase (CBS) 
and cystathionine γ-lyase (CSE) (Patel 2009)  act on the sulphur containing amino 
acids, cysteine and homocysteine, to produce H2S (Li 2011, Hughes 2009).  At least two 
enzymes have been identified that degrade H2S to thiosulfate and sulphate, thiosulfate 
sulphur transferase and Thiol S- methyltransferase (Teague 2002, Li 2011, Ramasamy 
2006). Thus H2S will be physiologically regulated within cells and rapid rates of turnover 
enable it to function as a signalling molecule (Vitvitsky 2012). 
The effects of H2S have been examined in several smooth muscles and decreased 
contraction is the most common finding e.g. vas deferens,(Teague 2002), blood vessels 
(Webb 2008) GI tract (Teague 2002, Zhao 2009, Dhaese 2009). The mechanism by 
which H2S produces its effects on smooth muscle contractility is not clear, although KATP 
channels have been implicated in some studies (Dawe 2008, Distrutti 2006, Tang 2005, 
Zhao 2001). Other studies however have found no role for KATP channels (Boyarsky 
1978, Dhaese 2009, Kubo 2007).  In the myometrium  although KATP channels are 
expressed  (Curley 2002)   they so far appear to have only a limited functional 
importance  compared to voltage dependent K channels (Heaton 1993, Aaronson 
2006,Longo 2003 ) , thus other targets for H2S  may  be important in the myometrium. 
Changes in intracellular [Ca2+] are known to underlie contractility changes in response 
to agonists and tocolytics in myometrium (Longo 2003, Szal 1994, Wray 2005). 
Recently, a study in cardiomyocytes suggested, H2S might inhibit L-type [Ca
2+] 
channels through sulfhydration as NaHS decreased the functional free sulfhydryl 
groups available in the L-type [Ca2+] channel (Zhang 2012). In non-contracting 
(butanedione monoxime treated) cerebral artery, Tian et al, (Tian 2012) used fluo-4 
and showed decreases in Ca2+ levels as NaHS was increased from 0.1 to 1 mM, and 
suggested  that NaHS relaxes these vessels by reducing L-type Ca2+ current. There have 
however been no simultaneous measurements of the changes of intracellular Ca2+ that 
occur when changes in contraction result with H2S production in any tissue, and hence 
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its role in the mechanisms of H2S’s effects is unclear. Understanding how H2S affects 
Ca2+ signalling in smooth muscle will provide further insight into how H2S can affect 
force                                                                                                                                                                                                                                    
There is a pressing need to better understand how uterine contractility is controlled 
and to develop better tocolytics to reduce the morbidity and mortality associated with 
pre-term delivery (Goldenberg 2002, Wray 2008).  Thus an endogenous molecule that 
can reduce contractility is of interest.  It has already been shown that the 
uterus possesses the enzymes to produce H2S from L-cysteine, and reports have shown 
H2S to be able to reduce contractions of myometrium from rat and human (Patel 2001, 
Hu 2011, You 2011). Thus alterations of H2S levels may be an attractive target for 
therapeutic manipulation in problematic labours.  It is not clear however if the effects 
of H2S are gestationally dependent, which would indicate that H2S is part of the 
mechanism maintaining uterine quiescence and governing the switch to labour onset, 
or if it remains at an unchanged constitutive level in myometrium.   
The previous studies investigating H2S in myometrium used addition of NaHS as a 
means of producing H2S.  This will produce H2S in a large, rapid bolus and thus it may be 
questioned how well this simulates the physiological condition. In addition because of 
its potential lethality, it is unlikely that NaHS will be a useful therapeutic tool. Recently a 
novel H2S generating compound, GYY4137 (morpholin-4-ium 4 methoxphenyl 
(morpholino) phosphinodithionate) has been developed. It slowly releases H2S, both in 
vitro and in vivo (Li 2008), and has been shown to slowly relax aortic rings and in vivo to 
cause vasodilation and act as an anti-hypertensive (Li 2008).  To the best of our 
knowledge this more physiological approach to the study of H2S in myometrium has 
not been examined.  This in turn limits information on which to judge the clinical 
potential/ usefulness of H2S manipulation in controlling uterine activity. In order to 
increase mechanistic understanding of how H2S reduces uterine contractility, 
simultaneous measurements of changes in intracellular Ca and force were also made 
(Kupittayanant 2002).  
The aims of this chapter were therefore to determine: (1) the effects of GYY4137 on 
contractions of human and rat myometrium, (2) how responses of the myometrium to 
152 
 
H2S vary with gestational state, (3) the effects of glibenclamide on GYY4137-induced 
changes in contractility; (4) the effects of H2S produced via NaHS and GYY4137 on 
spontaneous, oxytocin and high K+ depolarization stimulated contractions, and (5) the 
effect of GYY4137 on myometrial Ca signals.    
4.3 Methods  
4.3.1 Tissue 
 Strips of longitudinal myometrium (~ 1x5mm) were dissected from the uterus of 
humanely killed non-pregnant, 14 day, 18 day and 22 day gestation and labouring 
Wistar rats (Wray 2008) The gestation of the rat was defined from day 0, when the 
male was placed in the cage to mate. Human myometrial strips were dissected from  
biopsies obtained with informed consent and ethical approval  from women 
undergoing an elective term caesarean section (means gestational age 39 weeks, 
mean maternal age, 31; range 22-41 years, N=15 ) or pre-menopausal hysterectomy 
(mean age, 40; range 27- 48 years, N=12). Indications for caesarean section included 
maternal request, previous traumatic vaginal delivery, previous caesarean section or 
breech presentation. None of the women included in this study had any underlying 
diseases (hypertension, diabetes, pre-eclampsia, intrauterine growth restriction 
etc.). Indications for hysterectomy were menorrhagia, fibroids or prolapse. Biopsies 
were obtained from the upper lip of the lower segment uterine incision at caesarean 
section (Luckas 2000) and from corresponding macroscopic normal area of the 
uterus at hysterectomy.  
 
4.3.2 Solutions 
 All chemicals were produced as described in chapter 2. All chemicals were obtained 
through Sigma (UK), apart from GYY4137, which was obtained from Santa Cruz 
biotechnology, USA, NaHS, obtained from Alfa Aesar, uk and Indo-1, Invitrogen, uk. 
The composition of Physiological Saline Solution (PSS) was as follows (mM): 154 
NaCl, 5.1 KCl, 0.12 MgSO47H2O, 10.9 HEPES, 8 Glucose, 2 CaCl2, pH 7.4. In some 
experiments to depolarize the tissue, the KCl in the PSS was increased to 40 mM and 
NaCl reduced equivalently. In some experiments, 0.5 nM oxytocin was added to the 
PSS to study oxytocin induced contractions.  The H2S forming solutions were made in 
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PSS at 1mM for NaHS and 1n M, 1 µM, 0.1 and 1 mM for GYY4137, pH readjusted to 
7.4. (Olson 2012). Both GYY4137 and NaHS were made and incubations performed in 
a fume cupboard at 37oC. Glibenclamide was used at 10µM. Diamide and DTT were 
used at 1mM. 
4.3.3 Ca2+ and Force Measurements:   
Tissue preparation and measurements of calcium and tension are the same as 
described in Chapter2, general materials and methods. 
4.3.4 Incubation protocol 
 Contractile activity was seen in all myometrial strips within 60 mins for rat and 3 hours 
for human after perfusion with PSS (Noble 2006). The strips were allowed to contract 
spontaneously and an equilibrium period of at least 30 minutes with stable 
contractions was obtained before incubation in any chemical. After recording control 
activity, the effect of 45 minutes exposure to NaHS, GYY4137 or control (PSS) 
solution on uterine activity was examined by placing the strip in an Eppendorff with 
the agent, at 37oC within a fume hood due to the toxicity of H2S. The tissues were 
then carefully re-attached to the tension transducer, superfused with PSS and 
contractility again recorded. The same was performed for glibenclamide experiments 
only the control activity was exposed to 10µM glibenclamide as well as during 
incubation in GYY4137 1 mM or PSS. Each concentration of drug was obtained on a 
separate strip of myometrium. Control incubation traces can be found in chapter 2 
(page 91). 
4.3.5 Statistics 
Contractions were analysed for amplitude, frequency, and area under the curve, 
(AUC, in arbitrary units, au) for; 10 minutes, rat data; 30 min, human data (to 
accommodate the slower rate of contractions), and; 15 minutes, high K+, before and 
after H2S forming solution incubation, using Origin 8 (Shmigol 1998). Each strip 
tested for the effect of each H2S producer, had a paired control response in PSS 
rather than test solution. After incubation the contractions were assessed 5 minutes 
after re-attachment. Diamide and DTT were added directly to the bath to examine 
their effects comparing 10 minutes control and Diamide or DTT exposed in the same 
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way. Student’s t tests were performed to compare two groups. Anova with 
Bonferroni post hoc tests were used to compare more than two groups. P was taken 
as showing a significant difference when P<0.05. Each n was from a different biopsy 
or rat.  
4.4 Results 
4.4.1 Establishment of spontaneous contractions and control incubation protocol  
All tissues were superfused with physiological saline salt solution (PSS) at 37oC, pH 7.4 
until spontaneous contractile activity was established. The commencement of 
spontaneous contractile activity of rat myometrium was always within an hour were as 
spontaneous contractile activity of human myometrium was within 2 hours of 
continuous superfusion with PSS at 36-37oC. Where spontaneous activity did not occur 
following 2 hours, the strip was subjected to a 1 (rat) or 2 minute (human) high K+ and 
the strip was further monitored for spontaneous contractions between 30 minutes and 
1 hour. If no further activity was recorded the strip was discarded and another strip 
tried. All samples included in this study were spontaneously active. 
Due to the great toxicity of H2S the tissue strips with the H2S producing solutions, were 
incubated in a fume cupboard and then re-attached via their clips, to the tension 
transducer at the end of the incubation period.  It was therefore necessary to show that 
under control conditions i.e. incubation with PSS and re-attaching, no significant 
changes in contractile parameters were found when contractions were re-established.  
Figure 2.7 within chapter 2 shows that this was the case. Analysis of 4 strips (non-
pregnant rat), 6 strips (14 day gestation rat), 7 strips (18 day gestation rat), 7 strips (22 
day, term pregnant rat), 4 strips (labouring rats), 6 strips (non-pregnant human) and 6 
strips (pregnant human) showed that there were no significant changes to any of the 
parameters of contractions (Table 4.1).  
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Table 4.1. Changes in contractile parameters of myometrial tissue in response to 
control incubations  
 
 NP 14 day 18 day 22 day 
(term) 
 
Labouring Non-
pregnant 
Human 
Term 
pregnant 
human 
n-number 4 6 7 6 
 
4 7 4 
Force 
Amplitude 
(%) 
96±6% 104±1.9% 101±4% 99 ±2% 102±4% 97±3% 
 
90±7% 
Frequency 
(%) 
89±13% 100.4±7.6
% 
92±3% 100±7% 95±9% 93±6% 
 
106±5% 
Duration 
(%) 
101±9% 97.0±6% 105±4% 99±4% 90±5% 94±6% 
 
102±7% 
AUC (%) 85±12% 107±3% 97.1±7.3
% 
95±5% 104±4% 88±9% 
 
104±6% 
 
 
Rat myometrial or human myometrial strips were studied from 4-7 animals. After 
baseline values were obtained (10 minute period immediately before incubation in 
experimental solutions,100 %), tissues were incubated in either physiological saline 
(control) for 45 minutes and then the parameters of contraction re-measured, and 
expressed as the percent of baseline values (i.e. paired data).Values are means ± 
s.e.m.  
No Significant differences were found between any of the values. 
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4.4.2 Dose dependent effects of GYY4137 on spontaneous contractions in non-
pregnant rat myometrium 
Having established a robust protocol (section 4.4.1) I proceeded to determine the 
effects of GYY4137 on myometrial contractility. Concentrations of GYY4137 from 1nM 
to 1mM were examined in non-pregnant rat myometrium. Typical results for each 
concentration are shown in figure 4.1A. The mean data is presented within figure 4.1 B. 
 As seen in the original traces, no significant changes in non-pregnant contractility 
profiles where seen upon increasing doses up to 1mM GYY4137.  At the highest 
concentration 1mM GYY4137 the force remained unaffected (100.8±7% relative to 
control of 100%, n=4). Even integrating the differences in force, duration and 
frequency by measuring the AUC, at 1mM GYY4137 showed no significant change 
(93.6±28% relative to control period of 100%, n=4).  
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Figure 4.1: Dose dependency of GYY4137 in non-pregnant rat.  
(A) Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from non-pregnant rat, before and after 45 minute incubations in i) 1nM, ii)1µM, 
iii) 0.1mM, iv) 1mM GYY4137. (B) Mean data± s.e.m, denoted by error bars, showing the 
dose dependent decrease in i) Amplitude, ii) Duration iii) Frequency, iv) AUC in response to 
GYY4137. Values within bars indicate n-numbers. No significant differences in contractile 
activity were found, using Anova with Bonferroni post hoc tests.  
 
158 
 
4.4.3 Dose dependent effects of GYY4137 on spontaneous contractions in term 
pregnant rat myometrium 
 
Exposure of contracting term pregnant rat myometrium to increasing concentrations 
of GYY4137 from 1nM to 1mM caused a dose dependent decrease in the amplitude 
of force of contractions (figure 4.2).  Representative traces of each concentration are 
illustrated in Figure  4.2 A. The mean data presented in graphical form can be 
found in figure 4.2B.  
The decrease in force was most marked at the highest concentration of GYY4137 
1mM (34.0±6% relative to control period 100%, n=6). Statistical analysis showed a 
significant decrease in contractility from 1nM to 1mM (p=0.003) and from 1nM to 
0.1mM (p=0.030). The decrease in frequency of contractions was significant at 
concentrations from 1nM and 1µM to 1mM GYY4137 (p=0.002, p=0.042 
respectively). There was no significant effect on duration of contraction after 
increasing concentrations of GYY4137. However, by integrating the differences in 
force, duration and frequency by measuring the AUC, showed a dose dependent 
decrease with increasing concentrations of GYY4137 which was most marked at the 
highest concentration of GYY4137, 1mM (22.0±10% relative to control period 100%, 
n=6). With significance at concentrations of 0.1mM and 1mM (p=0.014, p=0.003 
respectively). These results show that GYY4137 causes a dose dependent decrease in 
myometrial contractility in pregnant rat myometrium. 
 
A dose response curve for the effect of GYY4137 on the force of myometrial 
contractions showing the logEC50 is shown in Figure 4.3. 
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Figure 4.2: Dose dependency of GYY4137 in term pregnant rat. 
(A) Representative isometric recordings of spontaneously contracting myometrial 
strips obtained from 22 day  gestation rat, before and after 45 minute incubations in 
i) 1nM, ii)1µM, iii) 0.1mM, iv) 1mM GYY4137. (B) Mean data± s.e.m, denoted by 
error bars, showing the dose dependent decrease in i) Amplitude, ii) Duration iii) 
Frequency, iv) AUC in response to GYY4137. Values within bars indicate n-numbers.  
* represents P<0.05, ** represents P<0.01, using Anova with Bonferroni post hoc 
tests.  
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Figure 4.3 LOG dose response curve for pregnant rat myometrium  
Log dose response curve for the effect of GYY4137  on rat myometrial contractility, 
showing sigmoidal relationship. The EC50 value of -5.873 depicts the concentration 
required to reduce myometrial contractility by 50% compared to minimum and 
maximum values. 
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4.4.4 Gestational dependent effects of GYY4137 and NaHS 
Having shown that GYY4137 can reduce contractions of term pregnant myometrium, I 
next examined if its efficacy varied throughout pregnancy, and as no data were 
available on this point for NaHS, it was also investigated. Typical examples of the effects 
of 1mM GYY4137 (n =4-7) and NaHS (n =4-7) from non-pregnant, 14, 18 and 22 day 
pregnant and labouring rat myometrial tissue are shown in Figures 4.4A and 4.5A 
respectively. 
 Exposure of non-pregnant, 14 day, 18 day, 22 day and labouring contracting 
myometrial tissue to 1mM GYY4137 caused a gestational dependent decrease in the 
amplitude of force of contractions (figure 4.4).   Increasing effects of GYY4137 on 
contractility as gestation progressed were found (Figure4.4Aii-iv). It can be seen that 
GYY4137 has no significant effect on non-pregnant myometrium (Figures 4.4A and Bi). 
As shown in the mean data, (Figure 4.4B), amplitude, frequency of contractions and 
AUC are progressively reduced by GYY4137 from mid-gestation up until labour onset. 
No significant differences were found at day 14 as effects were small. Effects increased 
as gestation advanced with significant decline in force of contraction at day 18 and day 
22 (23.3±12.7% and 34.4±5.6% respectively). There were no significant changes to 
frequency, or duration, However by integrating the differences in force, duration and 
frequency by measuring the AUC, showed large decreases at day 18 and day 22 
(21.4±12.3% and 21.7±10.3% respectively). There was a marked reversal of the 
inhibitory effect of GYY4137 once labour was initiated. No effect on any of the 
parameters of spontaneous contractions of labouring tissue in response to GYY4137 
was found (Figure 4.4Av). Statistical analysis showed a significant increase in the force 
and AUC of labouring contractions in response to GYY4137 when compared to day 18 
and day 22 (106.1±4.8%, 103±10% respectively). 
As revealed in Figure 4.5A the effects of NaHS also increased as gestation advanced.  
As with GYY4137 there was no significant effect on the non-pregnant (Figure 4.5i) or 
labouring (Figure 4.5v) myometrium. The mean data for the effects of NaHS 
throughout gestation are shown in Figure 4.5B and the significant decrease on force 
compared to non-pregnant myometrium can be seen at 22 days gestation (14.9±8.0%). 
Significant decreases on AUC in response to NaHS were also seen at day 18 and day 22 
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(40.9±9.3% and 16.6±13.5% respectively). Once labour was initiated, statistical analysis 
showed a significant increase in the force and AUC of labouring contractions in 
response to NaHS when compared to day 18 and day 22 (99.1±6.7%, 99.3±5.7% 
respectively). 
Figure 4.4 and 4.5iv) shows a term pregnant myometrial strip which had been 
incubated in 1mM GYY4137 and NaHS respectively, clear effects on contraction are 
apparent. The mean data for contraction amplitude, Duration, frequency and AUC 
measured over 10 minutes, after incubation with GYY4137 and NaHS, compared with 
the immediate control period are shown in Table 4.2; significant reductions in all 
parameters of contraction occurred except for changes to duration. Figure 4.4 and 
4.5iv) also shows the gradual recommencement of force after return to control 
solutions. 
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Figure 4.4: Rat myometrial contractility changes over gestation in response to 1mM 
GYY4137.   
(A) Representative isometric recordings of spontaneously contracting myometrial 
strips obtained from i) non-pregnant (NP), ii) 14 day, iii) 18 day, iv)22 day gestation 
and v) in labour rats before and after incubation in 1 mM GYY4137. (B) Mean data ± 
s.e.m, denoted by error bars, of the gestational dependent decrease in i) Amplitude, 
ii) Duration, iii) Frequency, iv) AUC in response to GYY. Values represent Means ± 
s.e.m, denoted by error bars. Values within bars indicate n-numbers.  * represents 
P<0.05, ** represents p<0.01, *** represents p<0.01, using Anova with Bonferroni 
post hoc tests.  
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Figure 4.5: Rat myometrial contractility changes over gestation in response to 1mM 
NaHS.  
(A) Representative isometric recordings of spontaneously contracting myometrial 
strips obtained from i) non-pregnant (NP), ii) 14 day, iii) 18 day, iv) 22 day gestation 
and v) in labour rats. (B) Mean data ± s.e.m, denoted by error bars, of the gestational 
dependent decrease in i) Amplitude, ii) Duration, iii) Frequency, iv) AUC in response 
to NaHS. Values within bars indicate n-numbers.  * represents P<0.05, ** represents 
p<0.01, *** represents p<0.01, using Anova with Bonferroni post hoc tests.  
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Table 4.2. Changes in contractile parameters in response to 1mM NaHS and 
GYY4137 in term pregnant rat myometrium 
Parameter 
measured 
 
Control 
(% ± SE, n=7) 
NaHS 
incubated 
(% ± SE, n=7) 
GYY4137 
incubated 
(% ± SE, n=6) 
Contraction 
Amplitude 
99 ±2% 15±8%* 34±6%* 
Frequency 100±7% 23±9%* 42±10%* 
Duration 99±4% 59±28% 121±35% 
AUC 95±5% 16±13%* 22±10%* 
 
Term (day 22) rat myometrial strips were studied from 4-7 animals. After baseline 
values were obtained (10 minute period immediately before incubation in 
experimental solutions,100 %), tissues were incubated in either physiological saline 
(control) or the solutions indicated, for 45 minutes and then the parameters of 
contraction re-measured, and expressed as the percent of baseline values (i.e. paired 
data).Values are means ± s.e.m.  
* represents significant differences in contractility compared to preceding control 
period (p<0.05, t-test).  AUC; area under the curve. 
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4.4.5 Recovery periods and times to contract within the rat myometrium. 
The length of time it took for the strips incubated in GYY4137 and NaHS to start 
contracting after the 45 minute incubation was monitored to see whether this was 
affected in response to H2S. There was no significant differences, however in Figure 4.6  
you can see that with GYY4137 incubations (Figure 4.6A) and NaHS incubations (Figure 
4.6B) there is a trend of an increase in the length of time to contract up to term which 
is reversed upon labour onset. 
The maximum recovery amplitude of contraction after incubation was examined for 
both GYY4137 (Figure 4.7A) and NaHS incubated (Figure 4.7B)   strips where possible. 
This showed no significant differences over gestation using Anova with bonferroni 
post hoc testing illustrating significant recovery was achieved. Presumably the H2S 
had volatilised and oxidized. It can still be seen that the most significantly affected 
gestations 18 day and 22 day recovered the least.  
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Figure 4.6 Times to contract after incubation of rat myometrium over gestation. 
 
Mean data ± s.e.m, denoted by error bars, of the times to start contracting after 45 
minute incubations in (A) GYY 4137 (B) NaHS. A trend of increased time to contract 
can be seen up until 22 day gestation, which disappears upon labour onset. Values 
within bars indicate n-numbers.  No significant differences were found using Anova 
with Bonferroni post hoc tests.  
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Figure 4.7 Amplitude of contraction recovery in response to GYY4137 and NaHS of rat 
myometrium over gestation. 
 Mean data ± s.e.m, denoted by error bars, of the maximum recovery amplitude of 
contraction after 45 minute incubations in (A) GYY 4137 (B) NaHS. Values within bars 
indicate n-numbers.  No significant differences were found using Anova with 
Bonferroni post hoc tests.  
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4.4.6 Effects on calcium entry and Calcium signalling  
As the above data show very clear reductions in the strength of myometrial 
contractions in the presence of H2S, it was next determined if Ca
2+ channels and 
transients are affected by H2S producers in two ways.  Firstly, high K
+ was used to 
depolarize the myometrium and open voltage gated Ca2+ channels (Noble 2006). If the 
response to depolarization is unaltered by the H2S donors then this would indicate that 
their effects were on the normal processes leading to membrane depolarization.  
Secondly, direct measurements of intracellular Ca2+  simultaneously with force in the 
absence and presence of GYY4137 were made. If Ca2+  entry is decreased, then this 
should be apparent in the associated Ca2+  transients (Shmigol 1998). 
 
High K+ depolarisation 
Depolarisation using 40mM High K+ for 15 minute was examined before and after 45 
minutes incubation in 1mM NaHS (figure 4.8B, n=6) and GYY4137 (figure 4.8C, n=8). In 
day 22 pregnant rats, the two successive applications of high K+, produced very similar 
contractile responses; a rapid rise in force which plateaus and shows only a small 
decrement until the tissue is returned to control solution (Figure 4.8). As shown in 
Figures 4.8B and C, both H2S producers inhibited the amplitude of the High K
+ 
contractions significantly (43±10%, NaHS 82±6% GYY4137) and AUC (34±4%, NaHS 
84±7% GYY4137) compared to control (95±5%, 105±3% respectively, figure 4.8A).  
 
Calcium signalling 
In a subset of studies described within this chapter term pregnant myometrial tissue 
was loaded with intracellular calcium indicator indo-1. Strips loaded and incubated in 
control solution, PSS, showed no changes in force and underlying calcium transients 
(figure 4.9A). An overlay of both force and calcium under control conditions (PSS, 
figure 4.9Bii) shows that changes in calcium precedes the changes in force. The 
effects of 1mM GYY4137 on Ca2+ signalling on day 22 of gestation were examined. 
Figure 4.9B clearly shows spontaneous Ca transients (indo-1 fluorescence) underlie 
the phasic contractions of the myometrium. As before, GYY4137 produced 
significant decreases in contraction amplitude, which as can be seen in Figure 4.9B, 
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are accompanied by a significant decrease in the amplitude of Ca2+  transients to 76 ± 
8%,  (n = 5). Figure 4.9Bii shows an overlay of force and Ca2+ in the presence of 
control and GYY4137 conditions, illustrating the decline in force and calcium in the 
presence of GYY4137. 
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Figure 4.8:  Effects of NaHS and GYY4137 on High K+ depolarisation.  
High K+ (40 mM) depolarisation, 15 mins,  of  term pregnant rat myometrial strips and the 
effects in the presence of A) physiological saline solution (PSS), B) 1mM NaHS (n=6) C) 1mM 
GYY4137 ( n=8). All solutions were used at 37oC and pH 7.4.  
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Figure 4.9:  Effects of GYY4137 on calcium signalling.  
 Recording of force and intracellular Ca (from Indo-1–emitted fluorescence F400:500), 
measured simultaneously in spontaneously contracting myometrial strips dissected from 
term rat myometrium before and after incubation in A) Control (PSS, n=3), Bi) GYY 1mM 
(n=5). Bii) an overlay of both force and calcium showing that the change in calcium precedes 
the changes in force as well as showing the decrease in contractions in the presence of 
GYY4137 1mM compared to control. All solutions were used at 37oC and pH 7.4.  
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4.4.7 Effects of KATP channel inhibition on GYY4137-induced changes in 
contractility. 
Studies have demonstrated that KATP channels are involved in H2S modulation of 
smooth muscle tone (Tang 2005, Zhao 2001) but this has not been studied in rat 
uterus. In 4 paired experiments the effects of GYY4137 in the presence of 
glibenclamide, (10 µM) a blocker of KATP channels was investigated. As previously 
found (Heaton 1993) glibenclamide had little effect on spontaneous contractions 
shown in Figure 4.10A. The mean data for the effects of Glibenclamide, 
Glibenclamide & GYY4137 as well as GYY4137 incubations is shown in Figure 4.10C 
and Table 4.3.  Incubation of term myometrial tissue in GYY4137 in the continued 
presence of glibenclamide had little effect on the parameters of contraction within 
rat myometrium when compared to GYY4137 alone (Figure 4.8B). As can be seen in 
Table 4.3, GYY4137 did not produce any significant effects when glibenclamide was 
present on force, frequency or AUC when compared to GYY4137 alone (73±19%, 
101±28%, 72±14% compared to 34±6%, 42±10% 22±10% respectively relative to 
paired control of 100% (normalised). There was no significant change to duration. 
 
.  
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Figure 4.10:  Effects on calcium entry and calcium signalling.  
KATP channel inhibitor glibenclamide (10µM)  was applied to rat myometrial strips 20 
minutes before and during the 45 minute A) control incubation (PSS) and B) GYY4137 
(1mM, n=4) incubation period. All solutions were used at 37oC and pH 7.4.  C) Illustrates 
the mean data± s.e.m, denoted by error bars. Values within bars indicate n-numbers.  
* represents P<0.05  
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Table 4.3. Changes in contractile parameters in response to GYY4137, 
Glibenclamide and GYY4137 with Glibenclamide, in term pregnant rat myometrium 
Parameter 
measured 
 
Control  
(PSS) 
 
Glibenclamide 
(% ± SE, n=4) 
GYY4137+ 
Glibenclamide 
(% ± SE, n=4) 
GYY4137 
incubated 
(% ± SE, n=6) 
Contraction 
Amplitude 
100% 81±12% 73±19% 34±6%* 
Frequency 100% 99±13% 101±28% 42±10%* 
Duration 100% 92±15% 124±16% 121±35% 
AUC 100% 84±21% 72±14% 22±10%* 
 
Term (day 22) rat myometrial strips were studied from 4-6 animals. After baseline 
values were obtained (10 minute period immediately before incubation in 
experimental solutions,100 %), tissues were incubated in either physiological saline 
(control) or the solutions indicated, for 45 minutes and then the parameters of 
contraction re-measured, and expressed as the percent of baseline values (i.e. paired 
data).Values are means ± s.e.m.  
* represents significant differences in contractility compared to control period 
(p<0.05).  AUC; area under the curve. 
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4.4.8 Effects of sulfhydryl-modifying reagents Diamide (DM) and Dithiothreitol 
(DTT) on contractions of term rat myometrium 
Sulfhydryl modifiers can help to simulate or prevent S-sulfhydration. DM is an 
oxidizing sulfhydryl modifying substance converting SH bonds to disulfide bonds 
reducing the amount of free sulfhydryl groups simulating the sulfhydration 
mechanism. Examining diamides response on contractility (Figure 4.11A) shows 
similar responses to GYY4137 and NaHS, i.e. a significant decrease in amplitude, 
frequency and AUC of contraction (all p<0.05, n=5) with no significant change to 
duration (Table 4.4). A representative trace is shown in Figure 4.11A. DTT is a 
reducing sulfhydryl modifying reagent which transforms disulfide bridges into 
sulfhydryl groups in cysteine-containing proteins. This had no significant effect on 
contractility as illustrated in Figure 4.11B and summarised in table 4.4, this highlights 
free sulfhydryl groups produce no significant effect on contractility. 
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Figure 4.11: Term rat myometrial contractility changes to sulfhydryl modifiers 
Diamide and Dithioreitol. 
Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from  22 day gestation animals in response to (A) Diamide (DM, 1mM) an 
oxidant sulfhydryl modifier and (B) Dithioreitol (DTT, 1mM), a reductant sulfhydryl 
modifier. Diamide significantly reduced amplitude, frequency and area under the 
curve similar to NaHS and GYY4137 (p<0.05, n=5). DTT caused no changes to 
contractility (n=3). Student t-tests were performed.  
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Table 4.4. Changes in contractile parameters in response to Dithioreitol and 
Diamide compared to control, in term pregnant rat myometrium 
 
 Control  
(PSS) 
Dithioreitol 
(DTT, % ± SE, n=3) 
Diamide 
(DM, % ± SE, n=5) 
Force 100% 89±11% 13±12%* 
Frequency 100% 122±16% 39±35%* 
Duration 100% 143±15% 21±16% 
AUC 100% 144±26% 6±5%* 
 
Term (day 22) rat myometrial strips were studied from 3-5 animals. After baseline 
values were obtained (10 minute period immediately before superfusion in 
experimental solutions,100 %), tissues were superfused in either physiological saline 
(control) or the solutions indicated, for 30 minutes and then the parameters of 
contraction re-measured, and expressed as the percent of baseline values (i.e. paired 
data). Values are means ± s.e.m.  
* represents significant differences in contractility compared to control period 
(p<0.05).  AUC; area under the curve. 
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4.4.9 Effects of GYY4137 and NaHS on non-pregnant human myometrium 
Having established in rat that GYY4137 and NaHS could significantly reduce force in 
term but not non-pregnant myometrium, next their affect on non-pregnant human 
myometrium were investigated.  Contractions were monitored and analysed 30 
minutes before and after incubation in the solution of interest. As revealed in rat 
myometrium there were no significant changes in force, duration, frequency, or AUC of 
control contractions, the same was found upon control incubations of non-pregnant 
human myometrium in PSS (97±3%, 94±11%, 93±6%, and 88±9%,respectively,  n=7, 
Figure 4.12A).  
Exposure of spontaneous by contracting non-pregnant human myometrium with NaHS 
(Figure 4.12B, n=6) showed no significant effects on force, duration, or AUC of 
contractions (90±9%, 99±13%, 80±10% respectively relative to control 100%). However, 
frequency was significantly decreased (60±16%).  Exposure of spontaneously 
contracting non-pregnant human myometrium with GYY4137 (Figure 4.12C, n=5) 
showed no significant effects on force, duration, frequency or AUC contractions 
(84±10%, 82±14%, 116±10%, and 88±19%, respectively relative to control). 
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Figure 4.12 Effects of NaHS and GYY4137 on non-pregnant human myometrium  
Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from non-pregnant human tissue. Strips were placed under a resting 
tension of 2mN and superfused continually with physiological saline solution (pH 7.4) 
at 37°C before and after 45 minute incubations in (A) physiological saline solution 
(control, represented in red), (B)1mM NaHS (blue), (C)1mM GYY4137 (green) all at a 
pH 7.4 and at 37°C.  
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4.4.10 Effects of GYY4137 and NaHS on term pregnant human myometrium 
In contrast to the non-pregnant human myometrium, as shown in Figure 4.13B and 
4.13C, both H2S producers generated clear effects on term human myometrium and 
significant reductions in force, as seen in Table 4.5. Statistical analysis showed 
significant decreases in force, frequency and AUC of contraction after incubation in 
NaHS 1mM (p=0.014, p=0.004, and p=0.020 respectively, n=6) and GYY4137 1mM 
(p=0.008, p=0.038, and p=0.010 respectively, n=7). Duration of contractions did not 
reach significance for either H2S producer (p=0.055, NaHS and p=0.070). These results 
show that GYY4137 and NaHS significantly inhibit contractions of term pregnant 
human myometrium and that contractions of non-pregnant human myometrium are 
not significantly affected. All except for frequency in the presence of NaHS were a 
reduction is found in both tissues (non-pregnant and pregnant). 
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Figure 4.13 Effects of NaHS and GYY4137 on term pregnant human myometrium  
Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from term pregnant non-labouring human tissue. Strips were placed under 
a resting tension of 2mN and superfused continually with physiological saline 
solution (pH 7.4) at 37°C before and after 45 minute incubations in (A) physiological 
saline solution (control, represented in red), (B)1mM NaHS (blue), (C)1mM GYY4137 
(green) all at a pH 7.4 and at 37°C.  
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Table 4.5: Changes in pregnant human myometrial contractile parameters in 
response to NaHS, and GYY4137 incubations with and without oxytocin.  
Parameter 
measured 
 
Control  
(%) 
NaHS 
incubated 
(% ± SE, n=7) 
NaHS 
+Oxytocin 
(%± SE, n=7) 
GYY4137 
incubated 
(%± SE, n=6) 
GYY4137 
+Oxytocin 
(%± SE, n=5) 
Contraction 
Amplitude 
100 10±4%* ‡ 40±9%* 35 ±14%* 33±14% 
Frequency 100 23±9%* ‡ 50±10%* 48±19%* 76±26% 
Duration 100 52±19% 71±25% 51±18% 68±17% 
AUC 100 3±2%* ‡ 22±7%* 23 ±10%* 29±12%* 
 
After baseline values were obtained (30 minute period immediately before 
incubation in experimental solutions,100 %), tissues were incubated in either 
physiological saline (control) or the solutions indicated, for 45 minutes and then the 
parameters of contraction re-measured, and expressed as the percent of baseline 
values (i.e. paired data).Values are means ± s.e.m. * represents significant 
differences in contractility compared to preceding control period.(p<0.05, t-test). ‡, 
represents significant reduction in spontaneous contractility when compared to in 
the presence of oxytocin (0.5nM) along with either GYY4137 or NaHS. AUC; area 
under the curve.    
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4.4.11 Effects of GYY4137 and NaHS on term pregnant human oxytocin-stimulated 
contractions  
In vivo term human myometrium will be stimulated by circulating oxytocin thus it could 
be posited that this stimulation prevents the effects of H2S, hence I investigated if 
GYY4137 and NaHS could reduce contractility in term myometrium stimulated by 
oxytocin. Oxytocin produces a clear increase in phasic contractions in pregnant 
myometrium, upon which the effects of, NaHS, (n=7) and GYY4137 (n=5) were tested 
(Figure 4.14B and 4.14C). Both compounds reduced significantly the parameters of 
contraction in all samples, but as can be seen in Table 4.5 the effects were not as 
potent as found for spontaneous activity. For incubations in NaHS 1mM, force, 
frequency and AUC of contractions were significantly reduced at 40±9%, 50±10% and 
22±7% respectively under the presence of oxytocin. Although not as significantly 
diminished as the response to NaHS 1mM, on force, frequency and AUC of 
spontaneous contractions, 10±4%,, 23±9%, 3±2% respectively. For incubations in 
GYY4137 1mM, force, frequency and duration of contractions were decreased but not 
significantly in the presence of oxytocin at 33±14%, 76±26% and 68±17% respectively. 
Although integrating force, duration and frequency to attain the AUC still showed a 
significant decrease in contractions (29±12%).  
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Figure 4.14 Effects of NaHS and GYY4137 on term pregnant oxytocin-stimulated human 
myometrium  
Representative isometric recordings of oxytocin-stimulated (0.5nM) spontaneously contracting 
myometrial strips obtained from term pregnant non-labouring human tissue. Strips were placed 
under a resting tension of 2mN and superfused continually with physiological saline solution (pH 7.4) 
at 37°C before and after 45 minute incubations in (A) physiological saline solution (control, 
represented in red), (B) 1mM NaHS (blue), (C) 1mM GYY4137 (green) all at a pH 7.4 and at 37°C.  
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4.5 Discussion  
 
The present study is the first to investigate the effects of the novel H2S generator 
GYY4137 in a non-vascular smooth muscle, the myometrium. The effects in rat and 
human myometrium were studied and I found that: i) GYY4137 causes a concentration-
dependent reduction in contractility of  myometrium, ii) The ability of H2S to inhibit 
contraction is not constant but rather is greatest close to term before disappearing 
during labour  iii) GYY4137 and NaHS significantly reduced contractility in pregnant but 
not non-pregnant human myometrium,  iv) H2S  significantly reduced tonic force 
produced by high-K  depolarization and oxytocin-stimulated contractions, and v) 
GYY4137 reduced the intracellular Ca transients underlying contractions and inhibition 
of KATP channels prevented the effects of GYY4137. Together these data suggest H2S 
affects both membrane potential and L-type Ca channels to relax myometrium and that 
physiologically, H2S levels may be altered during gestation to contribute towards 
myometrial quiescence until labour. This suggestion is supported by recent findings 
reporting that H2S production is decreased within human term labouring myometrium 
compared to non labouring myometrium (You 2011).  
4.5.1 Experimental conditions and protocols 
GYY4137, like NaHS, releases H2S when in aqueous solutions such as PSS, but was 
developed to release it with a slower and more prolonged time course than that 
obtained with sulfide salts (Li 2008, Wang 2012). Measurements of H2S in vivo and in 
vitro confirmed a release of H2S with GYY4137 taking several minutes to peak, whereas 
NaHS produces a larger, more or less instantaneous release of H2S (Lee 2011). In 
subsequent work it was confirmed that H2S release from GYY4137 was 10% of that 
observed with NaHS, but was sustained, (Lee 2011) and that a structural analogue, 
ZYJ1122, which lacked sulphur, was without effect. Our incubations were performed 
in a fume cupboard and tissue then transferred to the experimental rig for force and 
other measurements. I waited five minutes after re-attachment of the tissue to the 
force transducer, to allow the tissue to settle and wash off of the H2S producing 
compounds. This is likely therefore to have resulted in an under-estimation of the 
effects of H2S, and suggests in vivo that GYY4137 will be more potent than measured 
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in our in vitro studies.  As seen in many of the figures, force builds up throughout the 
period after incubation, presumably as the H2S is volatilized and oxidized (Olson 
2012).  Notwithstanding these experimental conditions clear effects of GYY4137 are 
apparent. Consistent with previous work (Hu 2011, Sidhu 2001) within this thesis it was 
found that NaHS decreased or even abolished spontaneous contractility in rat and 
human myometrium.  
4.5.2 GYY4137 and smooth muscle 
In the only other study on smooth muscle function, Li et al showed GYY4137 could relax 
contraction of aortic rings with an EC50 of 115 µM.  In the uterus I found contractions to 
be relaxed with an EC50 of 1.6 µM. NaHS has been reported to relax different vascular 
tissues with EC50 of 1-300 µM (Olson 2010), thus it is apparent that there is 
considerable inter-tissue differences in EC50 values, although experimental differences 
may account for much of the variation.  
As mentioned earlier, studies in both animal and human tissues over the last few 
years have demonstrated a role for H2S within smooth muscle. While many have 
reported relaxation (Webb 2008, Dhaese 2009, Teague 2002, Zhao 2009), some have 
found increased contraction or different effects dependent upon H2S concentration 
(Webb 2008, Zhao 2001). It has been suggested that these differences may be due to 
the lower conversion efficacy of NaHS to H2S at high concentrations (Tian 2012). 
Such dual responses were not found by us with NaHS in pregnant rat myometrium, 
consistent with previous findings in the pregnant human myometrium (Hu 2011). In 
vivo data points to relaxation being the predominant effect of H2S in the vasculature. 
Mice lacking CSE, the biosynthetic enzyme for H2S, are hypertensive and their blood 
vessels do not relax to acetylcholine, and administration of NaHS to animals causes 
vasodilation (Yang 2008, Ishii, 2010). 
4.5.3 Effects of H2S change with gestational state 
Striking differences in the response of the myometrium were found, both in rat and 
human tissue, to GYY4137 and NaHS depending upon the gestational state of the 
tissue. No significant effects on contractions in the non-pregnant tissue to addition of 
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either H2S source were found but clear effects by mid-gestation. The inhibitory effect 
on contraction then further increased until term. These data suggest that the relaxant 
effects of H2S are increased as pregnancy advances. The most striking effect however 
was the abrupt transition upon labour; H2S was without effect as seen by the data for 
both compounds. This suggests that H2S contributes to uterine quiescence in late 
pregnancy and that the myometrium can rapidly change its responses to H2S.   
 
4.5.4 Mechanism of H2S effects in myometrium 
There are many suggestions for the mechanism by which H2S exerts its effects and as 
with NO, it is likely that there will be many targets (Li 2011).  The main mechanism  
appears to be due to H2S  modifying cysteine residues in many proteins through S-
sulfhydration (Mustafa 2011) i.e. cysteine’s covalent modification by which -SH groups 
on  cysteine residues of a protein are converted to –S-SH, via addition of  sulphur 
from H2S (Mustafa 2009). This molecular mechanism is similar to the S-nitrosylation 
effect of NO, however, unlike S-nitrosylation, S-sulfhydration activates rather 
represses, its target proteins (Gallyas 2012). The data in this thesis using DTT, a 
reductant sulfhydryl modifier and Diamide, a oxidant sulfhydryl modifier supports this 
showing that firstly free sulfhydryl groups have no effect on contractility and that 
disulphide bonds cause a similar effect to NaHS and GYY4137.  Although it would be 
interesting to see whether using DTT could reverse GYY4137 and NaHS effects on force 
and calcium as in Zhang et al 2012 where it could markedly reverse the H2S donor-
induced inhibition of I Ca, L (L-type calcium current) in cardiomyocytes. Illustrating that 
if H2S targets on the crucial free-sulfhydryl groups on the L-type Ca
2+ channel and 
inhibits the L-type calcium current, the inter-chain disulfide bond linkages would be 
rapidly reduced by DTT, and therefore the inhibition would be reversed (Zhang 
2012). 
The most widely researched effect of H2S is on KATP channels within smooth muscle. In 
vascular smooth muscle cells H2S stimulated single-channel activity of KATP channels 
by directly increasing their opening probability (Wang 2012).  Recent work has made 
progress in identifying which residues in the channel are affected by H2S, with Cys 6 
and 26 on the extracellular N terminal of the SUR1 subunit of the channel being 
identified (Jiang 2010). KATP channels have been suggested as one of the targets of 
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H2S that lead to reduced myometrial contractility (Hu 2011).  In contrast, other 
studies showed that the KATP channels are not involved in H2S relaxation in smooth 
muscle tissues including vascular, bronchial, and gastrointestinal smooth muscle 
(Kubo 2007, Teague 2002, Lee 2007). Our data with glibenclamide would support a 
role for these channels in the mechanism of H2S effects in myometrium.  GYY4137 
had no significant effect on myometrial contractility when KATP channels had been 
incubated with glibenclamide.  As opening of these channels will cause 
hyperpolarisation, and this in turn decreases the opening of L-type Ca channels, this 
suggests that KATP are a target in myometrium. Hyperpolarization and relaxation 
induced by Na2S has been directly measured in arterioles (Liang, 2012). However as 
this hyperpolarization was shown to be due to activation of Ca sparks and opening of 
Ca-activated K (BK) channels, and Ca sparks are not present in myometrium (Burdyga 
2007),  this cannot account for hyperpolarization in the myometrium .  
4.5.5 Changes in intracellular Calcium 
The above suggests that L-type Ca entry will be reduced by H2S sources in the uterus.  
There are however few studies measuring the effects of H2S on Ca in any tissues, and 
none have done so simultaneously with contraction. Reduction of Ca by H2S has 
previously been demonstrated in non-contractile arterial segments (Tian 2012). Our 
simultaneous measurements of intracellular Ca and contractions show a H2S-
dependent reduction in intracellular Ca accompanies the decrease in amplitude of the 
phasic contractions.  To the best of our knowledge these are the first measurements 
directly demonstrating that the effects of H2S in producing reduction in force are due to 
decreased Ca transient amplitude.  
4.5.6 Effects of GYY4137 on depolarized and oxytocin-stimulated contraction. 
This study also shows in pregnant rat myometrium that the tonic force produced by 
depolarization with high K+, used to directly open L-type calcium channels, is reduced 
by GYY4137.  This suggests that mechanisms beyond membrane potential changes 
are also a feature of the H2S relaxation mechanism in the uterus.  There is now 
mounting evidence that the L-type Ca channels themselves are targets of H2S. Sun et 
al, (Sun 2008) in cardiac myocytes were the first to show that H2S can inhibit L-type Ca 
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channels. Recently others have shown inhibition of these channels by NaHS also occurs 
in vascular smooth muscle (Tian 2012, Al-Magableh 2011) and Zhang et al  (Zhang 2012) 
have gone on to show that this is dependent upon the protein sulfhydryl state of the 
channel. An increase in resting Ca2+  was also found in endothelial cells with NaHS 
(Bauer 2010), thought to be due to store operated Ca2+  entry. Thus direct effects on 
Ca2+  entry via L-type Ca2+  channels and other channels, also contributes to the relaxant 
effects of H2S. This inhibition of Ca
2+  channels will also explain why in some tissues 
inhibition with glibenclamide of KATP channels often does not fully prevent the relaxant 
effects of H2S donors. There is evidence from gastric fundus and distal colon, where 
glibenclamide is without effect, that H2S may affect Ca
2+  sensitization of the contractile 
machinery (Dhaese 2009, Dhaese 2010), but as Ca2+  sensitization plays little role in 
spontaneous activity of myometrium (Kupittayanant 2001), this is unlikely to be 
contributing to the data obtained within this chapter.  
Our data clearly show that H2S donors can reduce contractility even when stimulated 
by oxytocin in the pregnant myometrium. Oxytocin increases Ca2+ within the 
myometrium, partly by depolarization and increasing L-type Ca2+  channel entry (Wray 
2007).  Thus the mechanisms by which H2S suppresses spontaneous contractions are 
likely to also feature in the effects on oxytocin-induced contractions.  As shown in Table 
4.5, the effects of NaHS were less in the presence of oxytocin compared to 
spontaneous activity, presumably due to the increased contractile drive with oxytocin 
stimulation. This was not the case for GYY4137 perhaps as the H2S produced by 
GYY4137 outlasts the instantaneous H2S produced by NaHS and this allows the 
contractile drive to have more of an effect on NaHS incubated strips (Lee 2011).  
4.5.7 Gestational changes and H2S mechanism of action 
The above gives insight into the mechanism of action of H2S but does not explain the 
reasons for susceptibility changes over gestation. Suggestions include (i) increased 
vulnerability to sulfhydration of L-type calcium channels as L-type calcium channel 
subunits increase toward term (Collins 2000); (ii) reduction in kir6.1 and 6.2 KATP 
subunits once myometrium is labouring, as  before labour H2S exerts its effects on 
these subunits  (Xu 2011); (iii) up regulation of the H2S breakdown enzymes with 
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gestation, or (iv) changes in uterine environment with labour, such as hypoxia and pH 
changes, (Quenby 2004, Wray 1992) may result in faster breakdown of H2S, but this 
remains controversial, (Olson 2012, Doeller 2005).  The lack of specific inhibitors of 
these enzymes and the difficulty of accurately measuring H2S in tissues, hinders further 
study of these last two points. The differences between non-pregnant and term 
pregnant human and rat contractility responses could also be attributed to changes in 
suceptability of L-type ca channels and Katp channels to be sulfhydrated, down 
regulation of H2S breakdown enzymes at term or uterine environment changes where 
by H2S breakdown is hindered at term.  
4.5.8 GYY4137 and tocolysis 
The synthesis of GYY4137 and its cardiovascular effects in rats were first reported by Li 
et al 2008) (Li 2008).  As pointed out by these authors, while much data were being 
obtained showing the importance of H2S, studies were limited by the lack of a 
compound to better mimic the endogenous release of H2S in cells. The commonly used 
NaHS or Na2S release H2S instantaneously in aqueous solutions, producing very large 
and transient increases in its concentration. GYY4137’s potential as a slow-releasing H2S 
compound with effects on vascular smooth muscle in vitro and in vivo were shown, its 
time scale of H2S production measured and its lack of toxicity to aortic cells shown (Li 
2008). Subsequent work has supported low toxicity (Yu 2010) and also indicated anti-
cancer properties (Lee 2011), anti inflammatory activity (Li 2009), and anti apoptotic 
(Lavu 2011) activity of GYY4137. Thus GYY4137 or subsequent compounds, 
(Predmore 2012) may well be suitable for a variety of patho-physiological conditions, 
including tocolysis in threatened preterm labour, i.e. to stop the onset of labor,  
although further work, including studies on labouring samples, are needed to 
develop this suggestion. Recent studies of interactions between the enzymes 
producing or destroying H2S and their inhibitors, also represent another way of 
manipulating its effects in the uterus (Sun 2009)  The finding that free H2S values are 
up to 100-fold higher in smooth muscle (aorta) compared to liver, blood, heart and 
kidney, (Levitt 2011) also encourages these approaches. 
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4.5.9 Summary 
In conclusion, NaHS and GYY4137 relax term pregnant human and rat myometrium. 
Within the rat myometrium we show increased potency as term approaches is 
shown; an effect that is rapidly reversed as labour starts.  GYY4137 can reduce force 
produced spontaneously, by oxytocin or high K+ depolarization. The mechanism 
involves both KATP channels and importantly, L-type Ca channels. GYY4137 reduces 
the intracellular Ca transients that underlie spontaneous contractions. Our data and 
that of previous studies suggest H2S could contribute to uterine quiescence and that 
increasing its level in myometrium could be an attractive target for therapeutics to 
inhibit the onset of labor.  Increased understanding of the mechanisms for transition to 
labor should also follow from obtaining a better understanding of H2S in the 
myometrium. 
4.5.10 Limitations of study 
Limitations of study include: 
 No direct evidence of sulfhydration. Furture work using a biotin switch assay 
investigating sulfhydration of L-type and Katp channels in the uterus needed 
as using DTT and DM effect many mechanisms including oxidation of 
glutathione. 
 No work on human labouring samples, need to investigate human labouring 
samples to see whether the effect seen in the rat can directly relate. Difficult 
samples to attain. 
 When thinking about tocolytics many factors have to be borne in mind, 
including effects on other tissues, the fetus, tolerance, side effects, 
formulations and desensitization.  However this is a worthwhile goal, as 
illustrated by the successful introduction of atosiban, the Oxytocin receptor 
anatagonist. 
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Chapter 5 
Investigating the role of H2S through L-cysteine and expression of the 
enzymes producing and breaking down H2S. 
5.1 Abstract 
H2S is produced in vivo from L-cysteine, by cystathionine β-synthase (CBS) 
and cystathionine γ-lyase (CSE). The enzyme rhodanese has an isoform, TST involved in 
the breakdown of H2S. Thus H2S will be regulated within cells.  In the previous chapter it 
has been clearly shown that H2S producing compounds NaHS and GYY4137 have a 
relaxant effect on the myometrium and reduce Ca transients at term. However, is the 
same true for endogenous L-cysteine? This chapter investigates L-cysteine’s effects on 
simultaneous force and calcium measurements within non-pregnant and term 
pregnant rat (22 day) myometrium. L-cysteine’s effects were also examined in non-
pregnant and term pregnant human myometrium.  The characteristics of spontaneous 
and high k+ depolarisation induced contractions are discussed. Another question 
addressed by determining enzyme expression levels, is could the differences in 
contractility in non-pregnant compared to pregnant myometrium (Chapter 4) in 
response to H2S, be a result of differences in H2S production or removal rates within the 
uterus?   
There is no previous account of the effects of L-cysteine on non-pregnant and term 
pregnant rat myometrium and its effects are therefore unknown. In this chapter I 
therefore determined its effects and possible mechanisms of action, by studying 
changes in underlying calcium, intracellular pH, and changes in response to BayK 8644 
and high K+. L-cysteine and the contribution of its chemical effect were also assessed 
using D-cysteine, the stereoisomer of L-cysteine as well as, L-serine and sodium 
pyruvate both by-products of H2S production through L-cysteine. In addition inhibitors 
of both H2S producing enzymes were examined to determine whether changes to the L-
cysteine responses occurred. Finally, as H2S can be naturally produced by garlic, I also 
monitored changes in contractility in response to garlic.  
The distribution of CBS, CSE and TST were assessed using immunohistochemistry 
and/or Western blotting in NP, 10 day, 14 day, 18 day, and 22 day gestation rat 
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myometrium as well as within non-pregnant and term pregnant human myometrium.  
L-cysteine applied to term pregnant rat and human myometrium, dose-dependently 
and significantly decreased spontaneous contractions, and also reduced the 
underlying Ca transient (Indo-1 fluorescence). The frequency and AUC of contraction 
increased. The intracellular pH, measured via carboxy SNARF-1 fluorescence, 
declined in L-cysteine. L-cysteine had no effect in depolarized preparations. 
BayK8644 reduced the effects of L-cysteine although the initial increase in 
contractions once L-cysteine was applied remained significant.  
This data also shows only increases in frequency of contraction were found upon 
application of L-cysteine within the non-pregnant rat and human myometrium. 
Inhibitors of H2S production reduced or blocked the relaxant effect produced by L-
cysteine although stimulant effects remained. Garlic also produced similar responses 
to L-cysteine with decreases in amplitude as well as an overall increase in frequency 
and AUC. 
Both H2S production enzymes, but not TST, were present in all myometrium examined. 
Closer examination of the non-pregnant and term pregnant human tissue through 
western blotting illustrated that within the term pregnant tissue significantly less 
amounts of both enzymes are present.  
In conclusion L-cysteine caused an increase in frequency and decline in force 
amplitude. The effects on amplitude can be explained by L-cysteine affecting Ca 
transients and L-type calcium channels similar to GYY4137 and NaHS. However, the 
stimulatory effect caused by L-cysteine remains to be elucidated. Preliminary 
experiments with garlic shows tocolytic effects but remain to be further investigated, 
as does the H2S enzyme distribution decline from non-pregnant to term to allow for 
the onset of labour. 
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5.2 Introduction 
H2S has been around for millions of years and is well known for its smelly odour and 
toxicological effect (Reiffenstein 1992). However in recent years it has been 
recognized for its physiological role as a gaseous signalling molecule. Tissues produce 
H2S via two enzymatic pathways, cystathionine β-synthase (CBS) and cystathionine γ-
lyase (CSE) and L-cysteine is the substrate these enzymes use to produce H2S. 
Therefore as both enzymes are present in the myometrium (Patel 2009, You 2011), it 
is capable of producing H2S from the precursor L-cysteine. CSE and CBS are cytosolic 
enzymes. CBS is a homotetramer consisting of 551-amino-acid subunits with a 
subunit molecular weight of ~63KDa and  CSE is a 405-amino-acid protein consisting 
of a tetramer formed by two homodimers, with active and stable dimer of ~45KDa 
(Sun 2009, Whiteman 2011 Singh 2009, & You 2011). An enzyme called rhodanese 
has been implicated in the breakdown of H2S, specifically its TST isoform. However, 
neither H2S producing enzyme has been looked for in the non-pregnant myometrium 
or at different stage gestations in the rat and TST has not been examined in the 
uterus at all. The main finding on application of H2S through H2S donors is that it has 
a relaxant effect on smooth muscle, which has been clearly shown in Chapter 4, this 
stimulated the examination of L-cysteine’s effect on force and calcium of the 
myometrium as well as the presence of the H2S producing and breakdown enzymes 
with view to help develop new physiological and naturally occurring tocolytics and to 
help explore the physiological relevance of H2S in the myometrium.   
There have been few studies examining the effect of L-cysteine on uterine 
contractility. One study investigated the effect of increasing concentrations of L-
cysteine up to 1mM on 19 day rat myometrium, finding a dose dependent decrease 
in contractile activity (Sidhu 2001).  L-cysteine on term non labouring and labouring 
human myometrium also reduced contraction amplitude, but also increased 
frequency. This study also found that myometrial strips treated with glibenclamide 
an inhibitor of KATP channels abolished the effects of L-cysteine and that L-cysteine’s 
effects were less potent in the term labouring human strips (You 2011). The latter 
observations ties in with Chapter 4 were glibenclamide abolished the effects of NaHS 
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and GYY4137 and that both H2S-producer effects were eliminated upon labour 
onset.  
 
H2S is also naturally produced by garlic (Allium Sativum). Garlic consumption has 
been correlated with the reduction in multiple risk factors associated with 
cardiovascular diseases such as increased reactive oxygen species, and high blood 
pressure to high cholesterol (Banerjee 2002, Benavides 2007). Within isolated 
hearts, aortic rings, tracheas and intestines, garlic juice inhibited smooth and cardiac 
muscle contractions (Aqel MB 1991).  Given the need to find more efficacious 
tocolytics to prevent pre-term labour, the suggestion that H2S can relax uterine 
smooth muscle is important and if verified could form the basis of new methods to 
control uterine activity and maybe aid in the understanding of quiescence. It would 
be even more beneficial if this tocolytic could be naturally occurring from the food 
that we eat and this is why I have investigated the effect of garlic on myometrial 
contractility. If similar effects to GYY4137 and NaHS are found, then its use clinically 
will be of interest.  
As there is little mechanistic insight into the effects of L-cysteine on myometrial 
contractility, this was examined. This chapter aims to demonstrate the contractile 
responses of L-cysteine within non-pregnant and term pregnant rat and human 
myometrium. Characteristics of spontaneous and high K+ depolarisation-induced 
contractile activities are discussed. Further investigation into the mechanism of L-
cysteine with respect to BAYK 8644, Ca2+ signalling, intracellular pH and use of H2S 
producing enzyme inhibitors are also discussed. I also explored the contractility 
changes of the myometrium in the presence of garlic which naturally produces H2S. 
The enzymes CBS and CSE are widely distributed in tissues. In the cardiovascular 
system the expression of CSE is much higher compared to CBS, though the opposite 
is found in brain (Lowicka 2007, Awata 1995). Expression of both CBS and CSE have 
been documented in smooth muscle tissue. CSE seems to be the predominant 
enzyme responsible for H2S production in vasculature smooth muscle (Zhao 2001) 
were as in the gastrointestinal and penile smooth muscle both contribute (Fiorucci 
2005, De’Emmanuele Di Villa Bianca 2009). In the myometrium, Patel et al found the 
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presence of both H2S producing enzymes in rat non-pregnant and 19 day gestation 
uterus as well as human term pregnant myometrium. You et al further examined the 
presence of both enzymes in term non labouring and labouring human myometrium 
at the protein and mRNA level, finding both present and during labour H2S enzymes 
are down-regulated. No work has been undertaken to look at the expression of both 
enzymes within different stage gestation rat myometrium or looked at the presence 
in non-pregnant human versus term pregnant myometrium hence this was 
researched. 
TST is the isoform of rhodanese that detoxifies H2S to sulfite and sulfate from 
thiosulfate. (Caliendo 2010). TST is a mitochondrial matrix enzyme and ~33-kDa in 
weight (Ramfrez 2004). TST was shown to detoxify H2S in human colon but has yet to 
be looked at in the myometrium. Could TST have a role in the differences found in 
contractility? Does its presence differ at different stages of gestation in rat 
myometrium and in non-pregnant versus term pregnant human myometrium?, this 
will be investigated. 
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5.3 Methods 
5.3.1 Tissue 
 Strips of longitudinal myometrium (~ 1x5mm) were dissected from the uterus of 
humanely killed non-pregnant, and 22 day gestation (equivalent to term) Wistar rats 
(Wray 2008). The gestation of the rat was defined from day 0, when the male was 
placed in the cage to mate. Human myometrial strips were dissected from biopsies 
obtained with informed consent and ethical approval from women undergoing an 
elective term caesarean section (mean gestational age 39 weeks, mean maternal 
age, 29; range 27-37 years, N=8 ) or pre-menopausal hysterectomy (mean age, 38.2; 
range 27- 50 years, N=5). Indications for caesarean section included previous 
caesarean section or breech presentation. None of the women included in this study 
had any underlying disease (hypertension, diabetes, pre-eclampsia, intrauterine 
growth restriction etc.). Indications for hysterectomy were menorrhagia or irregular 
bleeding. Biopsies were obtained from the upper lip of the lower segment uterine 
incision at caesarean section (Luckas 2000) and from corresponding macroscopic 
normal area of the uterus at hysterectomy.  
 
5.3.2 Solutions 
 All chemicals were produced as described in Chapter 2. All chemicals were obtained 
through Sigma (UK), apart from garlic, which was obtained from RAJAH finest 
authentic foods, UK. The composition of Physiological Saline Solution (PSS) was as 
follows (mM): 154 NaCl, 5.1 KCl, 0.12 MgSO47H2O, 10.9 HEPES, 8 Glucose, 2 CaCl2, pH 
7.4. In some experiments to depolarize the tissue, the KCl in the PSS was increased 
to 40 mM and NaCl reduced equivalently. L-cysteine was made in PSS at 1n M, 1 µM, 
0.1 and 1 mM, then pH readjusted to 7.4. (Olson 2012). Garlic powder (Rajah), was 
diluted in PSS at 0.01, 0.2, 0.7 and 1 mg/ml and also pH readjusted to 7.4. Allicin 
(diallyl thiosulfinate), the main organosulfur compound, is produced from the amino 
acid alliin by action of the enzyme alliinase when garlic is crushed to a powder. 
Allicin, unstable in aqueous solution, rapidly decomposes mainly to diallyl sulfide 
(DAS), diallyl disulfide (DADS), diallyl trisulfide (DATS),and ajoene (Amagase 2006). 
BayK was used at 0.1µM, sodium pyruvate, L-serine and D-cysteine were used at 
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1mM. Enzyme inhibitors, propylargylglycine (PAG), O-(carboxymethyl)hydroxylamine 
hemihydrochloride (AOAA) and hydroxylamine (HA) were used at 0.1mM. All 
solutions were applied directly to the bath at 37oC. 
 
5.3.3 Ca2+ and Force Measurements:   
Tissue preparation and measurements of calcium and tension are the same as 
described in Chapter2, general materials and methods. 
 
5.3.4 pHi and Force Measurements:   
Tissue preparation and measurements of pHi and tension are the same as described 
in Chapter2, general materials and methods. 
 
5.3.5 Statistics 
Contractions were analysed for amplitude, frequency, duration and area under the 
curve, (AUC, in arbitrary units, au) for; 10 minutes, at the beginning and end of 
response to L-cysteine and garlic rat data, 30 minutes, high K, using origin 8. L-
cysteine’s response within human data was assessed over a 30 minute period to 
accommodate the slower rate of contractions. Each strip tested for the effect of L-
cysteine or garlic had a paired control response in PSS rather than test solution. 
Student’s t tests were performed to compare two groups. Anova with Bonferroni 
post hoc tests were used to compare more than two groups. P was taken as showing 
a significant difference when P<0.05. Each n was from a different biopsies or rat.  In 
some cases results are expressed as percentage of control contractions were control 
is 100%. 
5.2.6 Immunohistochemistry 
Sections of 4μm thick were cut in the pathology department and mounted onto glass 
slides. Sections were cut from 6 non-pregnant and 6 pregnant women as well as non-
pregnant, 10, 14, 18, and 22 day rat myometrium. The sections were stained as 
described in Chapter 2 section 2.6. Briefly sections from human myometrium were 
labelled appropriately before combining in a metal rack were rehydrated and placed 
into boiling 10mM Sodium Citrate buffer pH6.0 for antigen retrieval. Endogenous 
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peroxidise activity was blocked with 3% hydrogen peroxide before incubation non 
specific block 5% Bovine Albumin Serum (BSA) overnight incubation with 1:50 CBS 
and  1:150 CSE antibodies. Beta actin (Abcam) was used as an antibody control and 
Aorta and brain were used as a positive control for CSE and CBS, respectively. The 
following day the sections were incubated with secondary antibody before 
developing with 3, 3’-Diaminobenzidine (DAB) (Sigma). All slides from rat were 
developed for the same time to reduce any bias in the experiments. All slides from 
non- pregnant and term pregnant myometrium were developed for the same time to 
reduce any bias in the experiments. 10 images were photographed from each 
sample (6 non-pregnant and 6 term pregnant human myometrium as well as non-
pregnant, 10, 14, 18, and 22 day rat myometrium) using a 40x objective. (Nikon 
Biophot Microscope, Nikon Corporation, Tokyo 100-8331, Japan, Eclipsenet 
software, developed by Laboratory Imaging s.r.o. for Nikon Instruments Europe B.V., 
1170AE Badhoevedorp, The Netherlands). 
 
5.2.7 Western Blotting 
Protein was extracted, quantified and Western blots run as described in Chapter 2 
section 2.7. Briefly a small section of myometrium was dissected from non-pregnant 
and term pregnant myometrial biopsies, diced with a scalpel before placing into 
protein extraction buffer. The tissue was then homogenised, centrifuged and the 
supernatant removed and stored at - 20°C until use. Once quantified 25μg of protein 
was prepared in 3x loading buffer, boiled at 100°C. 10% acrylamide gels were cast 
and 20μl of the prepared proteins were added to the wells. The gels were run at 150 
volts for 90 mins before transfer to nitrocellulose membranes at 40V for 1hour and 
10minutes at room temperature. Once transferred the nitrocellulose membranes 
were placed into 5% BSA before overnight incubation at 4°C with primary antibody. 
The primary antibodies used were CBS at 1:250 (Abnova), CSE at 1:200 (Abnova), TST 
at 1:1000 (Abcam) and loading control Actin 1: 5000 (Abcam). The following day the 
primary antibody was removed and the membranes were incubated with the 
appropriate secondary antibody either Goat Anti Mouse, Goat Anti Rabbit (Thermo 
Fisher Scientific) before developing with SuperSignal West Pico Chemiluminescent 
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Substrate (Thermo Fisher Scientific). Analysis of Western blots was carried out in 
ImageJ using densitometry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
202 
 
5.4 Results 
5.4.1 The effect of L-cysteine on term pregnant rat myometrial contractility 
Exposure of contracting rat myometrium to increasing concentrations of L-cysteine 
from 1nM to 1mM caused a dose dependent decrease in the amplitude of force of 
contractions. Typical force traces are shown in figure 5.1i)-iv) and the mean data for 
amplitude, duration, frequency and AUC are presented in graphical form in Figure 
5.2 showing the results in response to L-cysteine in the first (Figure 5.2A) and last 
(Figure 5.2B) 10 minutes of perfusion. Looking at initial 10 minutes response to L-
cysteine (Figure 5.2 Ai-iv) showed no significant change until 1mM when a 
stimulatory effect on contractility was found. A significant increase in force 
amplitude, frequency and AUC, was seen at 1mM L-cysteine (p=0.007, 0.00009, 
0.005 respectively). There was no change in the duration of contractions.  
 
Examining the last 10 minutes of the response on application of L-cysteine (Figure 
5.2Bi-iv) highlighted a decrease in force amplitude, most marked at the highest 
concentration of L-cysteine 1mM (67±6%) relative to control period 100% (n=8). 
Statistical analysis showed a significant decrease in contractility from 1nM to 1mM 
(p=0.019). Increased frequency of contractions achieved highest significance at 1mM 
L-cysteine (p=0.002) as well as duration after increasing concentrations of L-cysteine, 
however by integrating the differences in force, duration and frequency by 
measuring the AUC, showed the most marked increase at the highest concentration 
of L-cysteine 1mM (180±28%) relative to control period 100% (n=8) and significant at 
1mM concentration (p=0.037). These results showed effects most prominent at 
1mM L-cysteine, myometrial contractility after 30 minutes showed a decrease in 
force amplitude with overall increase in AUC.  
A dose response curve for the final 10 minute effect of L-cysteine on the force of 
term pregnant rat myometrial contractions showing the logEC50 is illustrated in 
Figure 5.3. 
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Figure 5.1: Dose dependency of L-cysteine in term pregnant rat myometrium.  
Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from term pregnant rat (22 day gestation). Each myometrial strip was 
perfused with either i) 1nM, ii)1µM, iii) 0.1mM, iv) L-cysteine.  
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Figure 5.2: Mean data of dose dependency of L-cysteine in term pregnant rat myometrium.  
Mean data± s.e.m, denoted by error bars, showing the first 10 minutes (A) and the last 10 minutes (B) 
of applications of L-cysteine. The mean data for i) Amplitude, ii) Duration iii) Frequency, iv) AUC in 
response to L-cysteine. Values within bars indicate n-numbers. * is p<0.05. ** is p<0.01, ***p<0.001 
using Anova with Bonferroni post hoc tests. (A) shows a dose dependent increase in contractility as 
does (B) only with a significant dose dependent decrease in amplitude. 
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Figure 5.3 LOG dose response curve for pregnant rat myometrium  
Log dose response curve for the effect of L-cysteine on rat myometrial contractility, 
showing the sigmoidal relationship. The log EC50 value of -3.345 depicts the 
concentration required to reduce myometrial contractility by 50% compared to 
minimum and maximum values. 
Log (L-cysteine Concentration (M) 
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5.4.2 The effect of L-cysteine on non-pregnant rat myometrial contractility 
Concentrations of L-cysteine from 1nM to 1mM were examined in non-pregnant rat 
myometrium, original traces from each concentration are illustrated in Figure 5.4. L-
cysteine within non-pregnant myometrium, in the initial 10 minute (Figure 5.5A i-iv) 
period highlighted a dose dependent increase in contractile profile upon increasing 
doses. The stimulation seen only became significant in increasing the amplitude of 
contraction at 1mM (p= 0.003, n=10). No significance in duration and frequency was 
found. Were as integrating the differences in force, duration and frequency by 
measuring the AUC significance was found between 1nM and 1µM to 1mM 
(p=0.005, p=0.012 respectively) showing a dose dependent increase with increasing 
concentrations of L-cysteine which was most marked at the highest concentration of 
L-cysteine 1mM (198±17%).  
Studying the last ten minutes of the response to L-cysteine (Figure 5.5B i-iv) 
demonstrated a trend increase in all parameters with no significance. Frequency of 
contractions at 1mM L-cysteine showed a significant increase (p=0.013, n=10).  
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Figure 5.4: Dose dependency of L-cysteine in non-pregnant rat myometrium.  
Representative isometric recordings of spontaneously contracting myometrial strips 
obtained from non-pregnant rats. Each myometrial strip was perfused with either i) 
1nM, ii)1µM, iii) 0.1mM, iv) L-cysteine.  
208 
 
 
Figure 5.5: Mean data of dose dependency of L-cysteine in non-pregnant 
myometrium.  
Mean data± s.e.m, denoted by error bars, showing the first 10 minutes (A) and the last 10 minutes (B) 
of applications of L-cysteine. The mean data for i) Amplitude, ii) Duration iii) Frequency, iv) AUC in 
response to L-cysteine. Values within bars indicate n-numbers. * is p<0.05. ** is p<0.01, ***p<0.001 
using Anova with Bonferroni post hoc tests. (A+B) show a dose dependent increase in contractility.  
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5.4.3 Comparing the response of 1mM L-cysteine within non-pregnant and term 
pregnant rat myometrium 
The first and last ten minutes of responses to 1mM L-cysteine were compared in 
both term and non-pregnant myometrium. For the first ten minutes there was no 
difference in the parameters of the stimulation found. At the last ten minutes of 
activity the mean force amplitude of spontaneous contractions within term pregnant 
myometrium were smaller at 67±3% (n=8) compared to non-pregnant at 93±11% 
(n=10). The mean duration, frequency and AUC of contraction were not significantly 
elevated when compared to the non-pregnant. The overall mean data for all 
parameters can be found in figure 5.6, student t-tests were performed to look for 
significance at p<0.05. Therefore in conclusion the changes in contractile activity on 
application of L-cysteine to non-pregnant and pregnant myometrium were not 
significantly different apart from a remaining significant decrease in amplitude of 
pregnant myometrial contractions. 
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Figure 5.6: Comparison of rat non-pregnant and term pregnant L-cysteine 
responses.  
Mean data± s.e.m, denoted by error bars, showing non-pregnant (NP) and term pregnant differences 
in final ten minute perfusion with L-cysteine. The mean data for i) Amplitude, ii) Duration iii) 
Frequency, iv) AUC in response to L-cysteine. Values within bars indicate n-numbers. * is p<0.05. ** is 
p<0.01, ***p<0.001 using student ttests.  
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5.4.4 Effects on calcium entry and Calcium signalling  
The data above very clearly shows increased frequency of contractions that progress to 
a reduction in the amplitude of term pregnant rat myometrium in the last 10 minutes 
of L-cysteine application which could be attributed to the effects of H2S produced by L-
cysteine as found on incubation with H2S producers  NaHS and GYY4137 (chapter 4). 
Next it was determined if Ca2+  channels and transients were affected upon application 
of L-cysteine.  Firstly, high K+ was used to depolarize the myometrium and open voltage 
gated Ca2+  channels (Noble 2006). Secondly, direct measurements of intracellular Ca2+  
simultaneously with force in the presence of L-cysteine. If Ca2+  entry is decreased, then 
this should be apparent in the associated Ca2+  transients (Shmigol 1998). Thirdly, Bay K 
8644 was used to investigate whether upon opening L-type calcium channels changes 
the response of L-cysteine. As Bay K 8644 opens L-type Ca2+  channels and leads to a 
rise in cytosolic Ca2+, however the mechanism by which the sustained elevation in 
cytosolic calcium results in the generation of phasic contractile activity is unclear 
(chien 1996).  
Depolarisation using high K+ for 30 minutes was examined with and without 1mM L-
cysteine (n=5). In day 22 pregnant rats, the two consecutive applications of high K, with 
and without L-cysteine, produced very similar contractile responses; a rapid rise in 
force which plateaus (Figure 5.7A). No significant differences in AUC were found.  
The effects of 1mM L-cysteine on Ca2+ signalling in day 22 of gestation rat 
myometrium were examined. As Figure 5.7B clearly shows spontaneous Ca2+ 
transients (indo-1 fluorescence) underlie the phasic contractions of the 
myometrium. L-cysteine produced significant decreases in Ca2+ amplitude to 75±5%, 
shown in figure 5.7B with an overall increase in the frequency of Ca transients to 
129±25%.  (p=0.021, p=0.004 respectively, n = 5).  
Consistent with previous studies upon application of 0.1µM BayK (Figure 5.8) 
increased the intensity and frequency of smooth muscle contractions (Knot 1991, 
Sato 1988, Chien 1996). The effects of L-cysteine in the presence of BayK were not as 
pronounced, the decrease in contractility found after the 30 minute L-cysteine 
incubation did not reach significance (p=0.06). For duration, frequency and AUC 
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there were also no significant changes. Although, the AUC for the initial 10 minutes 
of L-cysteine incubation remained significantly increased.  
Overall L-cysteine affects Ca entry as it significantly decreases Ca2+ transient 
amplitude after 30 minute incubations as well as increases frequency. KCL and BayK 
8644 results show that the effects of L-cysteine are eliminated in the presence of KCl 
and partially inhibited in the response to bayK 8466.  
 
5.4.5 Examining the chemical effect of L-cysteine through use of D-cysteine and 
sodium pyruvate. 
To investigate whether the difference seen in responses to L-cysteine are not just 
simply a chemical effect D-cysteine, the stereo isomer of L-cysteine as well as sodium 
pyruvate and  L-serine, by products formed when the CSE and CBS enzymes use L-
cysteine to produce H2S, were studied (Figure 5.9). L-serine is an analogue of L-
cysteine. The optimum concentration of L-cysteine used was 1mM and this was the 
concentration used within this section to directly compare responses of D-cysteine, 
sodium pyruvate and L-serine. 
There was no effect on contractility in the presence of D-cysteine (n=4, Figure 5.9A) 
also previously found by sidhu et al 2001 (sidhu 2001). Both sodium pyruvate (n=4) 
and L-serine (n=2) produced a similar increased contractile profile upon initial 
application. No statistical analysis was performed on L-serine but sodium pyruvate 
showed a significant increase in amplitude of initial contractions once sodium 
pyruvate had been added at 113±3% (p=0.03). This lead me to the question could 
the initial stimulation of force in the presence of L-cysteine be due to an intracellular 
pH change?  
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Figure 5.7:  Effects on calcium entry and calcium signalling.  
(A)  High K (40 mM) depolarisation, 30 mins,  of  term pregnant rat myometrial strips and the 
effects in the presence of 1mM L-cysteine (n=5). (B) Recording of force and intracellular Ca 
(from Indo-1–emitted fluorescence F400:500), measured simultaneously in spontaneously 
contracting myometrial strips dissected from term rat myometrium in the presence of L-
cysteine (n=5). All solutions were used at 37oC and pH 7.4.  
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Figure 5.8:  Effect of L-cysteine on myometrial contractility in the presence of BayK 8644  
 A representative trace showing the reduced effects of L-cysteine on the contractility 
of term pregnant rat myometrium in the presence of BayK 8644. BayK 8644 L-type 
calcium channel opener. The decrease in contractions is abolished in the response to 
L-cysteine with BayK 8644 compared to the response to L-cysteine alone. In 
indo1AM loaded stripes whilst being excited at 340nM by a xenon lamp. The emitted 
light was measured by photomultiplier tubes at 400nM and 500nM. The ratio of the 
two fluoresces gives a measurement of the underlying calcium transients. All 
experiments were carried out a 37°C and pH7.4 
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Figure 5.9:  Effect of D-cysteine, sodium pyruvate and L-cysteine on term pregnant rat 
myometrium 
A representative trace showing A) no effect of 1mM D-cysteine on spontaneous 
contractility of term pregnant rat myometrium and the stimulation upon initial 
perfusion in B) 1mM sodium pyruvate and C) 1mM L-serine. All experiments were 
carried out a 37°C and pH7.4.  
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5.4.6 Monitoring intracellular pH of term pregnant myometrial contractions upon 
perfusion with L-cysteine. 
To investigate if the initial stimulation of frequency upon incubation with L-cysteine 
was due to an intracellular alkalinisation (Heaton 1992, Heaton 1993) the pH 
sensitive indicator carboxy SNARF-1 was used. In 6 myometrial strips from different 
term pregnant rats pH was measured simultaneously with spontaneous contractile 
activity and L-cysteine added. The initial changes in frequency and amplitude of 
contractions upon application of L-cysteine coincides with the period when pH 
decreased i.e. no alkalinisation occurred. (Figure 5.10A). Addition of pH 6.9 PSS 
illustrates the effects of external acidification (figure 5.10B) using Carboxy SNARF-1, 
supporting that upon incubation in L-cysteine an acidification roughly half the size is 
seen.  
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Figure 5.10 The effects of L-cysteine and external pH 6.9 on intracellular pH 
Simultaneous recording of force and pHi in term pregnant rat myometrium loaded 
with the pH sensitive indicator carboxy-SNARF. The tissue was excited at 530nm and 
a ratio of the emission signals at 590 and 640. Traces show a small decrease in pHi is 
associated with each phasic contraction. A) Shows an intracellular decrease in pH 
upon application of L-cysteine (n=6). B) Illustrates decreasing the pH of the perfusate 
from pH 7.4 to pH 6.9 increased force of contractions.  
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5.4.7 Do inhibitors of both H2S production enzymes abolish the response of L-
cysteine? 
Both CSE and CBS enzymes produce H2S through use of substrate L-cysteine. In order 
to confirm that the effects of 1mM L-cysteine were through producing H2S, CBS and 
CSE inhibitors were administered 20 mins before addition of L-cysteine to term 
pregnant rat myometrium. Within this section I describe the use of CSE inhibitor, 
PAG (0.1mM) and CBS inhibitors, AOAA (0.1mM) and HA (1mM).  PAG and AOAA 
have been used in human myometrium at these concentrations (You et al 2011). 
An original trace showing L-cysteine’s effects in the presence of PAG can be seen in 
Figure 5.11. As shown in Figure 5.12A, CSE inhibitor PAG did not block the initial 
stimulation caused by L-cysteine. Significant elevations in amplitude, duration and 
AUC remain (p=0.03, p=0.03, p=0.009, respectively, n=4). Frequency is elevated but 
not significantly, with increased n numbers this may change. However, illustrated in 
figure 5.12B, the decrease in amplitude of the contractions in the final ten minute 
period of L-cysteine exposure is partially blocked at 88±13% rather than 67±6% in L-
cysteine alone. Amplitude, duration and AUC remain significantly elevated. 
CBS inhibitors HA (n=5) and AOAA (n=4) were tested in the presence of L-cysteine 
and original traces can be found in figure 5.13. HA totally abolished contractions as 
well as the effects of L-cysteine. AOAA abolished the L-cysteine-induced decrease in 
spontaneous contraction amplitude found within the last ten minute of L-cysteine 
application. This is shown in the mean data within figure 5.14. All other parameters 
of contractility were not significantly changed in response to L-cysteine in the 
presence of AOAA at the beginning or end period of L-cysteine application, although 
overall resultant affects still remain on AUC. 
 
 Overall both inhibitors block or partially block the decrease in contractility, most 
likely a result of H2S production by the enzymes through L-cysteine. Although the 
effects of the acidification found upon application of L-cysteine remain, with an 
increase in the frequency and AUC of contraction demonstrated in figures 5.11-5.14.  
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Figure 5.11 The effect of L-cysteine in the presence of CSE inhibitor 
CSE inhibitor PAG (0.1mM) was applied to term pregnant rat myometrial strips 20 
minutes prior and throughout the 30 minute superfusion of L-cysteine (1mM). A 
representative trace is illustrated above (n=4). All solutions were superfused at 37oC, 
pH7.4. 
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Figure 5.12: Mean data showing the responses of L-cysteine with and without CSE 
inhibitor. 
Mean data± s.e.m, denoted by error bars, showing the first 10 minutes (A) and the last 10 minutes (B) 
of applications of L-cysteine (1mM) with and without CSE inhibitor PAG (0.1mM). The mean data for i) 
Amplitude, ii) Duration iii) Frequency, iv) AUC in response to L-cysteine. Values within bars indicate n-
numbers. * is p<0.05. ** is p<0.01, using student t-tests.  
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Figure 5.13 The effect of L-cysteine in the presence of CBS inhibitors 
CBS inhibitors  A) HA(1mM) and B) A0AA (0.1mM) were applied to term pregnant rat 
myometrial strips 20 minutes prior and throughout the 30 minute superfusion of L-
cysteine (1mM). A representative trace is illustrated above (n=5, n=4 respectively). 
All solutions were superfused at 37oC, pH7.4. 
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Figure 5.14: Mean data showing the responses of L-cysteine with and without CBS 
inhibitor A0AA. 
Mean data± s.e.m, denoted by error bars, showing the first 10 minutes (A) and the last 10 minutes (B) 
of applications of L-cysteine (1mM) with and without CBS inhibitor AOAA (0.1mM). The mean data for 
i) Amplitude, ii) Duration iii) Frequency, iv) AUC in response to L-cysteine. Values within bars indicate 
n-numbers. * is p<0.05. ** is p<0.01, using student t-tests.  
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5.4.8 The dose dependent effect of L-cysteine on term pregnant human 
myometrium 
The dose response of L-cysteine was examined in the term pregnant human 
myometrium. To see if similar effects were found.  To accommodate the slower rate 
of contractions the full 30 minute exposure to L-cysteine was assessed. Human 
myometrium was exposed to increasing concentrations of L-cysteine from 1nM to 
1mM. 
 
A trend dose-dependent decrease in the amplitude of force of contractions was 
found. At the highest concentration (1mM) this decrease in force almost reached 
significance at 57±8% compared to control (100%) (p=0.060, n=6). A typical dose 
response force trace can be seen in figure 5.15 and the mean data for amplitude, 
duration, frequency and AUC of contractions in response to L-cysteine are presented 
in graphical form in figure 5.16. All other parameters showed an increase in 
contraction (5.15 ii-iv) in response to increasing doses of L-cysteine, only the 
elevated frequency reached significance, from 1nm and 1µm to 1mM (p=0.033, 
p=0.025 respectively). Individual Student t-tests between control and 1mM L-
cysteine contractions showed a significant decrease in amplitude (p=0.001) and 
significant increases in duration, frequency and AUC (p=0.023, p=0.017, p= 0.040, 
respectively). Student t-tests between control and 0.1mM L-cysteine showed a 
significant decrease in amplitude as well as a significant increase in frequency 
(p=0.03, p=0.019). 
 
A dose response curve for the effect of L-cysteine on the force of term pregnant 
human myometrial contractions showing the logEC50 is illustrated in Figure 5.17. 
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Figure 5.15: Dose dependency of L-cysteine in term pregnant Human myometrium.  
Isometric recordings of spontaneously contracting term pregnant human myometrial 
strips superfused with increasing doses of L-cysteine from 1nm to 1mM at 37oC, 
pH7.4.  
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Figure 5.16: Mean data of dose dependency of L-cysteine in term pregnant human 
myometrium.  
Mean data± s.e.m, denoted by error bars, showing the mean data in the parameters of contractility i) 
Amplitude, ii) Duration iii) Frequency, iv) AUC in response to L-cysteine. Values within bars indicate n-
numbers. * is p<0.05. ** is p<0.01, ***p<0.001 using Anova with Bonferroni post hoc tests.  
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Figure 5.17 LOG dose response curve for term pregnant human myometrium  
Log dose response curve for the effect of L-cysteine on term human myometrial 
contractility, showing the sigmoidal relationship. The log EC50 value of -6.277 
depicts the concentration required to reduce myometrial contractility by 50% 
compared to minimum and maximum values. 
 
 
 
 
Log (L-cysteine Concentration (M) 
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5.4.9 The effect of 1mM L-cysteine on non-pregnant and Term human myometrium 
Looking at the statistical effect of 1mM L-cysteine on non-pregnant human 
myometrium (n=5) alone showed a significant decrease in amplitude of contractions 
at 90±2% (p=0.015) and significant increases in frequency at 364±100% (p=0.009) 
and AUC at 268±65% (p=0.048) when compared to control period (100%). 
Differences between the responses found to 1mM L-cysteine in non-pregnant and 
term pregnant human myometrial contractions were then examined. Representative 
traces of a non-pregnant (5.18A) and term pregnant human (5.18A) 1mM L-cysteine 
response is illustrated in figure 5.18.  The mean data are demonstrated in figure 5.19 
i-iv. As in rat myometrium l-cysteine responses, the only significant difference in 
response was to the decline in contractility as within the term human pregnant 
myometrium the contractions under L-cysteine application were significantly more 
reduced at 56±8% (p=0.008).  Therefore in conclusion the changes in contractile 
activity on application of L-cysteine within both groups are not significantly different 
apart from a residing significant decrease in amplitude when compared to non-
pregnant. 
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Figure 5.18: Effect of 1mM L-cysteine in non-pregnant and term pregnant 
myometrium. 
Isometric recordings of spontaneously contracting (A) non-pregnant and (B) term 
pregnant human myometrial strips superfused with 1mM L-cysteine at 37oC, pH7.4.  
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Figure 5.19: Comparison of non-pregnant and term pregnant L-cysteine responses.  
Mean data± s.e.m, denoted by error bars, showing non-pregnant (NP) and term pregnant differences 
in final ten minute perfusion with L-cysteine. The mean data for i) Amplitude, ii) Duration iii) 
Frequency, iv) AUC in response to L-cysteine. Values within bars indicate n-numbers. * is p<0.05. ** is 
p<0.01, ***p<0.001 using student ttests.  
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5.4.10 Does garlic affect the myometrium? 
Here preliminary experiments have been performed superfusing different 
concentrations of garlic powder, most likely a mixture of garlic derived organic 
polysulfides (Benavides et al 2007), within PSS for 20 minute periods. 
Initial experiments show a similar response to L-cysteine at 0.714mg/ml 
concentration of garlic (Figure 5.20A). The different concentration responses can be 
seen within figure 5.20 A-C. Upon increasing doses of garlic powder there is a trend 
of a dose-dependent increase in duration, frequency and AUC with not much change 
in amplitude for both the initial and end 10 minute period responses of garlic (Figure 
5.21 and 5.22). The most prominent effects were found at 0.714mg/ml and greater 
concentrations of garlic powder. At 0.714mg/ml the initial ten minute period of 
garlic application illustrated a small initial increase in amplitude of contraction at 
103±19% with increases in duration, 117±3%, frequency, 152±14% and AUC, 169±9% 
(Figure 5.21 i-iv, n=4). At  0.714mg/ml the  last ten minutes of garlic application 
showed amplitude decreased to 96±25% with increases in duration, 125±11%, 
frequency, 163±15% and AUC, 172±13%  (Figure 5.22 i-iv , n=4). Only underlying AUC 
reached significance for both initial and final exposures to 0.714 mg/ml garlic (5.21iv 
and 5.22ivp=0.030, p=0.007 respectively). All other doses were not assessed for 
significance due to low n-numbers of 1 or 2. 
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Figure 5.20: Effect of increasing doses of garlic powder on term pregnant rat 
myometrium. 
Isometric recordings of spontaneously contracting term pregnant human myometrial 
strips superfused with 0.01-1mg/ml garlic powder. A) shows the effect of 
0.714mg/ml garlic B) shows the effect of 0.2, 0.714 and 1mg/ml garlic C) shows the 
effect of 0.01, 0.2 and 0.714mg/ml garlic on contractility. 
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Figure 5.21: Mean data for the initial effects of increasing concentrations of Garlic on term pregnant 
rat myometrium.  
Mean data± s.e.m, denoted by error bars, showing the changes in contractility within the first 10 
minutes of applications of Garlic. The mean data for i) Amplitude, ii) Duration iii) Frequency, iv) AUC in 
response to L-cysteine. Values within bars indicate n-numbers. Only 0.714mg/ml garlic was tested for 
significance using student t-tests * is p<0.05.  
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Figure 5.22: Mean data for the final effects of increasing concentrations of Garlic on term pregnant 
rat myometrium.  
Mean data± s.e.m, denoted by error bars, showing the changes in contractility within the last 10 
minutes of applications of Garlic. The mean data for i) Amplitude, ii) Duration iii) Frequency, iv) AUC in 
response to L-cysteine. Values within bars indicate n-numbers. Only 0.714mg/ml garlic was tested for 
significance using student t-tests ** is p<0.01.  
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5.4.11 Expression of the CBS and CSE in the Myometrium of Non-pregnant, 10 day, 
14 day, 18 day and 22 day rat myometrium – Immunohistochemistry 
 
The expression of the CBS and CSE, H2S production enzymes were examined by light 
microscope of DAB staining which is equivalent to CBS and CSE expression. Positive 
controls for CBS (Brain) and CSE (Aorta) as well as negative controls for non-
pregnant, 10 day, 14 day, 18 day and 22 day rat myometrium are seen in figure 5.23, 
illustrating DAB staining in the positive controls and no staining in the negative 
controls. This shows that the staining is specific to either the CBS or CSE antibody 
depending on which antibody is used. A representative image of NP, 10, 14, 18 and 
22 day rat myometrium is shown in figure 5.24 (n=3 each tissue type). Staining was 
found in the myometrium of all samples as well as the circular muscle. 
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Figure 5.23 Positive and negative controls 
Positive staining for CBS and CSE in brain and aorta respectively was observed (A). 
No staining was found using BSA as negative control under the same conditions in 
non-pregnant, 10, 14, 18 and 22 day rat myometrium (B). 
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Figure 5.24 Expression of H2S producing enzymes CBS and CSE in rat myometrium. 
Expression of CBS and CSE can be see using DAB staining in i) non-pregnant, ii)10 
day, iii)14 day, iv)18 day and v)22 day rat myometrium. 
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5.4.12 Expression of the CBS and CSE in the myometrium of non-pregnant, and 
term pregnant human myometrium- Immunohistochemistry 
The expression of the CBS and CSE, H2S production enzymes were examined by light 
microscope of DAB staining which is equivalent to CBS and CSE expression. Positive 
control beta actin as well as negative controls for non-pregnant  and term pregnant 
human myometrium are demonstrated in Figure 5.25C&D and Figure 5.26C&D, 
respectively, illustrating DAB staining in the positive controls and no staining in the 
negative controls. This shows that the staining is specific to either the CBS or CSE 
antibody depending on which antibody is used. A representative image of non-
pregnant and term pregnant human myometrium stained with CBS (n=6) and CSE 
(n=6) can be found in Figure 5.25A&B and 5.26A&B, respectively. Staining for both 
enzymes was present in both types of myometrium showing H2S could be produced 
in the myometrium.  
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Figure 5.25: Expression of CBS and CSE in non-pregnant myometrium as shown by 
immunohistochemistry. 
A) A representative image showing the expression of CBS in the myometrium of a 
non-pregnant  women, as shown by the brown DAB staining n=6 
 
B) A representative image showing the expression of CSE in the myometrium of  a 
non-pregnant women, as shown by the brown DAB staining n=6 
C) Positive control & D) Negative control 
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Figure 5.26: Expression of CBS and CSE in term pregnant myometrium as shown by 
immunohistochemistry. 
A) A representative image showing the expression of CBS in the myometrium of a 
term pregnant women, as shown by the brown DAB staining n=6 
 
B) A representative image showing the expression of CSE in the myometrium of a 
term pregnant women, as shown by the brown DAB staining n=6 
C) Positive control & D) Negative control 
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5.4.13 Expression of the H2S producing enzymes CBS and CSE in non-pregnant and 
term pregnant myometrium – Western Blotting 
To investigate whether the differences in the effect of H2S on human myometrial 
contractility is related to more than modifications to ion channels, the expression of 
H2S production enzymes CBS and CSE were investigated, this was also to help 
understand the physiological relevance of H2S in the myometrium.  
The quantification of CBS (Figure 5.27) and CSE (Figure 5.28) was performed in non-
pregnant and term pregnant myometrium. Western blotting was carried out from 6 
non-pregnant and 6 term pregnant women and the expression of each enzyme 
measured. A representative image of 2 term pregnant and 4 non-pregnant repeats of 
western blots for CBS is shown in figure 5.27. The expression of CBS was measured 
as a percentage of the actin loading control. As can be seen in figure 5.27 there was 
a significant reduction in expression of the CBS enzyme in the myometrium from 
term pregnant women (10.1%) compared to non-pregnant (100%) p=<0.05. A 
representative image of 3 repeats of western blots in non-pregnant and term 
pregnant myometrium for CSE is shown in figure 5.28. The expression of CSE was 
measured as a percentage of the actin loading control. As can be seen in figure 5.28 
there was also a significant reduction in expression of the CSE enzyme in the 
myometrium from term pregnant women (51.0%) compared to non-pregnant (100%) 
p=<0.05. 
Overall both the CSE and CBS H2S producing enzymes are present in the non-
pregnant and term pregnant human myometrium, allowing H2S production to occur, 
although both are down regulated in the term pregnant myometrium. 
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Figure 5.27. The expression of CBS H2S production enzyme in non-pregnant and 
term pregnant myometrium – Western Blotting  
 
A) A representative image showing the results of western blot for CBS in human non-
pregnant and term pregnant myometrial protein extracts. L is for liver and K is for 
kidney. 
 
B) Bar chart showing the significant reduction in CBS expression in the myometrium 
of term pregnant women. 
 
Relative 
intensity (%) 
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Figure 5.28. The expression of CSE H2S production enzyme in non-pregnant and 
term pregnant myometrium – Western Blotting  
 
A) A representative image showing the results of western blot for CSE in human non-
pregnant and term pregnant myometrial protein extracts. 
 
B) Bar chart showing the significant reduction in CSE expression in the myometrium 
of term pregnant women. 
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5.4.14 Expression of the H2S detoxifying enzyme – Western Blotting 
 
Contrary to what I thought, there was a down regulation of both H2S producing 
enzymes at term. The next question was whether there was an upregulation in H2S 
breakdown in non-pregnant women, which help to reduce the effect of H2S 
producing compounds on contractility? TST has been implicated in H2S breakdown. 
The quantification of TST was performed in non-pregnant and term pregnant 
myometrium. Western blotting was carried out on tissue from 5 non-pregnant and 5 
term pregnant women and the expression of the TST isoform of Rhodanese 
measured. A representative image of 5 repeats of Western blots is shown in figure 
5.29A for its presence in non-pregnant human myometrium and figure 5.29B for its 
presence in the term pregnant human myometrium. No detectable expression of 
this enzyme was present in the human myometrium of either non-pregnant or term 
pregnant women, however its presence was strong in the rat liver and kidney 
positive controls. The presence in the non-pregnant, 14 day, 18 day, and 22 day rat 
myometrium also showed no presence of TST (Figure 5.29C). 
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Figure 5.29. The expression of TST, H2S detoxifying enzyme in non-pregnant, term 
pregnant human myometrium and rat myometrium – Western Blotting  
 
 A representative image showing the results of western blot for TST in A) human 
non-pregnant, B) Human term pregnant and C) rat myometrial protein extracts. 
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5.5 Discussion 
This is the first study to investigate the effect of L-cysteine within the term pregnant 
rat and non-pregnant myometrium as well as to simultaneously measure force- 
calcium and underlying intracellular pH changes in response to L-cysteine. This 
chapter is also the first time the response to garlic has been looked at in the 
myometrium. The presence of H2S producing enzymes in non-pregnant myometrium 
as well as in the myometrium of different stage rat gestations have never been 
examined. Neither has the H2S detoxifying enzyme isoform TST been monitored in 
the myometrium. 
5.5.1 The effect of L-cysteine on myometrial contractility 
This study has shown that L-cysteine, a precursor of H2S produces uterine relaxation 
in term pregnant rat and human myometrium although effects were not as 
pronounced as those of GYY4137 or NaHS.  The decrease in contractility appeared to 
be dose dependent and was more pronounced in the human myometrium. At the 
highest concentration of L-cysteine 1mM there was a significant decrease in the 
force amplitude of myometrial contractions relative to control period. Similar 
relaxant effects have been reported in vascular smooth muscle (Hosoki 1997, Teague 
2002, Zhao 2009, Ohia 2010, d'Emmanuele di Villa Bianca 2009). A single study 
within the rat myometrium has presented similar effects in 19 day gestation rats 
(sidhu 2001). The data inside this chapter was performed on 22 day gestation 
pregnant rat (term) myometrium, along with this relaxation an increase in frequency 
and overall AUC was found. This response was established also in the term pregnant 
human myometrium. The only other study within human myometrium by You et al 
used cumulative administration of L-cysteine (10-7–10-2 mol/L) and found a dose-
dependent decrease in the amplitude of spontaneous contractions in non labouring 
and labouring myometrial strips. In addition to L-cysteine at high concentration (10-3 
mol/L), increased frequency of spontaneous contractions and sometimes a tonic 
contraction were also found (You 2011), in support of the results within the rat and 
human myometrial data demonstrated in this chapter. Other research on neonatal 
rat bladders illustrated this facilitation of contractions was also produced in the 
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presence of L-cysteine. Its effects were reduced by the use of L-type calcium channel 
blocking agent nifedipine and a calcium activated K+ channel opener (Buyu 
knacar,2010). 
In the non-pregnant uterus it was found that the application of L-cysteine showed 
similar excitation without the pronounced decrease in force amplitude, implying 
once again that the non-pregnant tissue seems more resilient to the diminished 
force caused by H2S. This maybe similar to the effect found when using NO donors, 
where NO production was found to be lower in non-pregnant myometrium possibly 
through some involvement of oestrogens (Kakui 2004). Also within NO research, as 
with H2S, CBS and CSE produces H2S from L-cysteine, so arginase metabolizes L-
arginine. NO production depends on the availability of L-arginine to NOS. It was 
found L-arginine decreased during 7th-21st day of gestation. However, the enzyme 
activity became significantly higher at term gestation (22 day) than that in the non- 
pregnant myometrium (Hirata 2006). Both factors may play a part in the reason for 
the difference in responses found to L-cysteine in non-pregnant and term pregnant 
myometrium.   
5.5.2 The mechanism of L-cysteine’s effects in the myometrium 
One potential mechanism of action is that H2S is produced from L-cysteine endogenously in 
uterine tissues, which relaxes the smooth muscle. This is a biochemical pathway 
documented (Abe 1996, stipanuk 1982) and involves two main enzymes, CSE and CBS. These 
enzymes have been shown to be present in rat myometrium by a functional study (Sidhu 
2001) and human myometrium (Patel 2009) and quantified in non-labouring and labouring 
human myometrium (You 2011) although within the non-pregnant versus the term pregnant 
myometrium, each enzyme’s presence has not been quantified, as discussed below. 
Intracellular L-cysteine concentrations are reported to be 30-200µM (Griffith 1987) with 
tissue levels as 10-100µM (cooper 1983). This illustrates that concentrations used for dose 
responses are within an adequate range.  
L-cysteine reduced contractions via decreased Ca transient amplitude, suggesting that it 
could affect L-type Ca channels, possibly by sulfhydration as is proposed to happen when 
KATP channels are affected within vascular smooth muscle (Tang 2010) and L-type calcium 
channels in cardiomyocytes (Zhang 2012). BayK 8644 data also shows a reduction in the 
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response to L-cysteine, pointing towards L-type calcium channels being targeted. No 
differences in the response to L-cysteine were found in high K+ suggesting membrane 
potential is affected. Intracellular calcium leading to contraction is controlled by a 
multitude of mechanisms beyond the classic entry through voltage operated calcium 
channels, calmodulin binding pathway. Alterations too many of the ion channels in 
the myometrium can have a profound effect on contractility. 
Researchers working on vascular smooth muscle have shown KATP channels are directly 
involved in the mechanism of H2S by increasing their open probability, most likely 
through S-sulfhydration of specific cysteine residues of the KATP channel, promoting 
outward K+ flow and hyperpolarization, to cause a decrease in contractility (Zhao 2001, 
Wang 2012).  This conclusion is largely based on the ability of glibenclamide, a KATP 
channel antagonist, to block the vasorelaxant effects of H2S (Zhao 2001, Cheng 
2004), in addition to electrophysiological experiments providing direct evidence that 
exogenous H2S increases KATP currents, blocked by glibenclamide in isolated rat aortic 
and mesenteric SMCs (Cheng 2004, Zhao 2001). KATP channels have been suggested 
as one of the targets of H2S that lead to reduced myometrial contractility using 
glibenclamide (Hu 2011).  In contrast, other studies showed that the KATP channels 
are not involved in H2S relaxation in smooth muscle tissues including vascular, 
bronchial, and gastrointestinal smooth muscle (Kubo 2007, Teague 2002, Lee 2007, 
Kiss 2008). Our data with glibenclamide in Chapter 4 would support a main role for 
these channels in the mechanism of H2S effects in the myometrium. This decrease in 
rat myometrial contractility could be inhibited by both CSE and CBS inhibitors, 
suggesting that endogenous H2S generated by CBS and CSE can modulate the 
contractility of human myometrium during pregnancy as found in non-labouring and 
labouring human myometrium (You 2011). 
Hydrogen ions are known to interfere with uterine smooth muscle contraction and 
both extracellular and intracellular pH changes have been found to effect 
contractility (Parrat 1995, Taggart 1997). All solutions were pH readjusted to 7.4, so 
a change in extracellular pH could not explain the relaxant effect of L-cysteine in the 
myometrium. D-Cysteine was found to have no effect on contractility, which 
suggests that the relaxation was not produced by a simple chemical effect. Although 
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application of by products of H2S production through use of L-cysteine by CSE and 
CBS, L-serine and sodium pyruvate, caused initial excitation with significant increase 
in force amplitude upon application of sodium pyruvate. This led to the testing of 
Intracellular pH upon L-cysteine exposure. A decrease in intracellular pH was 
illustrated. The initial changes in frequency and amplitude of contractions upon 
application of L-cysteine coincided with the period when pH was seen to change. 
This rapid increase in [H+]i may lead to this initial stimulation by displacing Ca
2+ from 
intracellular binding sites as protons and Ca2+ are known to compete for intracellular 
binding sites (Wray, 1998).  In contrast decreased intracellular pH using NaHS within 
rat aortic smooth muscle was related to the relaxation monitored (Lee 2007). This is 
the first study that has shown the effects of cysteine are seen even though there is 
an intracellular acidification and that an alkalinisation cannot explain the effects of 
cysteine.  
It is possible that NaHS, GYY4137 and L-cysteine have quite different mechanisms of 
action and therefore different potencies. L-cysteine could act as an agonist at amino 
acid receptors, as this is usually excitory, this could be also a target to produce the 
stimulation upon incubation of myometrial tissue in L-cysteine. This is something 
that could be further investigated. L-cysteine is thought to achieve its effect on the 
cell through the help of an excitory amino acid transporter subtype and possibly by a 
zwitter ion amino acid transporter subtype (EAAT3)(Zerangue, 1996) and possibly by 
a zwitterionic amino acid transporter (ASCT1)(Palacin 1998). Both of these 
transporters are widely distributed in tissues. Once inside the cell as H2S could be 
released enzymatically from L-cysteine and therefore L-cysteine could act as a direct 
intracellular donor H2S or HS-. Normally L-cysteine is transported into cells as cystine, 
which then splits into two molecules of cysteine, but it is possible that L-cysteine 
could be transported directly when applied extracellularly (Sidhu 2001).  
5.5.3 Effects of garlic  
H2S is produced naturally by garlic as well as from L-cysteine within human tissue. 
Here I found that the myometrial contractility changes of garlic were comparable to 
L-cysteine with initial stimulation in contractility, which then results in decreased 
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amplitude of contractions (something needed to be further investigated, shown in 
figure 5.20 A). Further work on Garlic power needs to be performed to investigate its 
effects. Although garlic oil produced through crushing garlic would be better to use 
as Allicin (diallyl thiosulfinate), the main organosulfur compound, is produced from 
the amino acid alliin by action of the enzyme alliinase when garlic is crushed. Allicin, 
unstable in aqueous solution, rapidly decomposes mainly to diallyl sulfide (DAS), 
diallyl disulfide (DADS), diallyl trisulfide (DATS), and ajoene (Amagase 2006).  It 
would also be of interest to look at active garlic derived polysulfide compounds, 
which are converted to H2S. This could help find a naturally occurring H2S compound 
to reduce contractility allowing the monitoring of different polysulfides active in 
garlic. Within vascular smooth muscle different polysulfides have been looked at and 
H2S production amounts monitored, DATS and DADS produce the greatest amount of 
H2S and cause the greatest relaxation in aorta (Benavides 2007), good candidates to 
further research garlic’s use on the uterus.  
Preliminary investigations show 0.714mg/ml and above concentrations of garlic 
show similar responses to L-cysteine with increased contractility although no 
significant changes in amplitude of contraction was found with low n numbers.
The frequency of myometrial contractions is directly related to changes in 
membrane potential and the frequency of burst or the increased frequency of 
contraction may also be attributed to faster repolarisation or recovery of the 
membrane to resting potential.  Further investigation is needed to examine these 
effects and mechanism found by the use of L-cysteine and garlic. Electrophysiological 
techniques such as voltage clamp could be used to measure the membrane potential 
of the smooth muscle cells in the presence and absence of L-cysteine and garlic to 
examine their effect on membrane potential. Overall in this chapter we find 
differences and similarities in myometrial contractility changes in response to L-
cysteine when compared to the response found through use of H2S producers NaHS 
and GYY4137. It would also be of interest to monitor H2S production using a 
polarographic electrode (Olson 2012), to compare the H2S produced by NaHS, 
GYY4137, L-cysteine and garlic and to assess whether the decrease in contractility 
was directly related to H2S production or an unidentified sulfide moiety.  
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5.5.4 Regulation of H2S production and breakdown in the myometrium. 
In the myometrium, Patel et al found the presence of both H2S producing enzymes in 
rat non-pregnant and 19 day gestation uterus as well as human term pregnant 
myometrium. You et al quantified the presence of both enzymes in term non 
labouring and labouring human myometrium at the protein and mRNA level as well 
as looking for their expression in sections, finding both present and during labour 
H2S enzymes are down-regulated. No work has been undertaken to look at the 
expression of both enzymes within different stage gestation rat myometrium or 
looked at the presence in non-pregnant human versus term pregnant myometrium. 
This chapter showed the expression of both the CSE and CBS enzyme in non-
pregnant, 14 day, 18 day and term pregnant rat myometrium as well as non-
pregnant and term pregnant human myometrium. This showed that the myometrial 
tissues assessed are able to produce H2S endogenously. Their presence was further 
defined through quantification of CBS and CSE in non-pregnant and term pregnant 
human myometrium via Western blotting. It was found that the presence of both 
enzymes was significantly decreased in the term pregnant myometrium, perhaps in 
preparation for the onset of labour as the enzymes further decline upon the onset of 
labour (You et al), allowing the production of H2S to no longer keep the powerful 
contractions at bay to cause labour.  
As I have found that H2S producers have more of an effect at term the question was, 
could the breakdown of H2S be higher at term when compared to non-pregnant 
human myometrium as clearly there are the tools to have a greater production of 
H2S in the non-pregnant myometrium although we see the effect at term. TST is the 
isoform of rhodanese implicated in detoxifying H2S in human colon (Ramasamy 
2006), however its presence has not been investigated in the uterus. I have shown 
clearly that in human non-pregnant and term pregnant human myometrium in 
addition to non-pregnant, 14 day, 18 day, term rat myometrium that it was not 
detectable and is not likely to be involved in H2S breakdown in the myometrium. This 
is not to say that the increased effects seen upon application of NaHS, GYY4137 and 
L-cysteine throughout gestation are not due to H2S removal rates as other enzymes 
may exist. Recently, mice lacking ethylmalonic encephalopathy 1 (Ethe1) exhibit 
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elevated sulphide levels, suggesting that Ethe1 is the sulphur dioxygenase involved in 
H2S metabolism (Linden 2012). Also could this affect be due to the up regulation of a 
SH- channel at term?  Recent work identified a channel permeable to HS− anions in 
the bacterium Clostridium difficile, although there is a long way to go and much 
research to be performed to elucidate the mechanism of H2S although perhaps such 
channels/ receptors are present in mammalian tissues (Czyzewski 2012).  
5.5.5 Conclusions 
L-cysteine causes an initial dose dependent increase in frequency and a decrease in 
amplitude of myometrial contractility in both term pregnant rat and human 
myometrium. The effect on frequency could not be explained by intracellular 
alkalinisation, as pH falls when L-cysteine is applied. The effects of L-cysteine are not 
as prominent as those upon incubation in GYY4137 or NaHS. The mechanism of the 
initial enhanced contraction frequency remains to be elucidated. The mechanism of 
L-cysteine inhibitory action on myometrial contractions is suggested to be due to 
corresponding decreases in the calcium transients, probably due to H2S production; 
CSE and CBS inhibition with PAG and AOAA prevented this decrease in contraction. 
In the human term pregnant myometrium the dose response of L-cysteine was more 
apparent than in rats with a log EC50 value approximately doubled, similar to the 
differences in NaHS and GYY4137 responses in non-pregnant and term pregnant 
tissues, reduced inhibitory effects of L-cysteine were found when applied to non- 
pregnant myometrium. Preliminary investigations show 0.714mg/ml and above 
concentrations of garlic show similar responses to L-cysteine with increased 
contractility although no significant changes in amplitude of contraction was found 
due to low n numbers. 
This chapter has also highlighted that both H2S enzymes are present within all the 
myometrial tissues tested within this thesis and that there is a down regulation of 
both enzymes at term. Also no presence of the H2S detoxifying isoform of 
rhodanese, TST, was found in rat or human myometrium. 
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5.5.6 Limitations of study 
 
 Low n numbers for sodium pyruvate, L-serine, Garlic powder work. More n 
numbers are required 
 
 Results using CBS and CSE inhibitors are limited due to their poor selectivity. 
 
 Garlic oil is more active and contains a greater content of polysulfides to 
produce H2S due to crushing garlic rather than drying in the case of garlic 
powder. Future work should use garlic oil. 
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Chapter 6- Final Discussion 
The aims of the work described within this thesis were firstly to characterise the 
non-pregnant human myometrial tissue samples to see how contractility changes 
with age, menopausal status or with the condition endometriosis, and then to 
examine H2S and its effects on myometrial contractility of human and rat tissue, 
using three H2S producing compounds, NaHS, GYY4137 and L-cysteine. In addition to 
investigating the mechanism by which H2S reduces contractility I also investigated 
any differences in response to H2S over gestation and thus its potential involvement 
in quiescence. The presence of H2S producing enzymes CBS and CSE were also 
explored to confirm that H2S could be produced within the myometrial tissues 
studied. My overall aim is to gain a better understanding of the role of H2S in the 
myometrium and to investigate its potential as a preterm preventative. I consider I 
have addressed and achieved many of my specific aims and that the work presented 
here has built on previous studies and highlighted the physiological relevance of H2S 
in the myometrium and its effects throughout gestation as well as in human 
myometrium.  
 
6.1 Characterisation of non-pregnant myometrium 
Myometrial contractility from pre-, and post-menopausal women as well as from 
women with endometriosis were compared.  The effect of advancing age on the 
non-pregnant myometrium was also addressed. The data demonstrated clear effects 
of age and menopausal state upon myometrial contractility. It shows that aging 
significantly decreases uterine contractility as does progressing menopausal state, 
which is not surprising as there is a strong relationship between the two.  
Endometriosis also shows an increase in frequency of contractions and a non-
significant but consistent decrease in the other parameters of contractility. 
Consistent with an earlier in vitro study which had found spontaneous activity in 
post-menopausal women, and earlier in vivo studies showing more frequent  
contractions within myometrium with endometriosis (Domali 2001, Bulletti 2002), 
these changes in the myometrial contractions of women with endometriosis could  
have a causal role in the genesis and continuation of the disease. 
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The reasons behind this impaired contractility may be related to alterations in 
calcium signalling in the post menopausal women and women with endometriosis. 
Reduced calcium transients are indicative of less calcium entry through L-type 
voltage calcium channels or perhaps alterations in the expression of L-type calcium 
channels. This is supported in the high K data within chapter 3, where High K+ 
contractions were reduced in the post menopausal women as well as a trend to 
decrease in women with endometriosis. Reduced muscle content could also be 
contributing to the reduced contractility, especially with advancing age. Further work 
needs to be performed to investigate this. 
Overall, contractions of the non-pregnant human myometrium were stable allowing 
for investigation of the effects of H2S compared with the term pregnant human 
myometrium. Therefore pre-menopausal women were used as the non-pregnant 
myometrium in chapters 4 and 5. 
 
6.2 The effect of H2S producers NaHS and GYY4137 on myometrial contractility 
The effects in rat and human myometrium were studied and I found that: i) GYY4137 
causes a concentration-dependent reduction in contractility of myometrium, ii) The 
ability of H2S to inhibit contraction is not constant but rather is greatest close to term 
before disappearing during labour  iii) GYY4137 and NaHS significantly reduced 
contractility in pregnant but not non-pregnant human myometrium,  iv) H2S  
significantly reduced tonic force produced by high-K  depolarization and oxytocin-
stimulated contractions, and v) GYY4137 reduced the intracellular Ca transients 
underlying contractions and inhibition of KATP channels prevented the effects of 
GYY4137.  A recent study supported the reduced effects of H2S upon labour in the 
human labouring myometrium in response to L-cysteine (You 2011). Other research 
also found NaHS reduced contractility of human term labouring myometrium and that 
the effects found were abolished in the presence of glibenclamide supporting the data 
found in this thesis at term (Hu 2011). No significant effects on contractions in the non-
pregnant tissue to addition of either H2S source were found, but clear effects were seen 
by mid-gestation. The inhibitory effect on contraction then further increased until term. 
These data suggested that the relaxant effects of H2S were increased as pregnancy 
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advances. The most striking effect however was the abrupt transition upon labour; H2S 
was without effect as seen by the data for both compounds. This suggests that H2S 
contributes to uterine quiescence in late pregnancy and that the myometrium can 
rapidly change its responses to H2S, perhaps through changes in H2S removal rates or 
channel susceptibility to sulfhydration.   
Studies were limited by the lack of a compound to better mimic the endogenous 
release of H2S in cells. The commonly used NaHS or Na2S release H2S instantaneously in 
aqueous solutions, producing very large and transient increases in its concentration. 
GYY4137’s potential as a slow-releasing H2S compound with effects on vascular smooth 
muscle in vitro and in vivo were shown, its time scale of H2S production measured and 
its lack of toxicity to aortic cells shown (Li 2008). Subsequent work has supported low 
toxicity (Yu 2010) and also indicated anti-cancer properties (Lee 2011), anti 
inflammatory activity (Li 2009), and anti apoptotic (Lavu 2011) activity of GYY4137. 
Thus GYY4137 or subsequent compounds, (Predmore 2012) may well be suitable for 
a variety of patho-physiological conditions, including tocolysis in threatened preterm 
labour, i.e. to stop the onset of labour,  although further work, including studies on 
labouring samples, are needed to develop this suggestion.  
Recently, H2S releasing drugs are an active area of research as these molecules have 
such benefits as suppressing breast cancer cell support for osteoclastogenesis and 
prevent osteolysis (Frantzias 2011), prevention of smooth muscle cell proliferation in 
diseases such as atherosclerosis and vascular restenosis (Baskar 2008) to anti 
inflammatory and anti cancer properties (Kodela 2012, Chattopadhyay 2012). Other 
drugs investigated include naturally occurring H2S producing agents such as DATS 
produced by garlic, which readily vasodilate rat aortas (Benavides 2007) and 
Sulforaphane, the isothiocyanate compound from broccoli, which has shown 
neuroprotective and anti inflammatory actions (Jackson 2007, Shan 2010,  Zhu 
2008). I speculate there will be further research and more slow releasing H2S 
molecules to come to help benefit therapeutically and give insight into the 
physiological roles of H2S. Interestingly, sulfide sensitive dyes similar to the well 
known ion-sensitive dyes such as the calcium reporter Indo-1 are currently being 
developed as to date they lack sensitivity, these molecules would resolve many of 
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the key questions regarding H2S signalling mechanisms (Lippert 2011, Qian 2011, 
Olson 2012), this further demonstrates H2S and its releasing compounds are an 
active area of research. 
My data and that of previous studies suggest H2S could contribute to uterine 
quiescence and that increasing its level in myometrium could be an attractive target 
for therapeutics to inhibit the onset of labour.  Increased understanding of the 
mechanisms for transition to labour should also follow from obtaining a better 
understanding of H2S in the myometrium. 
6.3 The effect of H2S producing enzyme substrate, L-cysteine 
L-cysteine at 1 mM, caused an initial increase in the frequency of uterine 
contractions, but a decrease in amplitude of myometrial contractility in both term 
pregnant rat and human myometrium. The effect on frequency could not be 
explained by intracellular alkalinisation, as pH falls when L-cysteine is applied. The 
effects of L-cysteine are not as prominent as those upon incubation in GYY4137 or 
NaHS. The mechanism of the initial enhanced contraction frequency remains to be 
elucidated. The mechanism of L-cysteine inhibitory action on myometrial 
contractions is suggested to be due to corresponding decreases in the calcium 
transients, probably due to H2S production; CSE and CBS inhibition with PAG and 
AOAA prevented this decrease in contraction. In the human term pregnant 
myometrium the dose response of L-cysteine was more apparent than in rats with a 
log EC50 value approximately doubled. Similar to the differences in NaHS and 
GYY4137 responses in non-pregnant and term pregnant tissues, reduced inhibitory 
effects of L-cysteine were found when applied to non-pregnant myometrium.  
 
6.4 Mechanism of H2S in the myometrium 
There are many suggestions for the mechanism by which H2S exerts its effects and it is 
likely that there will be many targets (Li 2011).  The main mechanism  appears to be 
due to H2S modifying cysteine residues in many proteins through S-sulfhydration 
(Mustafa 2011) i.e. cysteine’s covalent modification by which -SH groups on  cysteine 
residues of a protein are converted to –S-SH, via addition of  sulphur from H2S 
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(Mustafa 2009). The data in this thesis using DTT, a reductant sulfhydryl modifier and 
Diamide, an oxidant sulfhydryl modifier supported this showing that firstly free 
sulfhydryl groups have no effect on contractility and that disulphide bonds cause a 
similar effect to NaHS and GYY4137.  Although it would be interesting to see whether 
using DTT could reverse GYY4137 and NaHS effects on force and calcium as in Zhang et 
al 2012 where it could markedly reverse the H2S donor-induced inhibition of I Ca, L (L-
type calcium current) in cardiomyocytes. Illustrating that if H2S targets the crucial 
free-sulfhydryl groups on the L-type Ca2+ channel and inhibits the L-type calcium 
current, the inter-chain disulfide bond linkages would be rapidly reduced by DTT, 
and therefore the inhibition would be reversed (Zhang 2012). 
The most documented effect of H2S is on KATP channels within smooth muscle. In 
vascular smooth muscle cells H2S stimulated single-channel activity of KATP channels 
by directly increasing their opening probability (Wang 2012).  Recent work has made 
progress in identifying which residues in the channel are affected by H2S, with Cys 6 
and 26 on the extracellular N terminal of the SUR1 subunit of the channel being 
identified (Jiang 2010). KATP channels have been suggested as one of the targets of 
H2S that lead to reduced myometrial contractility (Hu 2011).  The data with 
glibenclamide would support a role for these channels in the mechanism of H2S in 
the myometrium, as GYY4137 had no significant effect on myometrial contractility 
when KATP channels were blocked with glibenclamide.   
The data within this thesis also suggested that L-type Ca2+ entry was reduced by H2S 
sources. Reduction of Ca2+ by H2S has previously been demonstrated in non-contractile 
arterial segments (Tian 2012) but had yet to be shown in the myometrium. My 
simultaneous measurements of intracellular Ca2+ and contractions show a H2S-
dependent reduction in intracellular Ca2+ accompanies the decrease in amplitude of the 
phasic contractions. Also when BayK 8644, a calcium channel opener is used in the 
presence of L-cysteine to produce H2S, reduces the reduction in contractility also 
pointing towards L-type calcium channels being targeted. L-type Ca2+ channels have 
also been shown to contribute to H2S effects, possibly by sulfhydration as proposed 
to happen when KATP channels are affected within vascular smooth muscle (Tang 
2010) and L-type calcium channels in cardiomyocytes (Zhang 2012). There is now 
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mounting evidence that the L-type Ca2+ channels themselves are targets of H2S. Sun 
et al, (Sun 2008) in cardiac myocytes were the first to show that H2S can inhibit L-type 
Ca2+ channels. Recently others have shown inhibition of these channels by NaHS also 
occurs in vascular smooth muscle (Tian 2012, Al-Magableh 2011) and Zhang et al  
(Zhang 2012) have gone on to show that this is dependent upon the protein sulfhydryl 
state of the channel. 
The above gives insight into the mechanism of action of H2S but does not explain the 
reasons for susceptibility changes over gestation. My suggestions include (i) increased 
vulnerability to sulfhydration of L-type calcium channels as L-type calcium channel 
subunits increase toward term (Collins 2000); (ii) reduction in kir6.1 and 6.2 KATP 
subunits once myometrium is labouring, as  before labour H2S exerts its effects on 
these subunits  (Xu 2011); (iii) up regulation of the H2S breakdown enzymes with 
gestation, or (iv) changes in uterine environment with labour, such as hypoxia an pH 
changes, (Quenby 2004, Wray 1992) may result in faster breakdown of H2S, but this 
remains controversial, (Olson 2012, Doeller 2005).  The lack of specific inhibitors of 
these enzymes and the difficulty of accurately measuring H2S in tissues, hinders further 
study of these last two points. 
 6.5 Expression of H2S production enzymes in the myometrium 
Within this thesis H2S producing enzymes CBS and CSE were expressed in non-
pregnant, 10 day, 14 day, 18 day, and term pregnant rat myometrium as well as in 
non-pregnant and term pregnant myometrium. This showed that H2S can be 
produced endogenously within the tissues assessed. Both enzymes have already 
been shown to be expressed in term non-labouring and labouring human 
myometrium in addition to 19 day gestation rat myometrium (Patel 2009, You 2011). 
Here we have also shown through quantification of the CBS and CSE enzymes that 
there is a down regulation of both enzymes within the term pregnant human 
myometrial tissue when compared to the non-pregnant human myometrium. This 
could be in preparation for the onset of labour as the enzymes are further declined 
upon the onset of labour (You et al), allowing the production of H2S to no longer 
keep the powerful contractions at bay to cause labour. In addition H2S production is 
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also found to be lower in labouring compared to non-labouring human myometrium 
(You 2011).  
6.6 Expression of H2S detoxifying enzyme TST 
TST is the isoform of rhodanese implicated in detoxifying H2S in human colon 
(Ramfrez 2004), however its presence has not been investigated in the uterus. I have 
shown clearly using Western blotting that in human non-pregnant and term 
pregnant human myometrium in addition to non-pregnant, 14 day, 18 day, term rat 
myometrium that it is not detectable, this is supported by TST being present in 
positive controls. A Western blot using increasing quantities of myometrial protein 
up to 100μg was also performed further demonstrating no detectable presence of 
the enzyme TST (not shown).  This makes it highly likely that TST is not involved in 
H2S breakdown in the myometrium although this is not to say other H2S breakdown 
enzymes such as sulfur dioxygenase enzymes may be present.  
I found in this thesis that there was greater inhibition of contractility at term in the 
presence of H2S producers, but that H2S producing enzymes are up regulated in the 
non-pregnant myometrium compared to the term myometrium. Thus the non-
pregnant uterus has the potential to produce H2S, but it does not affect contractility, 
at least under my experimental conditions. The question was, could the resistance 
against H2S effects be due to an up-regulation in H2S removal rates?  However as my 
data on TST were negative, it was not possible to further test this suggestion. 
Recently, mice lacking ethylmalonic encephalopathy 1 (Ethe1) exhibit elevated 
sulphide levels, suggesting that Ethe1 is the sulphur dioxygenase involved in H2S 
metabolism (Linden 2012), this enzymes presence in the myometrium could be 
investigated.  
 
6.7 Future work 
There are several subsequent studies that could be pursued following my work: 
The finding that post menopausal and old age cause reduced myometrial 
contractility could be further explored by examining the potential mechanisms that 
could be affected. Through monitoring changes in underlying calcium transients 
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using simultaneous force and calcium measurements using calcium sensitive 
indicator Indo-1. It would also be of interest to monitor changes in the expression of 
L-type calcium channel to see if there is a down regulation in the post menopausal 
and older age group. A reduction in L-type calcium channel expression has been 
shown to be linked with the decreased force produced in the diabetic myometrium 
(Al-Qahtani 2011). In the laboratory reduced muscle content in diabetic women was 
also found, a potential factor that could ultimately contribute to the poor 
contractility found in chapter 3, especially with advancing age.  Also working on 
further endometriosis samples would define the contractility better especially 
increasing the n numbers in the ‘no medication’ group. I could also test the 
hypothesis that ageing myometrium can respond to hormonal treatment and retains 
the ability to increase its strength. It would be interesting to look at the effect of 
different medications the non-pregnant women were on and compare contractility 
differences also once n numbers are increased. Likewise a comparion could then be 
made between Progestagen treated non- pregnant myometrium and pregnant 
myometrium to see possible similarities. 
It would also be worth monitoring the changes in H2S production over gestation and 
looking at the difference in H2S production from the H2S producers NaHS, GYY4137 
and L-cysteine used within this thesis. Using either analysis of H2S evolution into 
headspace gas and subsequent gas chromatography which has been used to 
measure both tissue and plasma H2S in the nanomolar range (Furne 2008, Levitt 
2011) or the well-known method of measuring thiols by derivatization with excess 
monobromobimane (MBB) and subsequent measurement of the stable sulfide-
diamine product with reverse phase high pressure liquid chromatography (HPLC) 
coupled with fluorescence detection, recently used to measure plasma H2S levels at 
the nanomolar range (Shen 2011, Wintner 2010). A good review of the H2S 
monitoring techniques was published by Olson 2012 concluding that there appears 
to be a lack of sensitivity to measure endogenous H2S at submicromolar levels and in 
real-time. This will give insight into H2S and its production throughout pregnancy and 
maybe confirming its involvement in quiescence. It would also be important to look 
at the effect of NaHS and GYY4137 on human labouring tissue to see whether the 
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effect seen in the rat can be related to the human. As well as investigating the 
effects of both H2S producers invivo and on the fetus using the rat model to help 
understand more clearly their side effects and potential use in pregnancy. 
L-type calcium channels have been implicated in the mechanism of H2S within this 
thesis. In non-contracting (butanedione monoxime treated) cerebral artery, Tian et al, 
used fluo-4 and showed decreases in Ca2+ levels as NaHS was increased from 0.1 to 1 
mM, and suggested  that NaHS relaxes these vessels by reducing L-type Ca2+ current. A 
recent study using cardio myocytes suggested, H2S inhibits L-type [Ca
2+] channels 
through sulfhydration, as NaHS decreased the functional free sulfhydryl groups in 
the channels (Zhang 2012). To further demonstrate the effect of H2S on L-type 
calcium channels in the myometrium, I could monitor the function free sulfhydryl 
groups in the myometrial tissue protein extract of a control incubated and H2S-
producer incubated tissue then using a biotin switch assay as used in Zhang 2012 
monitor any difference in functional free Sulfhydryl.  
KATP also play a role in the reduction in contractility of term myometrial tissue shown 
through use of glibenclamide a KATP blocker. To confirm if H2S affects membrane 
potential through KATP channels, patch clamp studies could be used to see how much 
the membrane hyperpolarises after exposure to H2S producers as examined in 
vascular smooth muscle (Zhao 2001). 
H2S producing enzymes CBS and CSE were expressed in non-pregnant, 14 day, 18 day 
and 22 day (term) rat myometrium. This could be further investigated through 
protein quantification via use of Western blotting to see whether there are any 
changes in the production over gestation implicating H2S in the mechanism of 
quiescence. 
TST the H2S detoxifying isoform of the enzyme rhodanese. This is not present within 
the uterus. Other breakdown mechanisms maybe involved such as ethylmalonic 
encephalopathy 1 (Ethe1) which is a sulphur dioxygenase enzyme involved in H2S 
catabolism as mice lacking Ethe1 exhibit elevated sulphide levels (Linden 2012). 
Naturally producing H2S compounds may be of use therapeutically, these include 
garlic derived poly sulphides already implicated to reduce cardiovascular risk. Human 
red blood cells convert garlic-derived organic polysulfides into H2S (Benavides 2007). 
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Diallyl disulfide (DADS), and Diallyl trisulfide (DATS) are the highest producing H2S, 
garlic-dervied polysulfides producing approximately 35 and 100 µM H2S, respectively 
on the addition of 100 µM of each polysulfide (Benavides 2007). There effect on the 
myometrium could be of interest because if a reduction in contractility is found they 
could help to reduce the onset of labour within threatened pre-term births. The use 
of garlic oil which produces these polysulfides when crushed would a better 
compound to perform experiments with as garlic powder is dried rather than 
crushed and does not retain the activity of the polysulfides. 
 
The investigation of intact tissue RNAi technique, reversible permeablisation to 
deliver SiRNA (Morgan 1982, Lesh 1995) was investigated as a potential useful 
technique for use in the uterus over the period of studying for my PhD. Preliminary 
experiments using Indo-1 pentapotassium salt (cell-impermeable calcium sensitive 
indicator) were performed (Figure 6.1).  
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Figure 6.1: Reversible permeabilisation of 22 day gestation rat myometrial strips. 
Figure A demonstrates the presence of cell impermeable Indo-1 inside the myocytes 
showing successful permeabilisation. The scale bar (white) in the right hand corner 
of the picture corresponds to 50µm. Figure B shows the contractility before and after 
treatment and the indicator emission ratio confirming some cells were successfully 
reversibly permeabilised.  
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Under the reversible permeabilisation technique, signalling will only be present if the 
cell impermeable Indo-1 manages to enter the cell and is cleaved by esters enabling 
it to bind to calcium and fluoresce. One problem with examining calcium signalling of 
reversible permeabilised strips is that the period of time the incubations occur over 
allows Indo-1 to enter and escape from the permeabilised membrane. Hence the 
indo fluorescent signalling may not be very strong. Considering this, pregnant tissue 
was dissected thinly and tested for contractility. Once 20 minutes of contractions 
occurred, the strips were incubated firstly in a solution containing EGTA, ATP and 
MgCl2 to permeabilise the tissue and then increasing concentration of MgCl2 was 
used to increase the permeability of the cell membranes. Following this, cell- 
impermeable calcium sensitive indicator, Indo-1 was introduced to the tissue and 
after this the holes in the membrane were closed using increasing concentrations of 
calcium in the presence of NaCl. This shows antagonism exists between Mg and Ca 
ions and alterations of the surface layer of cells which regularly accompanies 
changes of irritability, initiates changes in permeability (Gellhorn 1930). The 
contractility of the strip after treatment was tested as well as the presence of cell 
impermeable Indo-1 which is illustrated in figure 6.1. This figure shows that under 
the conditions of the reverse permeabilisation, contractility still occurred. The 
contractions post treatment were more regular and smaller in amplitude (Figure 
6.1A). Changes in indicator emission, which indicates the change in intracellular 
calcium, is shown in figure 6.1B suggesting that some smooth muscle cells were 
successfully loaded. 
This technique could possibly be used to knockdown ethe-1 a potential H2S 
breakdown enzyme, if present within the uterus, to monitor whether the same 
responses to H2S- producers are found throughout gestation and implicate a role for 
this enzyme in the breakdown of H2S in the myometrium.  
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6.8 Final Conclusions 
The key findings demonstrated in this thesis are: 
 Changes in contractility of the non-pregnant myometrium can be attributed 
to menopausal state, age or condition 
 A progressive decline in contractility over gestation in response to H2S 
producers GYY4137 and NaHS up until labour onset, an effect rapidly 
reversed as labour starts. A decrease was also found from non-pregnant to 
term human myometrium. 
  H2S effects involved both KATP channels and L-type Ca channels.  
 GYY4137 and L-cysteine reduced the intracellular Ca transients that underlie 
spontaneous contractions.  
 H2S producing enzymes have been shown to be down regulated at term 
perhaps in preparation for labour onset.   
Therefore my data and that of previous studies suggest H2S could contribute to 
uterine quiescence and that increasing its level in myometrium could be an 
attractive target for therapeutics to inhibit the onset of labour in threatened pre-term 
pregnancies perhaps via use as a gel or pessary.  
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